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Abstract 
Background: Breast cancer is considered the most widely spread cancer in Palestine and 
worldwide, it is being claiming the lives of hundreds of thousands of women each year and 
affecting countries at all levels of modernization.  
Objectives: This study aims to evaluate the management process of breast cancer in the 
Gaza Strip that affect in diagnosis and treatment processes serving breast cancer patients in 
the Gaza strip, to decrease the gaps in breast cancer management in order to decrease 
morbidities and mortalities that happened in addition to help health care providers and 
policy makers to formulate strategies for effective breast cancer management. 
Methodology: The study is triangulated, descriptive and cross sectional one that was 
conducted in order to evaluate the breast cancer management in the Gaza strip. The 
qualitative data included interviews with key informants as well as focus groups and life 
histories with breast cancer patients. The quantitative data was represented by four 
checklists that identified the number of the available health workforce, available beds and 
rooms for patients, diagnostic equipment and facilities and checking the completeness of 
breast cancer patients files.  
Results: The results of the study revealed that there are gaps and barriers facing breast 
cancer management in the Gaza Strip starting from patient chief complain, diagnosis 
process, and available treatment. Most of gaps and barriers are represented in inadequate 
health care human resources specially (oncologists in Gaza it equals (7) which represent 
about 0.4 per 100,000, pathologists (5) which represent about 0.3 per100,000, 
psychologists (1) which represents 0.05 per 100,000 and there is no any nutritionists), 
inappropriate infrastructure of oncology buildings with poor privacy, comfort and 
ventilation and deficiencies in necessary diagnostic equipment and supplies. Moreover, 
prolonged waiting times for patients. In addition, the results showed that there are gaps in 
referral systems between health facilities and health services abroad. Regarding the 
prevention and screening services for breast cancer, there is no any regular sustainable 
prevention programs for breast cancer except activities for screening. Breast cancer 
diagnostic services are facing many barriers and challenges that impede the early diagnosis 
of breast cancer. Some of crucial diagnostic facilities are very limited or unavailable in 
which are necessary for diagnosis as MRI, CT, PET scan, Gamma Camera, Linear 
accelerator, mammograms, tumor marker test, and other factors related to poor awareness 
of patients, cultural factors, physician and health system role. Regarding treatment options 
for breast cancer, there are several obstacles and barriers that affect negatively on the 
quality and completeness of care such as frequent shortages and interruptions in essential 
chemotherapy medications, and radiotherapy treatment is not available which consider one 
of the main treatment option for breast cancer patients, moreover there is no specific center 
for palliative care in Gaza. The information system, patients medical records and cancer 
registry are also facing many gaps. All of the previous factors affect negatively on the 
overall management process and quality of the health services provided to breast cancer 
patients. 
Recommendations: The study recommended enhancing policies for breast cancer 
prevention, screening and management. In addition, to improve the infrastructure of both 
facilities and human resources for breast cancer management. The study also 
recommended the importance of improving the communication and coordination between 
health facilities. Improving and enhancing palliative care for breast cancer patients. In 
addition to improve the available information system, cancer registry and using ICD-O3 
and for further research studies related to breast cancer management and control. 
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1 Chapter One 
1.1 Introduction 
Breast Cancer (BC) is one of the most commonly occurring cancers in females not 
only in Palestine but also all over the world, according to the American Cancer Society 
(ACS). Breast cancer represent 25 percent of all new cancer diagnoses in women 
universally (ACS, 2016). In 2012, nearly 1.7 million new cases were diagnosed worldwide. 
It‘s one of the Non-Communicable Diseases (NCD) that form biggest challenges and major 
public health problem that most countries especially the developing countries face 
(Younes, 2015). Breast cancer cases have been an obvious increasing over the last decade, 
bringing with it significant burden on women and a severe impact on morbidity, mortality 
and the quality of life for women and their families (UNFPA, 2018).  
In the other side, most of cases are diagnosed in late stages which increase the burden of 
the disease and the outcome of treatment given is therefore unsatisfactory. Since no 
effective primary prevention is presently possible, efforts should be made to detect the 
disease in its early stages to decrease morbidity and mortality. It is also the leading cause 
of cancer-related deaths in low-resourced countries. Causes of breast cancer are still 
unknown, but studying some of the risk factors continues to be significant in many 
epidemiological studies. The incidence of breast disease and mortality rates is increasing. 
Breast cancer could either occur by chance or by multiple factors including lifestyle, 
environmental and hormonal factors. Some of these factors are not modifiable such as 
gender and age. The reason that breast cancer is also rare in men suggests directly an 
influence of sex steroid hormones. According to the registry center in Gaza Strip, the 
incidence of breast cancer is 18 per 100,000 population making it the most prevalent type 
of cancer (20.5%). The Palestinian health ministry reports showed that 60% of women in 
Gaza Strip were diagnosed in late stages after the disease had already spread to other parts 
of the body. In particular, 42.2% of these cases the disease had spread to the lymph nodes 
at the time of diagnosis. Tumors in the Palestinian women tended to be large, as they are 
detected late by physical examination and not by screening mammography (Odeh, 2011). 
Recently, medical treatment has developed significantly which helped in cancer treatment. 
After long years of struggling with various cancers, medical care providers are now 
becoming more aware and oriented of the causes of these diseases, how to be diagnosed, 
treatment options and what it can be prevented. Breast cancer, remains one of the major 
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priorities and concerns in the medical field, mainly because it has multiple, risk factors and 
affect a large number of women (Odeh, 2011). 
In this study the researcher aims to evaluate the management process of breast cancer 
patients that help in diagnosis and treatment process in addition to services serving breast 
cancer patients in Gaza strip, to decrease the gap in breast cancer management in order to 
decrease morbidities and mortalities that happened from breast cancer and to help health 
care providers and policy makers to formulate strategies for effective breast cancer 
management. 
1.2 Problem statement 
Breast cancer is considered the most common type of cancer among women both in the 
developed and developing countries. Globally, cancer diseases are considered as one of the 
most important health problems in all over the world for its high incidence, cost, and 
mortality. In Palestine, over the last decade, breast cancer has increasingly been a 
significant public health and policy concern, as large number of Palestinian women were 
diagnosed and died from breast cancer as consequence it causes the highest cancer-related 
mortality in Palestinian women, 23.2% of all female deaths from cancer. Breast cancer 
reached a rate of 11.2% of deaths caused by cancer in Palestine (MOH, 2016). In the Gaza 
Strip the number of breast cancer cases was 684 a rate of 20.5% of all cancers and 36.9% 
from female cancers and incidence rate 18/ 100,000 from all population, MOH health 
system is fragmented and facing many gaps and challenges that imped its tasks in 
providing the appropriate services for cancer patients. Moreover health services that are 
used in breast cancer management are insufficient or not available like (radiotherapy, 
chemotherapy, Positron emission tomography (PET) scan, and plastic surgeries post 
mastectomy and palliative treatment). 
This problem is triggered by the presence of economic crisis, and political instability in 
addition that there is no clear referral system is used for cancer patients. Moreover, 
protocols and management plans that are used in breast cancer management are fragmented 
and facing challenges and barriers that affect negatively in the management process, in 
addition to that there is no previous studies were done about the evaluation of breast cancer 
management services. Most of studies that done for studying risk factors and survival 
analysis for breast cancer. For that, this study will be the first study to evaluate the 
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available strategies and provided services for breast cancer management in order to provide 
baseline for future improvement to enhance the quality of life for breast cancer patients. 
1.3 Justification  
Health care services that are provided for all patients should be sufficient with high quality 
especially for cancer patients, due to their complicated situations and long management 
journey. The last reports which studied the health status in the Palestinian Territories 
presented by National or international institutions showed that there is an obvious marked 
increase in the number of morbidities and mortalities related to breast cancer (MOH, 
2016). In addition there is no accurate or reliable data that reflects the current quality of 
care provided for breast cancer patients in Gaza strip (Abed, 2007). This study is 
considered the first kind of studies that is conducted in Palestine regarding evaluation of 
breast cancer management for that, this research will add valuable information, knowledge, 
benefits to the researcher himself, health system, patients, government and the community. 
Breast cancer is very hard to be treated completely if patients are diagnosed in late stages 
in addition to the current political situation in the Gaza Strip which characterized by siege, 
shortage of a lot of essential drugs and limited resources and research all these factors slow 
the management process of breast cancer. A multidisciplinary evaluation should be applied 
to enhance patients quality of life and increasing survival rate. In addition, to have a good 
health we should have a strong breast cancer management program that will prevent, 
protect, detect early breast cancer cases in all population, moreover to manage and promote 
a holistic and high quality care for all breast cancer patients. 
 So this study is conducted to evaluate the available strategies and management services for 
breast cancer management in the Gaza strip to help heath care providers and stakeholders 
to identify and treat gaps and weaknesses in the available management strategies in 
addition to promote a plan to improve and strengthen the quality of provided breast cancer 
services in the Gaza Strip. This enhance to decrease morbidities and mortalities rates in 
breast cancer patients, moreover enhancing the quality of life for breast cancer survivors. 
In addition, this study may provide guidelines for other researchers to conduct other studies 
in this field and give suggestions or highlights about improving the quality of breast cancer 
services. 
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1.4 Aim of the study  
The aim of this study is to evaluate the current strategy for breast cancer management. This 
study may help us to identify the weaknesses and gaps in the management strategy that 
may enhancing to decrease mortality and morbidity and improve health-related quality of 
life for patients, in addition to provide the policymakers with recent evidence based 
information that may be helpful to correct any under or mal-performance and rank their 
priorities.  
1.5 General objective 
To evaluate available strategies and health care facilities serving breast cancer patients and 
challenges- barriers for service provision in the Gaza Strip. 
1.6 Specific objectives 
 To identify management strategies for breast cancer patients in the Gaza strip 
 To assess management protocols for breast cancer patients in the Gaza strip. 
 To assess availability of management facilities for breast cancer patients in the 
Gaza Strip 
 To develop recommendations that will help in developing management process of 
breast cancer patients. 
1.7 Research Questions  
1. Do we have a functional written strategy to control breast cancer? 
2. Is the available action plan for prevention, early detection, diagnostic and treatment 
adequate and acceptable? 
3. To which extent the managers involved in controlling the breast cancer are aware 
of the breast cancer control strategy in the Gaza Strip? 
4. What are the actual implemented activities to control breast cancer disease in the 
Gaza strip? 
5. Does the available oncology services buildings meet the expectations of medical 
staff and breast cancer patients? 
6. Are there adequate supportive and palliative care services for breast cancer 
patients? 
7. Do breast cancer patients have positive attitude and perspective about the provided 
health care services? 
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8. Is the internal reporting adequate and accurate in estimating the incidence of 
morbidity and mortality and if it is helpful tools in recourses distribution? 
9. What are the appropriate, feasible, economic, suggestions for possible 
improvements in the provided health care services for breast cancer patients? 
10. Are there any obstacles in the internal referral, and coordination between services 
serving breast cancer patients? 
1.8 Background 
1.8.1 Geography 
Geographically, Occupied Palestinian territories is Palestine but due to the current political 
situation it includes two main separated areas which are: the West Bank and Gaza Strip. 
West Bank constitutes an area of 5,655 Km2 west to the Jordanian river, Gaza Strip is one 
of the most densely populated area in the world with an area of 365 Km2 with total area of 
27.009 Km2(Annex No.1) (PCBS, 2017). Most Gaza Strip population are concentrated 
mainly in cities, small village and eight refugee camps  distributed in different areas in the 
Gaza Strip which contain two third of the population, however in West Bank more than 
half of the population lives in approximately 400 villages and rural refugee camps. Gaza 
Strip is considered one of the weakest economic situation areas compared with the 
neighboring areas, which affect negatively in public health and all other aspects of life. 
Gaza Strip had two main ports for patients referral when the treatment options are not 
available in Gaza which are Rafah crossing port and Erez Crossing points.  
1.8.2 Demography 
The last report of the Palestinian Central Bureau of Statistics (PCBS) mentioned that the 
estimated population of Palestine was 4.78 million by the end of the year 2017, which 
distributed as the following: 1.9 million in the Gaza Strip and 2.8 million in West Bank 
(PCBS, 2017). The population distribution shows that there are higher percentage of 
population which constitutes 58.6% live in the northern governorates (West Bank) and 
39.7% in the southern governorates (Gaza Strip). Population distribution by sex shows that 
there are slight differences between males and females, 50.8% of the population is male 
and 49.2% is female (PCBS, 2017). 
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1.8.3 Life expectancy and mortality 
In the last year, the improvement in the health conditions was increasing in Palestine and 
the gradual decline in infant, child mortality rates and maternal mortality, life expectancy 
has increased. A report was published in 2016 shows that the life expectancy for 
Palestinian people is 73.7 years in general, but males had lower life expectancy rates than 
females which is 72.1 years for males and 75.2 years for females, with variations between 
West Bank and Gaza Strip. In West Bank is slightly higher than in the Gaza Strip, it was 
74.0 years; 72.4 years for males and 75.5 years for females. In Gaza Strip, life expectancy 
was 73.1 years; 71.5 years for males and 74.6 years for females (PCBS, 2017). 
1.8.4 Health and Health Care System  
 MOH report (2016) reveals that cardiovascular disease is considered the main leading 
cause of deaths in Palestine, which constitutes 30.6% of total deaths in 2016, followed by 
cancer reported with percentage 14.0% from total deaths in Palestine (MOH, 2016). Health 
care system in Palestine is still fragmented and facing many gaps that impeding its 
functions, because of multiple health care providers it leads to numerous challenges in 
providing a well-organized services with high quality in all moments normal or 
emergencies times(Health & Assessment, 2014). In Palestine there are four major health 
care providers which include: the ministry of health (MOH) which consider the main 
health services provider in the Gaza Strip followed by United Nations Relief and Work 
Agency (UNRWA), non-governmental organizations (NGOs), and private for-profit 
providers. MOH provides holistic services for populations including primary, secondary 
and tertiary health services and purchase the unavailable tertiary health services for the 
needed patients from domestic and abroad health care providers. UNRWA which consider 
the second health care provider after MOH, it provides primary health care services, only 
for refugee patients and purchase secondary care services for the hardship cases from other 
providers like MOH and private hospitals. NGOs provide primary, secondary and some 
tertiary services depends on the projects and funds. Private sector provides services at the 
three level of care through a private specialized hospitals and centers for profit reasons.  
1.8.5 Health services  
Public health sector should be regularly monitored for its functions and quality. Most of 
public health services are facing many challenges and gaps that impeding it to provide high 
quality and adequate services and it should be reviewed and upgraded. While Israeli 
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authorities permit the access of medical supplies into Gaza, there are frequent interruptions 
of medical equipment resulting from power interruptions and water impurities, in addition 
to other factors. For that and for other reasons, many patients are forced to travel abroad 
Gaza to seek treatment and for other challenges and gaps in health services in the Gaza 
Strip, which is difficult due to movement restrictions imposed by the blockade.  
 There are three oncology and hematology departments in the Gaza Strip distributed among 
three hospitals: Shifa Hospital, Gaza European Hospital in Khanyounis and Rantisi 
specialized pediatric Hospital, including many services for diagnosis and treatment of 
breast cancer, but other services are not found which constitute an obstacle for breast 
cancer management, for that many patients try to be referred abroad to have her treatment. 
 There is extreme deficiency in health services for breast cancer patients in the Gaza Strip, 
in addition to the shortage of most essential drugs and treatment facilitates, poor referral 
system, no training programs for staff. All that adversely affects the patients chances of 
survival, recovery and increase the burden of the disease. 
1.8.6 Shifa Hospital 
Shifa hospital is considered the largest medical complex and central major hospital in the 
Gaza Strip. Shifa hospital consists of three major departments: Medical department, 
Surgical department and Obstetrics and Gynecology department in addition there also 
another main building but still under construction. The onco-hematology department in 
Shifa hospital was established before twenty-five years as one room and over the last 
years, it provides holistic diagnostic services for patients; which includes clinical, 
histopathological and radiological diagnostic services, in addition to multidisciplinary 
medical services includes many departments, even oncology department. The total beds of 
Shifa hospital are 490 beds with 635 physicians and 362 nurses (MOH, 2012). 
1.8.7 European Gaza Hospital 
The European Gaza Hospital (EGH) is considered as one of the advanced medical centers 
in Palestine, it is located at the southern of the Gaza Strip in Khanyounis Governorate. The 
hospital provides facilities for a full range of primary, secondary and planned tertiary 
patient care services for both inpatients and outpatients. The services of the 204 beds 
center are at a high level of professional standards (MOH, 2012). 
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The oncology- hematology department was established in 2000 and it contained at that 
time 24 beds. In 2005 part of this service was transferred to in vitro Fertilization Center 
(IVF); this reduced the provided services to the half with a capacity of 12 beds. . Later on 
in 2008, the oncology service was transferred nearby the Neuro- surgery department in the 
same hospital. Nowadays, the oncology services were transferred to another building 
(European Gaza Hospital Records, 2010). This frequent movements negatively affected on 
the services especially for the cancer patients who usually need continuous health care 
services. Currently the European Gaza Hospital is considered the second main hospital for 
cancer services in the Gaza Strip after Shifa hospital, which provide holistic health care for 
patients which include: diagnostic, treatment and follow up services. The hospital has a 
department for the cancer and hematology services and has outpatient clinic with total 
number of 29 nurses and 6 physicians. 
1.8.8 Rantisi specialized pediatric hospital 
Rantisi hospital is specialized in Pediatrics and provides specialized medical services for 
children. It is located in Al-Nasr area. It started operation in 2008. It includes 
subspecialties in pediatrics, Pediatric diseases, neurological diseases, children, pediatric 
and gastrointestinal diseases, intensive care for children, outpatient clinics, laboratories, 
blood bank, radiology and pediatric physiotherapy, as well as brain and muscle imagining 
services. Oncology unit services extend from North Gaza to the South for different types of 
cancers (Pediatric specialist hospital records, 2012) 
In 2015, Oncology adult department was transferred for temporal time from Shifa hospital 
to Rantisi specialized hospital until the oncology department at Shifa hospital be finished 
and ready for serving cancer patients. The oncology department in Rantisi specialized 
hospital consists of 30 inpatient beds, 15 beds for the males cancer cases and the other 15 
beds for females cancer cases. The oncology department has oncology outpatient clinic 
from which work from Sunday to Thursday, with total of 30 registered and practical nurses 
and 6 physicians divided on the outpatient clinic and inpatient departments. 
1.8.9 Cancer Registry Center 
Cancer registry is defined as a well-organized system which include variety of functions 
which include: collection, storage, analysis, and interpretation of data on persons with 
cancer. Cancer Registry Center was established in 1998 in coordination between Ministry 
of Health and Middle East Cancer Consortium (MECC) in both Gaza Strip and West Bank, 
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which play important role in reporting and classifying the malignant diseases. The main 
sources of data collection are; Governmental hospitals, histopathological laboratories, 
private radiology centers and UNRWA, referral office for treatment abroad, and death 
certificates (El-Sakka, 2006). The main center for Palestinian cancer registry in Shifa 
hospital to cover north of Gaza, Gaza town and the middle area, the second branch of 
Palestinian cancer registry in European Gaza hospital and serve Rafah and Khanyounis 
governorates. 
1.9 Operational Definitions 
1.9.1 Cancer 
Cancer is a generic term for a large group of diseases characterized by the growth of 
abnormal cells beyond their usual boundaries that can then invade adjoining parts of the 
body and/or spread to other organs. Other common terms used are malignant tumors and 
neoplasms. Cancer can affect almost any part of the body and has many anatomic and 
molecular subtypes that each require specific management strategies (WHO, 2019). 
1.9.2 Breast Cancer 
Breast cancer starts when cells in the breast begin to grow out of control. These cells 
usually form a tumor that can often be seen on an x-ray or felt as a lump. The tumor is 
malignant (cancer) if the cells can grow into (invade) surrounding tissues or spread 
(metastasize) to distant areas of the body. Breast cancer occurs almost entirely in women, 
but men can get breast cancer, too (CDC, 2016). 
1.9.3 Evaluation 
Evaluation is an independent, systematic investigation into how, why, and to what extent 
objectives or goals are achieved. It can help the Foundation answer key questions about 
grants, clusters of grants, components, initiatives, or strategy.  
1.9.4 Cancer treatment 
 Treatment is the series of interventions, including psychosocial support, surgery, and 
radiotherapy, chemotherapy that is aimed at curing the disease or prolonging life 
considerably while improving the patient's quality of life (WHO, 2009). 
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1.9.5 Screening 
 Screening is defined as the presumptive identification of unrecognized disease in an 
apparently healthy, asymptomatic population by means of tests, examinations or other 
procedures that can be applied rapidly and easily to the target population (WHO, 2019). 
 
1.9.6 Management  
Management is the process of planning, organizing, leading and controlling the efforts of 
organization members and of using all other organizational resources to achieve stated 
organizational goals (Eze, 2007). 
1.9.7 Health services  
Consist of medical professionals, organizations, and ancillary health care workers who 
provide medical care to those in need. Health services serve patients, families, 
communities, and populations. They cover emergency, preventative, rehabilitative, long-
term, hospital, diagnostic, primary, palliative, and home care. These services are centered 
around making health care accessible, high quality, and patient-centered. Many different 
types of care and providers are necessary in order to offer successful health services. 
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2 Chapter Two 
2.1 Conceptual Framework (self-developed) 
 
Figure (2.1): Conceptual Framework (self-developed) 
Conceptual framework is crucial as it gives the holistic, critical, historical perspective of 
the research topic, and it indicates research gaps. As Bordage (2009) mentioned that, 
Conceptual frameworks are used to represent thinking methods about a problem or a study, 
or it shows in simple way complexity of the problem and how difficult thinks work.  
This conceptual framework was developed by the researcher to illustrate breast cancer 
management in the Gaza Strip based on WHO six building blocks which are: 
2.1.1 Health services delivery  
Good health services which include personal and non-personal health interventions that are 
delivered to persons who are need it in holistic manner with guarantee of its safety, 
effectiveness and high quality and it takes in consideration the appropriate time and place 
without harm to anybody and minimum waste of resources (Beange, 1996). Personal health 
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services are delivered individually. They can be of therapeutic or rehabilitative nature, and 
may generate positive externalities. Non-personal health services are actions applied either 
to collectives (e.g., mass health education) or to the non-human components of the 
environment (e.g., basic sanitation) Health services consist of all services that patients need 
for diagnosis, treatment and follow up of disease, or the promotion, maintenance and 
restoration of health. Health services are the most apparent functions of any health system. 
Service provision can be referred to the way inputs such as financial costs, staff, facilities, 
equipment and medications are combined to allow the delivery of health interventions in a 
good manner. Improving coverage and quality of health services depends on availability of 
main resources which are needed for patients; and how those services are used, well 
organized and managed in best ways (ICHSM, 2019).  
2.1.2 Health workforce  
Health workforce is considered as the backbone of the health care system, good health 
workforce is one which has well performance with fast response and efficient ways to 
gather the best health results as possible as when there are enough available resources that 
help in their tasks and in addition to the good circumstances, sufficient number of staff 
who are competent, productive and fairly distributed.
 
There are many challenges still facing developing countries, they are working hard to 
overcome it especially on the sustainability and development of health workforce as 
availability of sufficient number of staff, competency, training, rapid responsive in addition 
to adequate support to meet population needs and have positive outcomes. 
WHO mentioned some key areas for health workforce support which include: HWF 
strategic response to evolving and unmet health service needs, education, training and 
continuing competence, utilization, management and retention, in addition to governance, 
leadership and partnerships for sustained contributions to improve populations outcomes. 
2.1.3 Health information system  
A well organized and performing health care system which apply its functions effectively 
and properly which include: data collection, production, analyzing, reporting, 
dissemination of data to whom it may concern, in addition to the use of reliable 
information on health system performance and health status. It is used by different groups 
of qualified people in different aspects in health include: policy makers, decision makers, 
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planners, health care providers and other key informant people who have a good thinking 
approaches to set and modify health policies which facing gaps and to make effective 
health decisions that will give positive outcomes and high level of satisfaction from 
population. In developed countries, there are sustainable efforts from all levels to improve 
health care system from various aspects like: availability, quality, staff, staff, needed 
equipment and use of health information at country, regional and global levels. 
Using appropriate health data standards, good validation processes, data sharing and data 
analysis will improve the utilization and quality of health information as consequence 
decrease the gaps that impeding its functions. WHO has ongoing efforts to develop health 
care system in developed in developing countries. It assists them to strengthen capacity, 
improve data quality and put in place information systems to generate more reliable 
population health information, such as vital statistics (WHO, 2015). 
2.1.4 Leadership and governance  
A strong and effective leadership and governance which ensure the availability of strategic 
policies that meet population needs and combined with effective planning, monitoring, 
appropriate regulations and accountability. Health governance (or stewardship) is defined 
as the wide range of functions and tasks carried out by governments to improve population 
health and achieve population health needs while ensuring equity in access to services, 
affordability of services, quality of services, and patient's rights of health. Governance is 
also concerned with the roles and responsibilities of all country sectors which include: 
public, private and voluntary sectors - including civil society - and their relationships with 
each other in pursuit of national health goals (WHO, 2015).  
2.1.5 Health financing system  
One of the most advantages of good health financing system that it ensure adequate funds 
for health, in clear ways that ensure people can use needed health services easily, protect 
them from financial burden that increase population costs. 
Health and health care are major economic and political issues. Health economics is a 
branch of economics that is concentrated on how health resources are allocated in its 
appropriate places and how it used in different health systems in effective ways. Health 
financing is a major focus of health economics and is important in establishing and 
analyzing health policies, sources of funds and effectiveness of health services delivered to 
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the population. The major goal of health financing is to ensure adequate spending on health 
and effective allocation of financial resources to different types of public and personal 
health services that meet population needs and satisfaction. In most developing countries 
still there are many challenges that interfere with health services delivery as consequence it 
affect negatively in the quality of care provided. 
2.1.6 Essential medications 
 Equity in access to essential medicines is part of human right. The title itself give an 
important impression, Essential medicines is consider as a basic of life for its importance 
because it can save lives, reduce sufferings and improve health and all it happened if it was 
available, easy access to it and affordable. In addition quality should be assured and it 
should be properly used by both providers and patients to meet needed outcomes. Essential 
medications should be available at all times, in all circumstances in adequate amounts, in 
the appropriate dosages and at a price that individuals and systems can afford without any 
financial burden. Thus, they should be selected properly based on patients and population 
real needs, evidence of efficacy and safety and cost effectiveness.  
2.2  Literature Review  
2.2.1 Overview of cancer  
Cancer is defined as abnormal cells growth and division without control and have the 
ability to invade other tissues. Normal body cells are grow, divide and then died in normal 
body mechanisms. In normal differentiated cells, there are cellular mechanisms, which 
control cell division. When these mechanisms do not function properly, cells may multiply 
excessively forming a tumor(Cooper & Hausman, 2000). There are two types of tumors 
malignant and benign tumors. Malignant tumor is an abnormal growth and division of cell 
which form a mass of tissue have the ability to invade and spread into neighboring tissue 
and often to other parts of the body. Malignant tumors are composed of cancer cells. 
Cancer cells are very resemble to cells of the organism from which they originated and 
have similar deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Cancer cells form 
from cells dividing out of control caused by alteration (damage) of DNA, and these 
changes can occur at many levels. Changes in many genes are required to transform a 
normal cell into cancer cells (Cooper & Hausman , 2000). 
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2.2.2 Breast cancer 
Breast cancer happens when there is abnormal growth and out of control for breast cells. 
These cells combined together and forming tumor can often be diagnosed and seen on an 
x-ray or other diagnostic facilities or it can be felt as a lump when female make breast self-
examination. The tumor which formed as a result of adhesion of breast cells together can 
be malignant if the cells of the tumors invaded the surrounding organs, tissues or spread 
(metastasize) to distant areas of the body. Breast cancer occurs almost entirely in women, 
but men can get breast cancer, too but in low incidence rates (ACS, 2016). 
Breast cancers can be happened from different parts of the breast, but most of breast 
cancers starts in the ducts that carry milk to the nipple (ductal cancers). Other breast cancer 
start in the glands that make breast milk (lobular cancers). There are also other different 
types of breast cancer that happened but they are less common. A low percentage of 
cancers happen in other tissues in the breast, these cancers are called sarcomas and 
lymphomas and are not really thought of as breast cancers. In addition to that there are 
many types of breast cancer can cause a mass in the breast but not all types do that. 
Screening mammograms can be helpful in detection of breast cancer cases in early stages 
and before development of symptoms which give a chance for patients for early treatment 
and as sequence low mortality rates. Some of symptoms should be reported to a health care 
provider when it watched or felt. It‘s also important to recognize that most breast lumps or 
masses are benign and not malignant. Benign breast tumors which have abnormal growth 
and division, but they do not invade outside of the breast and they are not life threatening 
conditions, in the other side some benign breast lumps can increase a woman's risk of 
getting breast cancer if they didn‘t take care and make follow up. If there is any breast 
lumps or any changes in the breasts like its shape and color it should be checked by a 
health care professional to determine if it is benign or malignant (cancer) and if it might 
affect your future cancer risk and to make a plan for follow up to decrease possible 
complications. 
Women should know the normal shape and color of breasts because it will be easier to 
detect any abnormalities and in addition to have regular mammograms and other screening 
tests. Early detection of breast cancer in early stages gives a better chance for early and 
successful treatment. Screening tests can help find breast cancer in its early stages of the 
disease, before any symptoms appear or the disease become complicated and hart to be 
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treated. The most common symptom of breast cancer is a new lump or mass which had 
different signs and symptoms include: painless or in rare times it can be painful, hard 
mass that has irregular edges is more likely to be cancer, but breast cancers can be tender, 
soft, or rounded. For that, breast self-examination in regular matter is very important to 
early detect any new mass, lump, or breast changes in color or shape, it should be checked 
by a health care professional experienced in diagnosing breast diseases for early treatment 
and follow up (ACS, 2016). 
2.2.3 Epidemiology of Breast Cancer 
2.2.3.1 International epidemiology of breast cancer  
Over years the damned disease which named cancer has been threatening the comfort of 
scientists by its multi faced and the hard methods to combat this disease. The word cancer 
alone is enough to induce fears and desperation inside us, but not anymore, nowadays 
physicians feel more excited to be engaged in this field because of the many research 
achievements related to it. 
 According to WHO global health estimates report (2013) it showed that breast cancer is 
the most common cancer in women all over the world. It was obvious that there are 
increasing in the mortality rates from breast cancer, it is estimated that worldwide over 508 
000 women died in 2011 due to breast cancer. (GLOBOCAN 2008) mentioned that breast 
cancer is thought to be a disease of the developed countries in the world, almost half of 
breast cancer cases and 58% of deaths occur in developing countries which indicate to 
burden of this disease. There are variation of incidence rates of breast cancer among 
countries from 19.3 per 100,000 women in Eastern Africa to 89.7 per 100,000 women in 
Western Europe. In most of the developing regions the incidence rates are below 40 per 
100,000 (GLOBOCAN 2008).  African countries had the lowest incidence rates but breast 
cancer incidence rates are also increasing. 
Breast cancer is consider the most frequent diagnosed type of cancers and the leading 
cause of cancer death among females all over the world, with an estimated 1.7 million 
cases and 521,900 deaths in 2012. Breast cancer alone accounts for 25% of all cancer cases 
and 15% of all cancer deaths among females (WHO, 2014). 
There are variation of survival rates between countries worldwide, ranging from 80% or 
over in North America, Sweden and Japan to around 60% in middle-income countries and 
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below 40% in low-income countries (Coleman, et al. 2008). There is still low survival rates 
in developing countries due to mainly the lack of prevention and early detection programs, 
which lead to delay diagnosis of breast cancer or to be diagnosed in late stages after the 
disease was metastasized in the body, as well as by the lack of adequate diagnosis and 
treatment facilities and in addition to insufficient number of specialists in oncology (WHO, 
2016). 
2.2.3.2 Regional epidemiology of breast cancer 
Arab world countries still have many challenges and gaps in the availability of data; some 
countries either have a national or regional registry for data collection, analyzing and 
reporting, while others have no data to be used for cancer control, but breast cancer still 
ranks the first type of cancers among females in Arab countries with a young age of around 
50 years (13-35% of all female cancer). The disease remains very common in Egypt, 
Tunisia, Saudi Arabia, Syria, Palestine and other countries (El Saghir, et al. 2009). El 
Batrokh study (2013) reported that the 72% of breast cancer patients were >45 years old 
with statistical significance. 10.7% of the participants have family history of breast cancer 
of which 15 had breast cancer with statistical significance. Fertility among breast cancer 
(92.9%) was lower than control (100%) with statistically significant. The mean number of 
parity for breast cancer and controls was found to be (6.83 and 6.01), respectively with 
statistical significance. The mean of duration of breast feeding in month for cases and 
control equals (14.15 and 17.25 month) respectively and this disparity was statistically 
significant.  
2.2.3.3  Local epidemiology of breast cancer  
Nationally, according to the Palestinian Health Information Center (PHIC) and MOH 
annual reports in Palestine it reveals that breast cancer at the forefront of cancers that affect 
the Palestinians. Breast cancer in the Palestinian women is continuously increasing; it 
occurs at younger age at onset and advanced stage at presentation. In Gaza Strip the 
number of breast cancer cases was 684 a rate of 20.5% of all cancers and 36.9% from 
female cancers and incidence rate 18/ 100,000 from all population. In 2005 a report 
showed that breast cancer causes the highest cancer related mortality among Palestinian 
women, 21.1% of all deaths from cancer, and 5.2 deaths per 100,000 women.  
A study was made among Palestinian women who are resident in the West Bank to 
evaluate the use of screening method and mammography for the detection of breast cancer. 
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The study revealed that more than 70% had never undergone mammography or clinical 
breast examination and 62% done self-breast examination. Large tumors are diagnosed in 
advanced stages because most women fear of cancer and fear of social withdraws that 
affects woman‘s standing in the community and affects her daughter‘s chances of being 
married. Adding to this, the ignorance about the disease itself and the difficulty of access 
to the breast health care centers (Younes, 2015). 
2.2.4 Risk Factors of Breast Cancer 
2.2.4.1 Gender: Being a Woman or Men  
Women's breast maturity takes 3 to 4 years and usually complete by age 14. It's once fully 
formed, breast cells are very immature and highly active until a woman's first full-term 
pregnancy. When women still immature, there breast cells are very responsive to estrogen 
and other hormones.  In the other side men's breast cells are inactive and most men have 
extremely low levels of estrogen and not responsive to estrogen hormone. Particularly 
during the extra-sensitive period of breast development, is why breast cancer is much more 
common in women than in men. In 2016, an estimated 246,660 new cases of invasive 
breast cancer diagnosed in women in the U.S., along with 61,000 new cases of non-
invasive breast cancer. In contrast with males there were about only 2,600 new cases of 
invasive breast cancer are diagnosed in men in 2016. A man‘s lifetime risk of breast cancer 
is about 1 in 1,000. So, that‘s mean the rate of morbidity and incidence rate of breast 
cancer are higher in females than males, but if it happened with males they have high 
mortality rates and low survival rates than females, but breast cancer  is still rare to occur 
in males, but it does happen. A large study showed a results were presented on May 4, 
2012 at the annual meeting of the American Society of Breast Surgeons found that when 
men are diagnosed with breast cancer in early stages they have more percentage to die 
from the disease than women.  
There are records were reviewed by researchers from large database of breast cancer 
patients called the National Cancer Data Base. It revealed that people who are diagnosed 
with breast cancer between 1998 and 2007, there are very low percentage of all cancer 
cases are males and all other cases were females. From the aspect of the survival rate in the 
5 years after diagnosis it showed that the differences are not too large: 74% for men and 
83% for women while lower survival rate with males who are diagnosed with breast cancer 
seen in cases who are diagnosed in early stages of the disease. It showed also people who 
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are diagnosed with late stages of breast cancer, there are equal chance of survival for both 
gender. Advanced-stage breast cancer is cancer that has disseminated to non-breast tissue 
in the breast area (locally advanced cancer) or metastasized to other parts of the body away 
from the breast (metastatic cancer). Five-year survival for late stage breast cancer was: 
16% for men and 19% for women. On average, the breast cancer stage at diagnosis men 
have higher incidence compared to females. When breast cancer is diagnosed in men it 
tended to be: larger in size, higher grade, which relates to how aggressive the cancer cells 
are and it easily metastatic to other part of the body, treatment of breast cancer in males not 
always the same as treatment of breast cancer for females, though the researchers aren‘t 
sure why. For cancer in men they have higher percentage to be hormone-receptor-positive 
than females (88% in men vs. 78% in women), but in the other side men were less likely 
than women to get hormonal therapy than females as part of treatment plan. Hormone-
receptor-positive breast cancers are cancers that depend on the hormone estrogen level, its 
growth and spread, men's bodies secrete estrogen but in low level compared to females. By 
minimizing or blocking estrogen‘s effects in the body, hormonal therapy can help in 
treatment of hormone receptor-positive breast cancer and make its recurrence rare to 
happen.  
 When men are diagnosed with breast cancer and have surgical treatment, it's rare to use 
radiation therapy after surgery not like women it's more common to use it. Radiation 
therapy is often given after breast cancer surgery to reduce the possibility that the cancer 
will come back in the breast area (local recurrence). 
There are many main reasons for the variations in breast cancer rates between genders 
which are: 
 Development of female's breast is usually completed by age 14, not like male to be 
fully formed, in addition most of male breasts are fatty and not formed glands.  
 When women breasts are fully formed, breast cells still immature and highly active 
till full term pregnancy, and cells became very sensitive to estrogen and hormones 
changes. 
 Most of men have low levels of estrogen and their breast cells are inactive. 
Due to highly responsive and vulnerability of breast cells in women from hormonal 
stimulation, especially during breast development time, this is increase the incidence of 
breast cancer in females more than males (Breastcancer.org, 2019). 
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2.2.4.2 Age  
Females who are diagnosed with breast cancer in their second and third decades of age 
have high possibility of mortality and slow prognosis compared to females who are 
diagnosed in other ages, but the reason of that is still unclear. Early aged women who are 
diagnosed with breast cancer tend to have affected lymph nodes, be negative for estrogen 
receptors and in addition to that the size of tumor are larger with advanced 
histopathological grading in comparing to other ages, many studies explained the reason of 
that and suggested that they have higher possibility for late diagnosis because it is difficult 
to detect breast cancer in young females due to high density of mammary glands which is 
more obvious in pregnant and lactating women, in addition to that young women still have 
higher risk than other women ages to have axillary lymph node diseases and tumors with 
negative estrogen receptor and advanced histopathological grading, for  that the cause of 
mortality among young aged females is usually from breast cancer itself.  
Young aged women tend to have more favorable chance to survive in advanced stages of 
breast cancer than other older females. When females diagnosed with breast cancer in age 
less than 40 years, they have poor chance of surviving stage I and stage II than older 
women. But when they diagnosed with stage III studies showed that younger females have 
favorable chance for surviving than old age females. It was evidenced based that older 
women tend to have milder severity of breast cancer than young age females, in contrast 
regarding survival rates, younger women have high survival rates than older females 
confronting advanced stages of the disease.  The highest survival rate in stage I of breast 
cancer tend to be in women with age group from 50 to 69. For other stages of breast 
cancers, women between 40 and 49 years of age show the highest survival rates. Women 
younger than 40 years tend to have the lowest level of survival rates for stages I and II 
breast cancers, while women over 70 tend to show the poorest survival rates for stage III 
and IV breast cancers.  
A prospective cohort study was conducted to examine the risk of breast cancer that 
influenced by maternal history of breast cancer prospectively with taking in consideration 
sister's history of breast cancer or mother diagnosis age. It showed that the risk of breast 
cancer is almost twice among females who had family history (mother) of breast cancer 
before the age 40 years or who had sister diagnosed with breast cancer, and it remains with 
high incidence rates for those whose mothers were diagnosed with breast cancer at the age 
of 70 years or older (Colditz, et al. 1993). 
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2.2.4.3 Family history 
There are evidenced based studies showed that there are increasing risk of breast cancer in 
females with family history of breast cancer by using different study designs. However, the 
extent of this risk varies according to the nature of the family history (who are affected, 
age at diagnosis and number of relatives affected) and may also vary according to age of 
the individual (Pharaoh, et al. 1997).  
Females who had family history especially close relatives who are diagnosed with breast 
cancer have higher possibility to develop breast cancer. In case of first-degree female 
relative (sister, mother, and daughter) who are diagnosed with breast cancer, the risk to 
have breast cancer is doubled. If there are two first-degree relatives have been diagnosed 
with breast cancer, the risk is greatly higher about 5 times to develop breast cancer. 
Sometimes, a strong family history of breast cancer is linked to have abnormalities in 
genes formation associated with a high risk of breast cancer. When comparing with women 
who didn‘t had family history, women with first-degree family history of breast cancer had 
a 40% reduction in the risk of dying. Women who are diagnosed with breast cancer and 
have family history with breast cancer second degree have the same mortality percentage 
to those women without family history of breast cancer, in addition to that the risk of death 
is reduced in women with family history and greater number of affected relatives. This 
can't be explained by the differences in screening, diagnosis and treatment. Tumors in 
women with a first-degree family history had generally more favorable prognostic profiles.  
A study was conducted by medical students from Al Azhar University in (2016) and they 
found that only 26.1% of breast cancer patients in the Gaza strip have a family history of 
breast cancer, 57.1% second degree relative 42.9% first degree relative (Medical students, 
2016). 
2.2.4.4 Obesity and Overweight 
In the last two decades it was noticed that the percentage of overweight and obesity in 
adult and children have been increasing, in US it was estimated that one third of adults are 
obese which increase the risk of other diseases. Some studies revealed that obesity is a risk 
factor of breast cancer postmenopausal period and it increase the risk to develop other 
types of cancer. In addition to the impact of obesity on cancer risk, obesity play an 
important role to be recognized as a poor prognostic factor among survivors of breast and 
colon cancers. Other studies showed that an obvious increasing of mortality rate in breast 
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cancer patients due to obesity it is estimated that 11,000 to 18,000 deaths per year as a 
result of breast cancer in US women age 50 years or older might be avoided if women 
maintained a body mass index (BMI) under 25 throughout their adult lives and make 
changes in sedentary lives. Obesity is still a common and public health problem but its 
modifiable risk factor, so it can reduced as sequence decrease the incidence and mortality 
rates of cancer.  The relationship between breast cancer and obesity still vague and 
complex, a major factor is the increased production of estrogen in excess adipose tissue in 
obese women after menopause which increase its level in the body. For that, estrogen-
sensitive tissues are exposed to more estrogen stimulation in obese than in other women, 
which can enhance the growth and development of breast cancer. Obesity-related effects 
on insulin levels and the insulin-like growth factor-1 (IGF-1) axis, in addition to altered 
production of adipokines by adipocytes, may be consider as important contributors to 
increase the risk for breast cancer development and progression. Furthermore, obesity is 
recognized as a pro-inflammatory state as it results in the release of inflammatory 
mediators that promote tumor growth. 
A case-control study was conducted by a group of medical students in (2016) from Al 
Azhar university to identify the major risk factors associated with mortality and survival 
from breast cancer in the Gaza Strip for 50 breast cancer patients and they found that 
women who their weights are between 76-90 kg, their heights above 160 cm, their BMI 
between 25-29.9, have tumor grade III, tumor stage IV, metastatic breast cancer, ER/PR 
negative, HER-2/neu negative and post-mastectomy radiotherapy, have higher mortality 
rates (Medical students, 2016). 
On the other hand, women whose weights are between 50-75 kg, their heights are between 
140-159 cm, their BMI below 25, have tumor grade I or II, early tumor stages (stage I or 
II), localized non-metastatic breast cancer, ER/PR positive, HER-2/neu positive and post-
mastectomy chemotherapy without radiotherapy, have higher survival rates. 
2.2.5 Management of breast cancer 
2.2.5.1 Breast cancer Prevention  
There is no confirmed method for breast cancer prevention, but there are things females 
can do that reduce the risk to develop breast cancer. There are risk factors are can't be 
modified, such as being female and the age, But other risk factors can be controlled and 
changed and may lower their risk to have breast cancer (Shamim, et al. 2008). Controlling 
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of modifiable breast cancer risk factors is consider an effective way for prevention of non-
communicable diseases which include: promotes healthy diet, increasing physical activity, 
reducing weigh and decrease exposure to hazardous materials, all this could eventually 
have an impact in reducing the incidence of breast cancer in the long term as sequence 
decrease the burden of this disease (WHO, 2016). 
2.2.5.2 Diagnosis of breast cancer 
There are multiple diagnostic tests used to evaluate and diagnose of a possible breast 
cancer usually starts when a woman have a mass or abnormal shape and color of the breast 
on a screening mammogram, or there is a lump or nodule in the woman‘s breast during a 
clinical or self-examination. In less common cases, females may notice swollen or red area 
in the armpit area (Cancer.net, 2019). 
2.2.5.3 Imaging tests 
Imaging tests are used to show pictures of the organs inside the body. There are series of 
tests are used to diagnose breast cancer or to confirm any suspicious area found in the 
breast during screening and these tests are the following: 
 Diagnostic mammography. Diagnostic mammography  is one test help in early 
diagnosis of breast cancer it is similar to screening mammography except that the 
number of pictures that taken for breast are more. It is often used usually when a woman 
is experiencing abnormal signs in the breast, such as a new lump, change in the size and 
color of the breast or nipple discharge. Diagnostic mammography may also be used as a 
first choice of diagnosis if there is something not confirmed is found during a screening 
mammogram. 
 Ultrasound (US). It's another device used to diagnose breast cancer. Its mechanism 
based on the uses sound waves to create a picture of the inner breast tissue. Its helpful 
method that can distinguish between a solid mass, which may be cancer, and a fluid-
filled cyst and mass, which is usually not cancer cyst. 
  Magnetic Resonance Image (MRI). It's an advanced device can be used before the 
diagnosis of breast cancer and after diagnosis for follow up. It works by using of the 
magnetic fields to produce detailed images of the small organs inside the body.  There is 
a special dye called a gadolinium contrast medium is used when women need to make 
MRI. This dye is given before making MRI scan which help to make a clear picture of 
the suspected cancer area. It can be given by different ways to the patients (injection 
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into a patient‘s vein).  MRI also can be used after women diagnosed with breast cancer 
for follow up the prognosis of the disease and response of women bodies to 
chemotherapy treatment and if tumor was shrink or not. Breast MRI is also can be used 
a screening option, for some women with a very high risk of developing breast cancer 
and other diagnostic devices didn‘t detect any abnormalities. 
2.2.5.4 Biopsy 
A biopsy is defined as the removal of a small part of tissue from body organs for 
examination under a microscope for more investigations. There are many tests can suggest 
the presence of cancer, but only a biopsy can confirm the diagnosis. After the biopsy was 
taken, a specialist pathologist analyze the biopsy under special circumstances. A 
pathologist is specialized doctor whose job is interpreting laboratory tests and evaluating 
cells, tissues, and organs to diagnose disease and give the final results. There are many 
types of biopsies, classified according to the method and size of needle used in taken 
biopsy and these types are as the following: 
 Fine needle aspiration biopsy:  This technique of biopsy is done through using a small 
needle to take a small sample of cells from the targeted organ.  There is a subtype of 
fine needle aspiration biopsy called core needle biopsy it's done by using a larger needle 
to remove a large sample of cells. This technique is the best and preferred method for 
discovering any abnormalities on a physical examination or an imaging test is cancer. 
During this procedure the doctor may use local anesthesia, to reduce pain discomfort 
during the procedure. 
 Surgical biopsy: It‘s a technique used when a large amount of tissues are removed.  It's 
done after the patient was diagnosed clinically with cancer, but this technique is not the 
best one to diagnose patients with breast cancer. In contrast core needle biopsies which 
are non-surgical procedures are recommended to diagnose breast cancer. This means 
patients with breast cancer need only one surgical procedure to remove the mass and to 
take samples for more investigations. 
 Image-guided biopsy: this type of biopsy is done through using a needle is guided to 
the identified location with the help of a continuous imaging technique, such as 
mammography, ultrasound, CT scan or MRI. A stereotactic biopsy is a special type of 
image guided biopsy and is done by using mammography to help in insertion the needle 
into the breast. There is a small metal clip may be fixed into the breast to identify the 
place of the biopsy sample was taken, in case more surgeries or investigations were 
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needed. This clip is made from titanium which will not cause harm or complications to 
the patient in the future imaging tests, but patients need to make follow up and 
consultation from doctors before any imaging tests. An image-guided biopsy can be 
done using the previous mentioned techniques as a fine needle, core, or vacuum-assisted 
biopsy, it depends on the amount of tissue are needed to be removed (Cancer.net, 2019). 
2.2.6 Staging of breast cancer 
Staging of breast cancer depends on a special criteria which include: breast tumor size, the 
location of the tumor in the breast in addition whether it has metastasized to lymph nodes 
or other organs of the body. Stages of breast cancer are described by using the Roman 
numerals 0, I, II, III, and IV and the letters A, B, and C. while Stage I in breast cancer 
means the patient has breast cancer in early stage, and Stage IV it means that the patient 
has advanced cancer stage that has metastasized to other organs in the body, such as the 
lung.  
2.2.6.1 Clinical staging 
 This type of staging is based on the estimation of the extent of the tumor bases on physical 
examination, other imagining tests and tumor biopsies results. There are some types of 
cancers used blood test results to define the stages of cancer. The clinical stage is consider 
the most important part of deciding the best treatment to use for the disease. It‘s also used 
as baseline to compare patient current situation with her past condition and if there is any 
response to the treatment or not (ACS, 2015). 
2.2.6.2 Pathologic staging 
 This type of staging is done based on the results of surgical procedure so it can determine 
the pathologic stage (also called the surgical stage) of the cancer. The pathologic staging 
can be identified based on the results of the previous exams and tests, in addition to the 
information about cancer that have been noticed during surgery. Surgical procedure is 
often used to remove cancer mass and other nearby affected lymph nodes, but also surgery 
may be done to check the size of the cancer is in the body and take tissue samples for more 
investigations. The pathologic stage gives the health care team more specific data about the 
cancer that will be helpful in setting treatment plan as sequence the patient response to the 
treatment and outcomes (ACS, 2015). 
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There is a special system used for categorizing cancer into stages, the staging system most 
widely used is the TNM (Tumor size, Node involvement, Metastasis)  
The T category gives details about the (primary) tumor, as its size, location in the body and 
if the tumor is metastasized to other body organs or not. 
 TX means that the tumor can‘t be measured. 
 T0 means there is no evidence of a primary tumor (it cannot be found). 
 Tis means that the cancer cells are only growing in the superficial layers of tissue, 
without invasion to the deeper tissues. It also be called in situ cancer or pre-cancer. 
 Numbers after the T (such as T1, T2, T3, and T4) describe the tumor size and/or 
invasion of the tumor into nearby structures. The higher the T number, the larger 
the tumor and/or the more it has grown into nearby tissues. 
The N category describes whether the cancer has metastasized into nearby lymph nodes. 
 NX means the nearby lymph nodes cannot be evaluated. 
 N0 means  there is no cancer in the nearby lymph nodes  
 Numbers after the N (such as N1, N2, and N3) describe the size, location, and/or 
the number of nearby lymph nodes affected by the tumor. The higher the N 
number, the greater the cancer spread to nearby lymph nodes. 
The M category give information about whether the cancer has spread (metastasized) to 
distant organs of body. 
 M0 means that  there is no cancer  affect the distant organs of the body 
 M1 means that the cancer has metastasized to distant organs or tissues  
Many cancer types have their own specific type of classification system, it means that 
letters and numbers don‘t have the same meaning for every type of cancer. For example, in 
some types of cancer, the T categories mean the size of the primary tumor, while in other 
types of cancer they describe how deeply the tumor has grown in to the organ it started in, 
or whether the tumor has metastasized to other organs of the body (ACS, 2015).  
2.2.7 Treatment of breast cancer 
  There are many types of breast treatment which include: surgical, systematic, radiation, 
chemotherapy, hormonal and targeted therapy. Breast cancer treatment and management 
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are based on the clinical staging of cancer, tumor biology, and molecular subtype, include 
surgery, local tissue-targeting radiotherapy, in addition to the systemic therapies such as 
chemotherapy, hormonal, and targeted therapy. In early stages of cancer, the surgical 
treatment of breast cancer by doing lumpectomy (breast-conserving surgery) or 
mastectomy (surgical removal of breast tissues) with the removal of clear margins of both 
invasive and non-invasive cancer, is required to remove the total breast mass and to 
decrease the possibility to be metastasized (Ng,Z et al. 2017). 
2.2.7.1 Surgical treatment 
Surgical treatment is consider the most common type of breast cancer treatment.  There are 
different types of surgical treatments that are used to manage early stages of breast 
cancers. Mastectomy is defined as the removal of the whole breast of the patient and it's 
used when cancer is suspected to develop bad complications that threatening the patient's 
life. Breast-conserving surgery, such as lumpectomy or partial mastectomy, can also be 
helpful for some women when tumor with small size that there is no need to make 
mastectomy. If a breast conserving surgery is combined with post-operative radiation 
therapy, it is as effective at curing breast cancer as a mastectomy. Sentinel lymph node 
biopsy (removing the first lymph node that drains the affected area) should be performed in 
invasive breast cancer cases staged I to III to make assessment about whether the cancer 
has begun to be metastasized to nearby lymph nodes. If the lymph nodes are affected with 
cancer, an axillary dissection is preferred to be done to remove the affected lymph nodes in 
addition to examine other nearby lymph nodes. To decrease the burden of mastectomy as 
there are changes in the women chest there is surgery called reconstructive surgery that can 
be done at the time of mastectomy or in later time to restore the shape of the breast 
(Stöppler, 2014) 
2.2.7.2 Radiation therapy 
 Radiation therapy is a common type of treatment for women with breast cancer who have 
had breast-conserving surgery and in sometimes it used to treat women who had 
mastectomy, particularly if the cancer had metastasized to the chest wall muscles or skin, 
or to the reginal lymph nodes. This type of treatment is done through using of high-energy 
rays to kill the remaining cancer cells after surgical treatment. It can be used in two ways 
externally or internally. While external radiation therapy is given in a special health clinic, 
usually five days a week for several weeks and it consider the most common type of 
radiation therapy used to treat breast cancer. But, internal radiation therapy can be used in 
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some cases. This done through placement of radioactive material which called 
brachytherapy directly into the breast tissue through a thin tubes and after short duration of 
time this material is removed. This procedure can be repeated daily for a week (Stöppler, 
2014). 
2.2.7.3 Systemic therapy  
 This type of breast cancer treatment is done through taking systemic therapy orally or 
through a vein that enter directly into the bloodstream to reach  the targeted cancer cells 
wherever they in any part of the body. There are 3 main categories of systemic therapy that 
are used for early-stage and locally-advanced breast cancer treatment which are: 
chemotherapy, hormonal therapy, and targeted therapy. Treatment options of breast cancer 
are based on the available information about the tumor in addition to the patient overall 
health and treatment preferences (Stöppler, 2014) 
2.2.7.4 Chemotherapy 
Chemotherapy is consider as a part of systemic therapy and it's another option for breast 
cancer treatment and it's defined as the use of chemotherapy medications to get rid of 
cancer cells, by inhibition cancer cells of uncontrolled growth and division. Chemotherapy 
treatment is just prescribed by a medical specialist oncologist (ASCO, 2018). 
Systemic chemotherapy gets through patient vein and directly into the bloodstream to 
reach the targeted breast cancer cells throughout the body. There are different methods that 
are used to give chemotherapy to patients and which include: intravenous (IV), 
subcutaneous or intramuscular, or orally through swallowing pills or capsules. It can be 
before surgery to shrink the size of a large tumor and make surgery easier and this called 
neoadjuvant chemotherapy.  In addition it can be also given after surgery to reduce the risk 
of recurrence or complication and this process is called adjuvant chemotherapy. A 
chemotherapy regimen, is usually consists of a specific number of cycles given over a set 
period of time. Chemotherapy may be given on many different regimens based on what 
worked best in clinical trials or evidenced based for that specific type of regimen. It may 
be given once a week, once half of month, once every 3 weeks, or even once one month. 
2.2.7.4.1 Hormonal therapy 
Hormonal therapy is a type of systematic treatment which called also endocrine therapy, it 
is one of the best treatment type for most cancer that has a positive result for estrogen or 
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progesterone receptors. Most tumor use hormones to enhance its growth and duplication. 
When hormones action are blocked this prevent tumors from recurrence and growth and it 
helps to kill breast cancer cells when it used alone or after adjuvant or neoadjuvant 
chemotherapy. In addition it can also be used before surgery to minimize the tumor size 
and to facilitate the surgery. This type of treatment is called neoadjuvant hormonal therapy. 
It can be also given after surgery to reduce the risk of recurrence and prevent tumor 
complication and this called adjuvant hormonal therapy (ASCO, 2018) 
2.2.7.4.2 Targeted therapy 
 This type of treatment works by targeting specific types of cancer genes, proteins, or the 
tissue environment that enhancing cancer growth, duplication and survival. Targeted 
therapy are more focused and work in different way than chemotherapy. It helps in 
blocking cancer cell growth and metastasis and its limiting damage to other healthy cells in 
the body (ASCO, 2018). 
2.2.8 Breast Cancer Treatment by Stage 
 Stage 0: Ductal carcinoma in situ (DCIS), in this stage breast cancer is localized in one 
place and didn‘t spread to any other organs of the body. Nowadays, there are a lot of 
interest in the diagnosis of this condition and the potential for over diagnosis and 
overtreatment because there are few as 14% to as many as 50% of cases of DCIS will be 
complicated to advanced stages and became into invasive cancer. Surgical treatment is 
preferred to treat DCIS, in addition to the radiation therapy is also used to minimize the 
risk of recurrence of the cancer. 
 Stage I and II: In these stages of breast cancers are treated surgically by removal of the 
tumor, either by a lumpectomy or mastectomy. Stage I cancers have a small size and its 
localized location and didn‘t spread to the lymph nodes or it spread to a small area 
within the lymph nodes.  In the other side, Stage II cancers are larger than stage one in 
size and it may be spread to a few number of lymph nodes. When surgery is done, 
affected lymph nodes are removed, a biopsy of a nearby lymph node is typically done. 
After breast conserving surgery (lumpectomy) or even after mastectomy in some cases, 
Radiation therapy is almost given to prevent the recurrence of cancer. Moreover after 
the surgery, if the tumor expresses hormone receptors, hormone therapy with tamoxifen 
or aromatase inhibitors may be given to shrink the tumor size and prevent it from 
recurrence and sometimes chemotherapy is used also. In some cases, neoadjuvant 
30 
 
chemotherapy is given before the surgery to decrease the size of the tumor and chances 
of other surgeries. 
 Stage III: In this phase, cancer have a large size and it spread to a larger number of 
lymph nodes in addition to that it metastasized to other body organs that are near to the 
breast and they didn‘t spread to distant body organs.  In this stage tumor can be treated 
surgically which may be followed by radiation therapy to prevent it from recurrence. 
Other types of treatments options can be used such as hormone therapy, chemotherapy, 
and drugs to target HER2 activity depending on the specific characteristics of the tumor. 
Treatment with chemotherapy may also be used before to surgery (called neoadjuvant 
chemotherapy) for stage 3 tumors to shrink the size of the tumor. 
 Stage IV (metastatic): This is advances stage which is breast cancers have spread to 
other distant sites and organs in the body. In stage 4, systematic treatment is used rather 
than local treatment because the cancer is more widespread. In addition to that, 
sometimes a combination therapy can be used such as chemotherapy, hormone therapy, 
and/or biologic therapy is the main treatment. Chemotherapy and radiation therapy can 
be used in some cases (Stopper, 2014). 
2.2.9 Quality of care 
All patients in general and cancer patients especially expect to receive a high quality of 
care, that‘s need appropriate services in a technically competent manner, good 
communication, involvement in decision making, effectiveness, safety, timely, efficient 
and equitable introduction of care (Berwick, 2002).but unfortunately; not all what we 
desire we always received, The complex management of cancer cases is based on the 
integration of multiple services, which involves multidisciplinary teams working at 
primary, secondary and tertiary care (Blazeby, et al. 2006). To provide high quality of care 
it is not enough to be effective in the technical spect, the client-centered approach is 
another dimension necessary to improve the quality of care and lead to better patient 
satisfaction (Massoud, et al. 2001; Davis, et al. 2005; Moran, et al. 2008).  
A study  was conducted by Anan (2011) it showed that there are three main factors 
identified by the patient as good quality of care is the availability of drugs (67,3%), 
respectful interactions with health care provider (46.5%), followed by being curing of the 
disease (34.5%) (Anan, 2011). 
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Another study was conducted by Abu-El-Noor about the quality of life care of patient with 
prostate cancer in Gaza, he identified many challenges that facing cancer patients and it 
revealed that 61% of patients reported that they face some barriers at a certain point and 
75% reported that they met at least one barrier. Abu-El-Noor categorized barriers into 
major categories and designed descriptive models for the barrier to health care (Abu-El-
Noor, 2010). 
2.2.10  Breast cancer survival 
The survival rate is defined as: ―The percentage of people in a study or treatment group 
who are still alive for a certain period of time after they were diagnosed with or started 
treatment for a disease, such as cancer‖ (National Cancer Institute, 2016). 
The most general health outcome measurement used is survival. For breast cancer as well 
as other cancers, 5‐year survival is often used to evaluate the success of treatment as a 
surrogate parameter for overall survival. However, a 5‐year perspective is not sufficient to 
estimate the rate of breast cancer patients that are actually cured since some patients may 
experience relapses after having been disease free for many years. It is therefore also 
relevant to look at 10‐year or even 15‐year survival rates in order to determine the actual 
outcomes in breast cancer.  
Europe‐wide analyses of cancer survival over the last two decades show a steady 
improvement of the relative survival from breast cancer in all European countries, but at 
different rates (Coleman,et al. 2003). Finland, France, Sweden, Italy, The Netherlands and 
Norway have reported the highest survival rates since the 1980s and to the current time. 
Spain reports a great improvement in breast cancer outcomes in the last two decades, from 
65% to over 80% and presents today survival data in line with the countries with best 
outcomes in Europe (left graph). Germany and Denmark have, despite relatively high 
survival rates already in the mid‐1980s, according to available data not reached survival 
rates above 80% in the latest assessment available (outcomes for Danish patients diagnosed 
in 2000‐2002 were not available). The UK and Slovenia reported survival trends that have 
increased from 60‐65% in the mid-1980s to 75‐80% according to the latest assessment and 
Poland reports an even higher improvement in survival in the last10 years (De Angelis, et 
al. 2009). 
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 A study was conducted by Alrun (2017) it revealed  that the survival rate of colorectal 
disease in Gaza is affected by co-morbidity status, smoking, stage of diagnosis, tumor 
grade, tumor site, and treatment type (Alrun, 2017). 
2.2.11  Evaluation 
WHO defined evaluation as a systematic examination and assessment of the features of an 
initiative and of its effects, in order to produce information that can be used by those who 
have an interest in its improvement or effectiveness (WHO, 1998). Wheelen (2006) 
defined evaluation as it is the process in which any organization control its activity and 
performance results are monitored. It compares the actual performance or achievement 
with the desired performance, allow the decision makers and planner to take a feedback for 
their action, to use those result to correct any underperformance or to take corrective action 
and intervention. Nevertheless, evaluation is a mandatory step it dons as final step for any 
strategy (Wheelen, 2006). An important item in the evaluation of cancer management is to 
identify the existing gaps and barriers. 
A study was conducted by (Abo Amer) 2012 about Cancer Prevention and Control 
Evaluation of the Strategy in Gaza Governorates and it revealed that there are many gaps 
in the strategy of cancer control in Gaza Governorates starting from planning phase to 
implementation phase. These gaps are mainly related to poor financial and administrative 
coordination, shortages in health care human resources and inadequate staffing, 
inappropriate infrastructure of oncology buildings and deficiencies in necessary equipment 
and supplies. Moreover, there are heavy workloads on health personnel, prolonged waiting 
times for patients joined with poor privacy and comfort ability. In addition, the results 
showed the absence of clear guidelines and policies that should regulate the workflow and 
referral systems between health facilities. Regarding the (Abo Amer, 2012). 
Another study was conducted by (Hamad, et al. 2016) about evaluation of palliative care 
services provided to cancer patients in the Gaza Strip, it revealed that a total of 374 
respondents out of 396 (94.4%) positively responded and participated in the study. The 
overall mean percentage of all items for all domains, which reflects the availability of 
palliative care, is 68.72%, which means that the provided palliative care services are 
reasonably moderate. The medical aspect of care provided by physicians elicited the 
highest score (74%); meanwhile, the nursing aspect of care scored less (68%). Younger 
patients, whose malignancies were discovered at early stages and those who were treated in 
33 
 
one single hospital, elicited higher scores with statistically significant differences in 
comparison to their counter groups. Despite being available, palliative care services are not 
well-framed in Gaza‘s hospitals (Hamad, et al. 2016). 
From the aspect of screening, a study was conducted by (lamyian, et al. 2007) about 
barriers to and factors facilitating breast cancer screening among iranian women: a 
qualitative study, it showed that the main facilitating factors for breast cancer were self-
care, fear, proactive coping, state of mind and advocacy. On the other side, barriers were 
negligence, cancer related fear, low self-efficacy, fatalism, misinformation, ineffective 
health communication and competing priorities (lamyian, et al. 2007). 
A cross sectional survey For 370 female teachers working at Governmental schools in 
Gaza city  was condected by Abu-Shammala & Abed (2015) about Breast Cancer 
Knowledge and Screening Behavior among Female School Teachers in Gaza City and it 
revealed that  more than 75% of women had never undergone clinical breast examination 
and 60% had never undergone mammography, whereas 62% performed breast self-
examination (BSE). Women who performed BSE had significantly higher knowledge 
about breast cancer screening (P=0.001). Women attending CBE and mammography 
screening also had significantly higher knowledge (P=0.001). There were significant 
associations between the practices and presence of positive breast cancer family history 
(P= 0.002) and the level of education of husbands (P=0.024). The oldest women 
demonstrated higher performance rates of screening methods than the youngest (P = 
0.001). Lack of breast screening knowledge was identified among more than one third of 
the women, and 24.6% of women did not know any screening method. About a half of 
women harbored misconceptions about breast cancer screening, including the belief that 
breast cancer not treatable. Women residing in Gaza city (P=0.00) and with husbands less 
educated were more likely to have a high level of misconceptions (P=0.01) (Abu-
Shammala & Abed, 2015). 
Regarding cancer management services, Evaluation of the strategic cancer care initiative 
report (2015) showed that the Gaza Strategic Health Plan indicates there are serious 
problems with the cancer services available in the Gaza Strip with shortages in human 
resources, inappropriate infrastructure and equipment for oncology services, deficiencies in 
necessary drugs and supplies, and an absence of clear guidelines and policies for referrals. 
It is thought that the shortage of drugs for chemotherapy in Gaza may contribute to 
increased referrals out of Gaza for treatment as well as failures in treatment. 
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3 Chapter Three 
Methodology 
3.1 Introduction 
This chapter discusses the method at which the relevant information is gathered in order to 
answer the research questions or in order to analyze the research problem, including 
research approach, research design, instrument modifications, recruitment sample, study 
population, eligibility criteria, pilot study, data collection procedures and way of data 
analysis. The analysis includes investigation of reliability and validity of the modified 
instrument, limitations of the study and ethical and administrative approval. 
3.2 Study Design 
Research design is the overall plan for connecting the conceptual research problems to the 
pertinent (and achievable) empirical research in which the researcher adopts to develop 
information that is accurate and interpretive. The design of this study is triangulated design 
in which both data quantitative and qualitative approaches are used in order to strengthen 
the design and reduces any weaknesses in either approach (Phellas, 2006 and Punch, 
2005). The triangulation model is frequently used in health research, the purpose of the 
triangulated design is to gather both quantitative and qualitative data at the same time 
(Bowling, 2005) and this method will increase the confidence in study research findings 
(Burns, 1997).  
The quantitative part presented by four checklists that developed to help in identification 
number of the available rooms for patients and beds, human resources, diagnostic 
equipment and for auditing the completeness of patient‘s files. The checklist part of the 
study helped the researcher to use structured framework (Stufflebeam, 2000). The 
qualitative method includes three parts; key informative interviews, breast cancer patient 
focus groups and life histories for breast cancer patients.  
3.3 Study Settings 
This study carried out in all centers and departments involved in breast cancer management 
in the Gaza Strip. This includes the main hospitals for providing the breast cancer 
management, Shifa hospital, which include the central Archive, histopathology laboratory, 
surgical department and radiology center. European Hospital, which includes cancer 
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outpatient clinic, surgery department and radiology center, and Rantisi Specialized 
Hospital, which includes cancer outpatient clinic and inpatient departments. In addition to 
all governmental hospitals which are known to be concerned about breast cancer 
management in the Gaza Strip. 
The study included also health information centers as information technology unit of MOH 
and Cancer Registry of the MOH as they considered of the main sources of breast cancer 
management data. 
By the end, the study concerned on the data from primary health care clinics, public breast 
cancer associations and private centers and non-governmental hospitals which are 
concerned with breast cancer management. 
3.4 Study Period  
The study started in February 2018 and completed in March 2019.  
3.5 Study population 
3.5.1  Quantitative study population 
Breast cancer patient medical records: are group of inpatient and outpatient files for each 
breast cancer units at (Shifa hospital, Al Rantisi Specialized Hospital and European Gaza 
Hospital) and it were selected according to its availability.  
 Diagnostic facilities: basic x- ray, basic lab, mammography, CT, fluoroscopy, MRI, 
Gama Camera, linear accelerator, pathology tests. 
 Breast cancer service rooms (cancer beds) of Shifa, European Gaza Hospital and 
Rantisi Specialized Pediatric Hospital. 
 The number of all health staff in oncology service, hematology, surgery, pathology, 
radiology service running the cancer beds/departments in Shifa, European Gaza 
Hospital and Rantisi Specialized Hospital. 
3.5.2 Qualitative study population 
Qualitative population includes: Health care providers, specialists, directors who are 
involved in breast cancer management, the selection criteria depended on their positions 
and roles in breast cancer management. In addition to the breast cancer patients who are 
receiving medical care. There are two separated groups of patients selected, one group of 
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patients from European Gaza hospital and other one of patients from Rantisi hospital, they 
asked to participate in focus groups to discuss their satisfaction and perspective toward the 
provided services, in addition to two life histories for two breast cancer patients, the 
selection of life histories based on the experiences of patients (referral process, diagnosis, 
survival, and treatment). 
3.6 Sampling process 
3.6.1 Sampling of quantitative data  
The researcher planned to collect data from a sample extracted from the expecting total 
registered breast cancer cases from the year of 2016-2017, which were 684 cases, but 
during data collection there are some gaps were faced in the availability of medical files. 
The researcher reached to 120 files from the three targeted hospitals which include: Shifa, 
Rantisi Specialized and the European Gaza hospitals and other files are not found during 
data collection; therefore, the researcher examined all the available files. 
3.6.2 Sampling of qualitative data 
The method of selecting patients to participate in the focus groups, the key informants for 
the in depth interview and life histories were a purposive sample. It is a non-probability 
method which aims to select people purposively whom are involved in breast cancer 
management, this method help the researcher to gather direct information from the target  
knowledgeable in addition to that, it's easier and quicker to do and economic method 
(Burns, 1997; Dolan, 2001) 
3.6.2.1 Selection of breast cancer patients to participate in focus groups 
Selection of breast cancer patients started in the outpatient clinic where the researcher 
observed the patients who are receiving oncological services. Then, the researcher took in 
consideration the appropriate time to make the first contact with potential participants. The 
researcher presented himself to the patients and explained the goals of the research, the 
importance of their role in participating in this research that might help in improving the 
quality of care for breast cancer patients. The researcher ensure the confidentiality and 
privacy. The researcher took the phone numbers of the patients who agreed to participate 
and called them to fix a tables appointments with them. The researcher was confirmed that 
all participants in the study agreed to participate (informed consent).The researcher 
selected two focus groups patients then the researcher conducted two focus groups one for 
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9 women from European hospital and the other for 10 women from Rantisi specialized 
hospital. Each group discussion last for 1-2 hours discussing their needs, satisfaction and 
their perspective about the services received, the building design, and quality of care 
services (Annex 7). This method is economical, quick appraisal technique that can provide 
managers with a direct qualitative information about the problem. It's more flexible than 
other techniques which allows the facilitator to discover unexpected issues and encourages 
interaction among participants (USAID, 2011a). 
3.6.2.2 Selection of key informants interviews 
The selection of the key informant is a purposive sample started by writing a list of 13 key 
informants from different places: MOH, NGO's and private sectors, who had the 
knowledge about breast cancer management and responsible for providing or planning for 
providing breast cancer services. The researcher started calling each key informant, 
introduce himself and the aim of the study and set a suitable appointment with him/her. 
The researcher assured the privacy and confidentiality, during the interview. The 
researcher answered all the key informant concern about the study. The researcher 
presented the administrative approval that obtained from the MOH to conduct the study. 
This way assisted the researcher to gather important information regarding the problem 
directly from knowledgeable people and it help to explore the other side of the picture with 
are hidden in reality in addition to that it provide a sense of flexibility which give the 
chance to discover new ideas and issues not expected during planning of the study, 
moreover its inexpensive and easy to conduct (USAID, 2011b). 
 
 
 
 
 
 
 
 
38 
 
Table (3.1) Distribution of key informants who are involved in the interviews 
Organization 
No. of key 
informants involved 
Speciality or position 
MOH 9 
Two consultants oncologists, Two 
specialists surgeons, Manager of 
cancer registry, Head of 
histopathology department, Nursing 
manager, Oncology pharmacy 
manager and Radiologist 
NGO's 1 
Manager of NGO which provide breast 
cancer services 
Private 3 
Manager of private hospital and  two 
consultant surgeon 
Total 13  
3.6.2.3 Selection of breast cancer patients to participate in life history interviews 
The life history approach attempts to structure the process of the telling of stories to yield 
rich, in-depth details about the specific life experiences, memories and interpretations that 
the individuals produce during her life, so the selection of breast cancer patients for life 
history interview was purposively from outpatient clinic or inpatient departments who are 
receiving oncology services based on the experiences of patients (referral process, 
diagnosis, survival, and treatment). 
The researcher presented himself to the patients and explained the goals of the research, 
the importance of their role in participating in this research that might help in improving 
the quality of care for breast cancer patients, the researcher ensured the confidentiality and 
privacy. The researcher selected two patients for life history interview then the researcher 
conducted two life histories interview one for woman from European hospital and the other 
another woman from Rantisi specialized hospital. Patients discussed their needs, 
satisfaction and their perspective about the health services received, the building design, 
quality of care services, referral process by their own words. The researcher has to be alert 
of his role during the discussion. The researcher must be sharp enough to probe the hidden 
issues to be raised in the surface. 
39 
 
3.7 Eligibility criteria 
3.7.1 Inclusion criteria 
3.7.1.1 Selection of focus groups participants 
 Breast cancer patients aging between 25- 65 years and were diagnosed during the 
last 2 years. 
 Who was diagnosed with breast cancer and receiving care from cancer services at 
least for six months. 
 Physically and mentally are being with the ability to respond.  
3.7.1.2 Selection of key informative persons:  
The researcher selected the managers based on their positions and participating in breast 
cancer management for at least two year and still working. 
3.7.1.3 Selection of life history patients: 
The researcher selected patients based on their experiences (referral process, diagnosis, 
survival, and treatment) and suffering who are diagnosed during the years 2016-2017. 
3.7.1.4 Selection of patients files:- 
Files are selected based on patients who are received breast cancer services in 2016-2017. 
3.7.2 Exclusion criteria 
3.7.2.1 Exclusion criteria for focus group:  
 Breast cancer patient suffering from contagious disease (to protect others 
participant patients). 
 Patients who are physically and mentally unable to participate in focus group. 
 Breast cancer patient who received breast cancer services for less than six months. 
3.7.2.2 Exclusion criteria for key informants: 
 Key informant people who have experience less than two year. 
 Key informant people who do not practice their tasks and responsibilities currently. 
3.7.2.3 Exclusion criteria for files 
 Damaged files. 
 Files of breast cancer patients who didn‘t receive any health services since 2016-
2017. 
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 Files of breast cancer patients, which is not presented in the archive of cancer 
service.  
3.7.2.4 Exclusion criteria for diagnostic facilities: 
 The ultrasonography in the maternity and cardiology services. 
 Damaged and not working equipment.  
3.7.2.5 Exclusion criteria for human resources  
 Human resources who are not on their jobs 
 Volunteers  
 New employees for less than 2 years. 
 
3.8 Development of tools 
3.8.1 Quantitative study  
The researcher used Adult Medical Record Review Tool-Primary Care Provider, Emblem 
health (2012) model to evaluate the breast cancer patients files that are selected according 
to the inclusion criteria (Annex 6). This model includes the following: biographical data 
about the breast cancer patient, author identification, medication record, allergic and 
adverse effects, illnesses, history and physical examination and follow up. 
3.8.2 Qualitative study 
Open-ended questions prepared for key informants, focus groups and life history, based on 
related literature reviews like-books, journals, articles periodicals, published and 
unpublished research studies, it was reviewed and used for the development of tool. 
Experts in public health and oncology units are consulted for developing appropriate tools. 
In the open-ended questions, designed topics, which reflect personal opinions, feelings, 
and views, were avoided.  
3.8.3 Development of checklist: 
The researcher used four checklist to evaluate BC management which include: number of 
the available rooms for patients and beds (checklist number one- annex 3), human 
resources (checklist number two- annex 4), diagnostic equipment (checklist number three- 
annex 5) and for auditing the completeness of patients files (checklist number four- annex 
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6). The checklists included the information that the researcher planed for covering about 
breast cancer management. 
3.9 Data collection 
Data collection process started after obtaining ethical and administrative approval from the 
appropriate departments, the collection of data started; privacy and confidentiality were 
maintained at all times. 
3.9.1 Quantitative data: 
The researcher selected tool to evaluate breast cancer patients file which are selected based 
on the inclusion criteria from Shifa, European and Rantisi Specialized hospitals. 
3.9.1.1 Checklist 
The researcher used four checklists helping to identify number of the available rooms for 
patients and beds (checklist number one- annex 3), human resources (checklist number 
two- annex 4), diagnostic equipment (checklist number three- annex 5) and for auditing the 
completeness of patients files (checklist number four- annex 6).  
The researcher collected data from the three major hospital providing cancer services: 
Shifa, European Gaza Hospital and Rantisi Specialized Hospital and other governmental 
hospitals in the Gaza strip in addition to private centers, hospitals and semi and non-
governmental hospitals. 
3.9.2 Qualitative data: 
3.9.2.1 Focus group 
The researcher conducted two focus groups one for 10 women from Rantisi specialized 
pediatric hospital (temporary place) and the other for 9 women from European hospital. 
Each group discussion was for 1-2 hours discussing their needs, satisfaction and their 
perspective about the services received, the building design, and quality of care services. 
Patients focus group discussion was in Arabic language, the patients used a surname for 
more confidentiality. 
Interviews schedule contained number of questions that were clear, brief, and reasonable 
sometimes others asked for more explanation or to expand on a topic. The interview 
conducted in a comfortable environment. The researcher choose the place to conduct focus 
group as it is quiet, accessible, neutral, secure and comfortable. 
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Open-ended questions were used because it's helpful that allow participants in the study to 
tell their story using their own words and add they can add details that were hidden for the 
researcher. The moderator and his assistant used tape recordings in addition to written 
notes. These notes should be holistic and reflect the content of the discussion as well as 
body language behavior (facial expressions, hand movements) should be written. As 
possible as after finishing each group interview, the team summarized information that 
gathered from the participant, in addition to the team‘s impressions, and implications of the 
information for the study (USAID, 2011a). 
3.9.2.2 Key informant  
The data gathered from key informative person's interviews were conducted at the place 
preferred by the key informant after taking a consent form to participate in the discussion, 
an explanation of the purpose of the interview, the intended uses of the information and 
assurances of confidentiality were provided. The data was collected through audio 
recording and written notes by the researcher (Annex 8), and the transcript was done 
immediately after the meeting. Theses transcripts were considered the study raw data, 
which after were analyzed and interpreted (USAID, 2011b). 
3.9.2.3 Life history  
The researcher was conducted two life histories interviews, one for life history interview 
was with breast cancer patient who have experience with referral process to seek for 
treatment and what are the obstacles that she faced it? And the other was with breast cancer 
patient who has experience with diagnosis journey and her feeling of survival after she had 
medications, after that the researcher took a consent form from the patients to participate in 
the study, an explanation of the purpose of the interview, the intended uses of the 
information and assurances of confidentiality were provided. The data was collected 
through audio recording and written notes by the researcher, and the transcript was done 
immediately after the meeting. Theses transcripts were considered the study raw data, 
which after was analyzed and interpreted (USAID, 2011a). 
3.10 Data analysis: 
3.10.1  Quantitative Data: 
The researcher used the Statistical Package for Social Sciences version 20 for data coding, 
entry and analysis. All data in patients medical files were statistically analyzed using SPSS 
computer software. This was done through several steps; checking and verifying the 
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collected data from errors as missing data. After that data was entered through the mode 
was prepared, data cleaning and then the processing of this refined data was established. 
SPSS program version 20 was used as statistical programs to analyze the obtained 
quantitative data. Each item of the breast patient‘s medical files was assessed through 
frequency tables. Numbers and percentages presented the results through the used tables in 
the result chapter.  
3.10.2  Qualitative data: 
The researcher analyzed the data after several consultations with the supervisor. The 
researcher obtained the main findings from the transcripts of the key informant interviews, 
focus groups and life histories. He started by deep reading of the raw data until he became 
familiar with it, in other words the researcher has become immersed with data.  
The researcher examined data again to identify words or phrases on common, highlighted 
them via software (Pope, 2000). This process was continued until the transcripts has been 
finished, at the same time a margin notes were taken that help in identifying themes 
(codes) which are health workforce, services delivery, health information system and 
research, essential medications, health financing, leadership and governance, buildings, 
breast cancer management in Gaza, screening, quality of care and follow up and referral 
system. The researcher was passed after that to the next step, which is the process of 
coding that means to integrate categories, condensing subcategories into broader categories 
where by comparisons were drawn amongst the emerging themes. The researcher was 
displayed the important data in a way that the interpretation became easy, the process 
permitted to assemble or reconstruct the data in a meaningful or comprehensible fashion 
(Abo Amer, 2012). 
3.11 Scientific rigor 
3.11.1 Quantitative data: 
Rigor refers to the working extent that the researcher applied to enhance the quality of the 
studies. In quantitative data, this is can be achieved through measurement of the validity 
and reliability. More effort was applied to improve validity in quantitative data which 
means the extent to which any measuring instrument measures what it is to be measured, 
so the researcher should take into his consideration that it is necessary to consider how 
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effective the instruments were used in collecting data which answers the research questions 
and is representative of the sample. 
From the reliability aspect, test is called a reliable when it can be used by a different 
number of researchers under stable conditions, with give consistent and fixed results. 
Reliability reflects consistency and replicability over time. In other words, reliability  
means to which degree is the test free from measurement errors, which mean the more 
measurement errors occur the less reliable the test, So the researcher tried to improve 
reliability by standardization of data collection methods, follow up for the gathered data 
was obtained for mistakes , in addition data review should be done before data analysis. 
3.11.2 Qualitative data: 
Unlike the quantitative data, the qualitative data reliability and validity replaced by data 
trustworthiness, which can be obtained and improved by the following criteria: 
 Credibility which means confidence in the truth of the findings. 
 Transferability which means that the findings and results of the study can be 
generalized to other contexts. 
 Dependability which means that the findings are consistent and could be repeated.  
 Conformability which means that the researcher is neutral, the findings are shaped 
by the participant and not researcher bias, and have no interest. 
There are several ways are used to increase credibility in qualitative data like the 
following: 
 Triangulation: in this method the researcher view the research problem from 
different aspects by using different data collection ways and use different theories 
to mirror the developing result (Ohman, 2005). 
 Peer review: the researcher prepared open ended questions for key informants 
interviews and focus groups, then asked two experts to revise the questions in order 
to enhance the quality of the questions and to assure that it will get the required 
answers for the research study. 
 Pilot interview and pilot focus group: before starting the study, the researcher made 
two pilot trials for the in depth interviews with key informant persons and the focus 
groups participants. This helped the researcher to assure the suitability of the 
questions, and examine the questions that understood well or not. In addition, this 
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allowed the researcher to measure the required time needed for the interviews and 
the focus groups. 
 Begin writing early, after finishing in depth interviews and the focus groups, the 
researcher should analyze them directly. This helped the researcher to memorize 
voice tones, facial expressions m body language and general discussion 
atmosphere. This enhanced the transparency and reliability of the results. 
 Prolonged engagement: this methods help the researcher to assure that the 
participants understand the meaning of questions and also search for the 
appropriate answer by asking questions from different aspects. 
 Audit trial: in this way the researcher explained the research steps through this 
chapter to assure the transparency of the research steps. In addition, the researcher 
kept all the records the tapes, the transcript, and written notes for the in-depth 
interviews and the focus groups, product of data reconstruction. 
 Member check external audit with the supervisor  
3.12 Pilot Study 
Pilot study is a preliminary small-scale studies which aim to investigate whether crucial 
components of a main study and it can reveals gaps in the design of a proposed procedure 
and these can then be addressed for small group of participants then after checking it 
expended on large scale studies. Pilot study was done before starting data collection for 
further improvement of validity and reliability of the study through taking consultation 
from experts' researcher to check and evaluate questions of focus group breast cancer 
patients and key informant questions. A pilot focus group and pilot key informant 
interview were done and they aren‘t included in the study analysis. The researcher should 
check the needed equipment is working well before the interviews are done.  
A pilot study was carried out in 5 breast cancer patients from Rantisi hospital. Cases were 
randomly selected from the list of patients were identified by the researcher to evaluate its 
clarity and to determine whether it was friendly and easy to understand, considering 
inclusion criteria in order to test the study tools and to revise the methods and logistic of 
data collection before starting the actual fieldwork. 
The pilot study also was investigated the following: (1) how long it takes to complete the 
questionnaire; (2) whether participants felt they had enough opportunity to share their 
views; (3) suggestions for changes; (4) other comments.  
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3.13  Ethical and administrative considerations: 
The researcher maintained throughout the research an adherence and commitment to the 
ethical principles developed by Helsinki declaration. Ethical approval to carry out the 
study was obtained (Annex 9). Approval letters were sent to the general director of 
hospitals (Annex 10). In addition to the approval was obtained from Al-Quds University 
before starting the thesis. Official letters were sent to the Palestinian Ministry of Health, 
the all governmental hospitals and other institutions to obtain the approval request for the 
study. An informed consent attached to each focus groups, life histories and key 
informants interviews obtained from each participant in the study. The researcher 
explained the purpose and the objectives of the study to all the participants, and the 
inclusion in the study was optional and confidential. Neither name nor personal data had 
been published. All participants were received sufficient information about the goal of the 
study and the procedure of data collection to encourage their participation, with assurance 
of their confidentiality and anonymity and having the freedom of being a member of the 
study population.  
Files manipulation were performed delicately to prevent any damage or loss. Honesty in 
data collection, reporting, analysis and respecting of results were assured, also sharing of 
findings with others whom are interested such as managers and associations to get 
maximum benefits of the research. 
3.14 Limitations of the study 
 The Arabic Publication: literature, research and studies are insufficient. 
 Qualitative methods often contain small samples and personal perception and could 
skew the sample towards patients who find it easier to talk about their illness. 
  There are some cultural barriers for women participation, the researcher sometimes 
need to take the approval from patients husbands in order to participate in the focus 
group. 
 The physical and psychological condition of the patients represented as a challenge  
to participate in the focus groups because sometimes they didn‘t have the enough 
energy to take due to medications side effects  
  Collection of patients in one place at the same time is considered another obstacle 
due to differences in patients priorities as work, social life and health conditions. 
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 Taking appointments from key informants for interviews was taken some times 
long periods due to their free times. 
 Cost and time. 
 Limited published up-to-date reports especially from the MOH. 
 Poor handwriting of some physicians in the patients medical files, made it difficult 
to read it and fill the checklist. 
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4 Chapter Four 
Results 
 
Introduction 
This chapter explains the results of the quantitative and qualitative data obtained in this 
study based on using WHO six building blocks which include: Health Workforce, Services 
delivery, Health information system and research, Essential Medicines, Health Financing 
and Leadership and Governance. The researcher thought that by using the qualitative data, 
probably he could illustrate some points about breast cancer management in the Gaza strip 
and he could discover where the gaps are. 
4.1 Human workforce  
Teamwork is fundamental to the successful delivery of breast cancer treatment. Human 
resources play a crucial role in the process of breast cancer management. Every cancer 
patient has the right for holistic health approach which include: timely access to diagnostic 
facilities, referral to specialists oncologist in efficient way, evidence based treatment and 
regular effective follow up care to ensure the best possible prognosis and quality of life. 
Breast cancer management can be effective when it starts prevention, including health 
education and promotion to the healthy population and those living with a cancer diagnosis 
after their treatment in addition to regular screening programs to detect the disease as 
possible as (Society and college of radiographers, 2014). 
As shown in (annex 11), there are lack of staff and other resources can be a significant 
impediment in the process of diagnosis and treatment of breast cancer patients. To be more 
specific if we look to the total number of oncologists in Gaza it equals (7) which represent 
about 0.4 per 100,000 who are responsible to treat and make follow up for all the cancer 
patients in the Gaza Strip. This situation will increase the burden and pressure on them 
despite obvious increasing in the number of cancer patients in the Gaza Strip, this will lead 
to increase the medical mistakes and decrease the quality of care and treatment plan will 
provided to the patients. The rate is 1.4 per 100,000 in Australia and 3.5 per 100,000 in the 
United States and 0.7 per 100,000 populations in Ireland. 
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The National Cancer Control Programme (NCCP) in Ireland recommends 1.8 medical 
oncologists per 100,000 populations, which means that the oncologists number are too 
much little comparing to Gaza Strip total population, in same time the total number of 
nurses who work in oncology departments in inpatient and outpatients departments equal 
(51), which the number is too low in comparing to the total number of cancer patients in 
the Gaza Strip, so this will effect on both staff that will be exhausted and to the quality of 
care provided to the patients that will be affected negatively. 
The shortage of human resources is not restricted to the oncologists but it includes also 
psychologists, radiologists, and pathologists, as mentioned in the table (annex 11) it 
appeared that the number of pathologists in the governmental hospitals of Gaza was only 
five which represent about 0.3 per 100,000 distributed as four at Shifa hospital and one in 
the European hospital. Pathologists are considered the core in understanding of disease and 
disease mechanisms to bear on patient diagnosis and management. We can conclude from 
the qualitative and quantitative data there is a severe shortage in pathology specialists in 
Gaza compared to the total number of patients in Gaza. Compared to the estimated number 
of pathologist in Egypt which is 369 (Regional Health system Observatory WHO, 2006a) 
and in Ireland 2.4/100,000 while 5.7 per 100,000 people in the U.S (Wolff, et al. 2013).  
Data in the (annex 11) shows that the number of radiologists in the three governmental 
hospitals were 17 radiologists doctors who served all the patients not only cancer patients 
which represent about 0.9 per 100,000. Alwan (2001) reported the shortage of the 
radiologist in EMR which was been estimated as 3 in 100,000 population compared to 
Europe where the number of radiologist is 8 per 100,000 population. While in 2015, the 
UK had an estimated 4.8 consultant radiologists per 100,000 people and 7 radiologists 
(including trainees) per 100,000 people and this consider as one of the lowest in Europe, 
and compares to a mean of 12 radiologists per 100,000 population for Western Europe (GE 
Healthcare Partners, 2018). 
  Healthy and good nutrition is considered as part of treatment for cancer patients because 
both the illness and its treatment can affect patient's appetite and have other side effects.  
Both cancer and cancer treatments can also affect negatively on patients body's ability to 
tolerate certain foods and use nutrients in addition affect to bowel movement (ACS, 2018). 
Nutrition therapy is used to support cancer patients to preserve on their healthy body 
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weight, structure, and strength, keep body organs healthy, and decrease side effects of 
treatment (NIH, 2018). It‘s a clear from the (annex11) that there is no nutritionist for 
cancer patients in all the three governmental hospitals which increase the burden on the 
patients as they need to know which nutrients they should eat and which they shouldn't, 
there also a great variation among countries as ranged from 0.19/100,000 in Indonesia to 
39.3/100,000 in Japan and 0.1/100,000 in Pakistan (ICDA, 2016). 
Increasing number of people who are with cancer will require more medical treatment for 
cancer, long-term surveillance system, in addition to advanced palliative care centers in the 
future. For that, cancer has become a life-threatening chronic condition conforming a large 
proportion of patients that enhancing new challenges for comprehensive cancer 
management. These include individual needs and expectations may influence the patient's 
role towards active engagement in treatment decisions and treatment itself. Treatment 
sometimes may produce substantial short- and long-term side effects, some functions are 
lost in different behavioral and life domains (physical, cognitive, emotional, social, and 
vocational), as well as psychosocial distress. As consequence, quality of life and other 
functional status of the patients may be affected and reduced, in addition to many obstacles 
facing patients and surrounding persons in coping and adjustment with the disease (Weis, 
et al. 1996). As mentioned in the (annex11) there is just one psychosocial worker at Rantisi 
hospital which represents 0.05 per 100,000 which is not enough and affect the quality of 
care and psychological status of the patients, in comparing to other countries like Egypt 
0.11 psychologists per 100,000 population(WHO, 2006a) while in Brazil 9.60 per 100,000 
(WHO, 2011). This give an overview to increase the number of psychosocial workers in 
oncology departments in Gaza to support patients and decrease the disease burden. 
 Qualitative analysis regarding distribution of human resources 
Apparently, Gaza suffers from this gap. Most of key informants agreed that the shortage in 
the human resources constitutes as a barrier in breast cancer management and they 
described that by the following: 
A manager oncologist said that ―MOH doesn’t provide enough attention or care to the 
oncology departments in the Gaza Strip in general‖. He added, ―At least we need 10 
oncologists in European Gaza hospital to meet patients needs and to cover the oncologists 
gap, we requested many times to increase the number of human resources who are 
providing oncology services for cancer patients, but no one  need to hear us or meet our 
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requirements‖. He also said ―there are many external medical delegations visit from 
different health departments, but there is no any foreign oncologist delegation so why?‖ 
A private hospital manager said that, ―We have a big gap and trouble in the health care 
system as any general physician is sent to the oncology department without any training or 
orientation despite that it’s the most dangerous department and its cost the MOH about 
60-70% of its financing‖. Another oncology consultant said that, ―The human resources in 
the oncology departments especially oncologists are greatly inadequate due to increased 
number of newly discovered cancer cases and the staff number still the same as in the 
past”.  
A manager surgeon explained that, ―We have strong human resources who are 
scientifically and practically based, but the number of them in comparison to the total 
number of cancer patients are not enough, there is a big shortage in the quantity of 
specialized oncologists, doctors and nurses, breast cancer specialists surgeons, social 
worker for cancer patients, psychiatrists and cancer specialized nutritionists Specialists‖.  
A manager of institution for breast cancer patients care said that "For sorrow we have only 
4-5 oncologists for all cancer patients in the Gaza Strip and this effect the quality of care 
provided for the patients so we should increase the number of oncologists to decrease the 
load on them". 
A manager pathologist said that, ―pathology department at Shifa Hospital is considered as 
the largest  and the main department of pathology in the Gaza Strip, which receive at 
average 5000 cases per year, which is a huge number comparing to the number of staff in 
the department which may cause overload on the staff and increase the number of 
mistakes―. He added "Due to the deficiency in the staff in the pathology department it was 
off for many days because the resident doctor was absent for health reasons". 
A radiologist said that "about surgical aspect we have a good number of surgeons and they 
have a good experience, regarding oncology, the number of oncologists isn’t enough, we 
have radiology specialization here in Gaza, we don’t have any experience about radiology 
scholarship abroad from MOH but most of doctors are self-developed". 
One of the key informants said, ―The radiologist doctors who have the ability to read 
magnetic resonance imaging are very rare number, their number is very limited which may 
effect on the process of breast cancer management in the Gaza Strip‖. 
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A manager in cancer registry said that "about the cancer center, the staff number aren't 
sufficient for the new system, but for the system that needs a lot more, and for the quality, it 
is self-propelled. However, development and improvement is lacking in epidemiological, 
statistical and researches aspects, even in cancer registries there are gaps". 
About the psychologists and social workers, one of the key informants explained that 
"Social and emotional support in our oncology departments are almost absent and MOH 
doesn’t provide any sense of this care". Another key informant added "actually poor 
patients have double disease burden because in addition to their bad economic status they 
don’t found any psychological support in the hospitals which in consequence deteriorate 
their conditions faster than others". Another added" Governmental health insurance 
doesn’t cover psychological which decrease the dire of patients to make psychological 
consultations" 
A manager nurse said that "as nursing staff we have defect in the number but we can deal 
with it, the great deficiency in the oncologists and the quality of care provided ". 
"We tried to make in service education for nursing staff but MOH itself rejected this and 
said you need approval for that". 
From the patient perspective the researcher found that there is gap in the oncologist 
number with is compatible with key informants interviews as one patient said " we are 
waiting long time, I came from 7 am to get my treatment because the number of doctors 
aren’t enough". 
Another patient said that "I am waiting from 2 hours to see my doctor because there are a 
large number of patients and limited number of doctors" "" ػار ِٟٛ٠" I lost my day".  
"We have an experienced doctors and they respect us as patients". 
Another women said that "we appreciate the health staff job but the problem is the number 
of cases that is too much, making overload and long waiting time". 
"Nursing staff is very qualified and very respectful". 
Another women said with anger " I am a cancer patient I shouldn’t wait for long time for 
my treatment they should increase the number of doctors and nurses ". 
Another women added "Nursing team is very qualified and support us as patients ". 
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"We have female nurses which we can talk and deal with them comfortably ". 
From the collected data (qualitative and quantitative), a significant shortage in oncologists 
number was clear. The shortage of human resources is not limited to the oncologists but 
included also surgeons, nurses, psychologists, radiologists, pathologists and nutritionists 
which will lead to bad quality care provided to the patients consequently bad outcomes. 
 Training for health workforce 
Training is considered as a central objective of health workforce progress and development 
which its aim is to have sufficient numbers of qualified health staff with theoretical and 
practical competencies in addition to the social attributes which facilitate their accessibility 
and ability to reach diverse clients and populations (WHO, 2006b). It must be strengthen to 
manage any educational or technical gaps in order to deal effectively and in evidence based 
with patients which enhance food quality of life and good prognosis in patients health 
condition. 
A well-qualified health workers and effective multidisciplinary health team help in 
services delivery in high quality with effective manner to the patients. if countries need a 
positive effect on health outcomes and good prognosis, it need to develop effective HWF 
training and education that has the capacity to produce , develop and improve health 
workers in different aspects (WHO, 2012). 
 Qualitative analysis regarding training 
In the same time with the shortage of the health workforce in the oncology departments 
another problem discovered which worsen the situation, it is represented by the lack of 
training for that workforce and this was clear by key informants explanations as the 
following: 
A manager oncologists said that "Training is the backbone of diagnosis and treatment 
plan, because if the staff didn’t know what he or she do then the diagnosis and treatment 
plan will be failed and then the outcome will be miserable". 
Another oncologist added "I was outside Gaza since 2010 and till now no one help me or 
give me a chance for training here or outside Gaza, MOH didn’t provide anything for 
oncology neither in the Gaza Strip or in West bank". 
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A manager consultant surgeon ―MOH doesn’t provide or give support to any training 
courses or scholarships for health care staff in the oncology departments, they don't give 
and tiny care for this important part”. Another surgeon added that” The quality of 
surgeries should be increased by providing intensive courses for specific surgeries as 
plastic mastectomy surgery as it is almost absent in the Gaza Strip”.  
A consultant surgeon ―We have no training at all, the general idea we have, that senior 
surgeon trains his staff on what he knew from his own experience, but we don’t know 
whether the training is right or not, we have no supervision on this form of training”. 
A manager nurse said that "We tried to make in service education for nursing staff but 
MOH itself rejected this and said you need approval for that". 
"I am in oncology department from about 9 years no one came and told us what types of 
training you need, where the weakness point to strengthen are it".  
 On the other side another surgeon stated ―Every 4-5 months there are specialists doctors 
in breast cancer come from abroad to make follow up for breast cancer cases and to revise 
protocols and types of surgeries and they already do surgeries about 12 cases, so training 
is available and its good”. 
From the collected data from key informant it showed that in addition to the shortage of the 
health workforce in the oncology departments another problem appeared which worsen the 
situation, it is represented by the poor and not enough training for that workforce in 
different aspects includes cancer surgery, oncology, palliative care and pathology, all this 
worsen breast cancer management in Gaza, the researcher recommended that policy 
makers should establish a strategy to develop the heath workforce in Gaza to help in breast 
cancer management and decrease the burden of that disease. 
4.2 Services delivery for breast cancer patients 
Services delivery concept is based on understanding that effective breast cancer 
management should have sustainable services that start from primary prevention, early 
detection through effective treatment, quality and safe care, pain management and follow 
up services. For health outcome improvement there should be a multidisciplinary effort 
from all aspects to improve breast cancer prevention and control programs. 
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 Health services includes personal and non-personal services. It is considered the most 
visible functions of any health system. Service delivery means the way inputs such as 
money, staff, equipment and drugs which are combined together to facilitate the delivery 
of health services to breast cancer patients. Availability of key resources in addition to 
their management and distribution are paly a vital role in improving coverage and quality 
of provided  health services (Regional Health Systems Observatory & Emro, 2006).It 
should be to take in consideration where are services located? And to the distribution of the 
services such as mammography, transportation, chemotherapy, other medications, social 
services, etc., and if it is accessible and affordable in the same time  
But in the other hand, lack of coordination among breast cancer management activities and 
services is still an obstacle commonly recognized by stakeholders and the patients too and 
it give adverse effects toward breast cancer patients. Collaboration among services is the 
key to overcome challenges that facing staff and patients and for high quality services for 
the patients. 
 Qualitative analysis regarding services delivery for breast cancer 
patients  
The researcher reached to this conclusion through collecting and analyzing many phrases 
cited by the key informants and breast cancer patients accompanied by some facial 
expressions difficult to describe but it may represent their dissatisfaction, upset, and their 
disagreement. 
 A manager of institution for breast cancer patient care said that "There’s no coordination 
or partnership between governmental and non-governmental hospitals and centers. So 
sometimes the story turned into business oriented, and the patient will be lost in the cycle". 
A specialist surgeon said that " The number of experts radiologists are very rare (MRI isn’t 
in a ratio with population, we have deficiency in MRI) in other hand, we can’t have MRI in 
all cities of Gaza Strip as expert in MRI are rare". He added "All options of treatment can 
be done in Gaza except for radiotherapy, and we have a problem in chemotherapy as we 
have interrupted cycles (on & off)". 
Another surgeon said "We should have central services center for cancer in Gaza as Gaza 
needs only one oncology center for best options of treatment, best surgery from the first 
time, and not everyone works based on his interests". 
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One specialist surgeon for breast cancer said that "It’s supposed to have centers for 
oncology to deal with the cases from A to Z, and this we deprived from it, the unified body 
to deal with cases is not present in Gaza".  
ُ"Every one work based on his interests"ٗف١و ع ًغزشث ْلاف ٚ ٗف١و ع ًغزش١ث ْلاف" 
From the focus group analysis and patient perspective the researcher conclude that most 
patients are not satisfied about the service delivery for them as one patient mentioned that" 
there is no complete services for us as patients in the hospital "  بٕؽاؼشزشزٕث " " we are 
insulted".  
Another women added "I must be referred from one hospital to another hospital for a 
specific health services and this takes very long time". 
Other women explained that "Cancer patient should be as angel and have all services 
because we know our end is death ". 
Another mentioned that "I must go to private doctor to facilitate my services at hospital ". 
From the collected data, we can reach to the result that the oncology service in Gaza are 
inadequate, unavailable and endure many gaps especially the limited space of the services 
which lead to overcrowded rooms and increase waiting time, as consequence reducing the 
privacy and comfort, and increase the negative stress and sometimes bad ventilation and 
cleanliness. Which may influence badly the quality of care, the staff performance, 
morbidity, and morality, the satisfaction of cancer patients and as consequence bad 
outcome. 
4.3 Diagnostic facilities 
A clinical assessment of breast complaints is a crucial first step in breast cancer diagnosis 
and treatment plan. Diagnosis process needs multidisciplinary efforts which include: a 
good referral process and timely coordination of services that include: initial presentation 
for evaluation of a breast complaint, to include a medical history and a clinical breast exam 
(CBE), imaging studies, biopsy of suspicious lesions, pathology (histology/cytology) 
studies and follow up visit to examine the results of diagnostic studies and to initiate the 
suitable treatment plan. Late diagnosis process may be due to present of gaps in the 
coordination process of care and in addition may the patient can't access the care which 
affect negatively in patient general health outcomes (Zujewski, et al. 2017). The accurate 
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and timely diagnosis of breast cancer is essential to improving patient outcomes. Patient 
delays in seeking medical care for a breast complaint and system delays in breast cancer 
diagnosis, all contribute to late initiation of treatment and affect quality of care and 
outcomes. Enhancement of early diagnosis and early detection of breast cancer can be done 
through improving the accessibility of health services in addition to the good utilization of 
these services which as sequence will enhance positive health outcomes, as well as 
increase survival and quality of life for affected patients. 
There are a lot of efforts exerted by the Palestinian Ministry of Health and its partners in 
order improve the process of detecting and treating cancer, but still there are a large 
percentage of patients who are diagnosed in advanced stages, more than 60% of breast 
cancer cases get detected in the third stage of disease which give a narrow area for 
effective treatment and long-term survival (UNFBA, 2018). 
(Annex 12) shows the availability of equipment and facilities that are necessary in cancer 
diagnosis and management, the researcher found that some diagnostic facilities as basic X-
ray, ultrasound and were available in the governmental hospital and in the private sector. In 
the other side there are a gap in some diagnostic facilities like CT scan, MRI, PET scan, 
Gamma camera and linear accelerator. Total number of CT scanners are 14 distributed as 8 
in the governmental hospitals and 6 in a private and semi-governmental and non-
governmental hospitals which represents 0.7 per 100,000 which is very low in comparing 
to other countries like Australia there are 6.4 devices per 100,000 inhabitants and in 
Switzerland 4 devices per 100,000 inhabitants while in US 4.3 devices per 100,000 
inhabitants (Statista, 2017), there is an obvious variation was noticed between Gaza Strip 
and other compared countries, in the Gaza Strip the total number of CT scan is not enough 
which lead to other problems and challenges to the patients like accessibility and waiting 
time . 
There were five MRI devices in Gaza 4 of them are working they were distributed as two 
in Shifa hospital (one is working and one is bread down), one in the European Gaza, and 
one in Al Quds hospital and one in Red Crescent society. Which represents 0.3 devices per 
100,000 population, comparing to other countries like Jordan 0.2 devices per 100,000 
population while Lebanon 0.9 devices per 100,000 population and Libya 0.5 devices per 
100,000 population and Malaysia 0.3 devices per 100,0000 population (WHO, 2015), the 
researcher found that there is no big variations among countries but in general the total 
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number of MRI devices in Gaza is still not enough comparing to the total number of 
patients which increase the burden on the patients from different aspects like accessibility, 
cost and waiting time . 
There is no PET scan devices in the Gaza Strip which make an obstacle facing the doctor 
and the patients in cancer management process, so the doctor should refer the patient 
outside Gaza to do it, the Gamma Camera and the Linear accelerator were present at Shifa 
hospital but unfortunately they doesn't work due to unavailability of some pieces of 
equipment for maintenance, in comparing to other countries, Egypt has 0.52 linear 
accelerators per million, Libya has 0.32 Gamma camera devices per million and 0.16 linear 
accelerator devices per million and Sudan has 0.13 Gamma camera devices per million and 
0.08 linear accelerator devices per million (WHO, 2015). The researcher found that other 
diagnostic facilities as basic X-ray, ultrasound and fluoroscopy were available in all 
governmental hospitals, private centers and hospitals and in semi and non-governmental 
hospitals which is a good indicator for breast cancer management in the Gaza Strip. 
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Table (4.1) Distribution of mammogram and fluoroscopy 
Hospitals 
Mammogram Fluoroscopy 
Governmental hospitals 
Abu Yousef Al-Najjar hospital 0 0 
Al-Aqsa hospital 0 0 
Shifa hospital 1 2 (1)1 
European Gaza hospital 1 0 
Indonesian hospital 1 0 
Nasser hospital 1 0 
Rantisi specialized hospital 0 0 
Private hospitals and centers 
Ajjour center 1 0 
Al-Hayat hospital 2 0 
El-Helou hospital 1 0 
Gaza scan center 0 0 
Palestinian German center 0 0 
Gaza Diagnostic center 1 0 
Semi and non-governmental hospitals 
Al-Ahli hospital 2 1 
Al-Awda hospital 1 1 
Al-Quds hospital 1 0 
Patient’s friend society 1 1 
Public Aid hospital 0 0 
Red Crescent society 1 0 
Total 15 5 
(-)1: No of working devices 
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 Diagnostic mammograms are used to assess and diagnose for breast cancer after a lump, 
discharge or other sign or symptom that have been discovered after physical examination, 
while screening mammograms are used to assess women who haven‘t  any abnormal signs 
and symptoms. Screening mammography is used for early detection of breast cancer in the 
early stage of the disease, as sequence it will reduce breast cancer morbidity and mortality 
(The Palestinian National Institute of Public Health & WHO, 2014(. The previous table 
shows the total number of mammogram devices in Gaza which are 15 distributed as the 
following: 4 in the governmental hospitals, 5 in the private hospitals and centers and 6 in 
the semi and non-governmental hospitals which represents 0.8 device per 100,000 
population in comparison to other countries like Turkey there are 117 mammogram 
devices per 100,000 population and in France 73 devices per 100,000 populations (OECD, 
2019). The researcher conclude that there are a great deficiency in mammogram devices in 
Gaza which interrupt breast cancer control and management and increase the burden of the 
disease by late discovering of the cases in late stages and decrease early detected case and 
increase mortality rate.  
By reviewing the previous table there are 5 devices of fluoroscopy helping in the process 
of breast cancer management that are distributed as 3 in the governmental hospital (two at 
Shifa "one isn‘t working") and 3 in semi and non-governmental hospital . These devices 
represent as 0.3 per 100,000 inhabitants, there is no clear data about the distribution of 
fluoroscopy devices worldwide, but the researcher conclude that the deficiency in this 
diagnostic facilities can be another obstacle facing breast cancer management in Gaza.  
4.4 Infrastructure 
4.4.1 Building Capacity and Quality  
The physical environment that surrounded patients paly as important role in the healing 
process, quality of care provided and well-being and this have been proved to be 
increasingly relevant for patients and health care staff who are included in the same 
environment. The well-built environment can reduce errors, falls, and spread of infections 
as well enhancing the quality of care. The built environment can enhance the privacy, 
comfort, and control which assist in providing positive health outcomes (Huisman, et al. 
2012).  
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Sanitation of the hospital is an important indicator of quality of care provided in addition it 
will reflect patient satisfaction. Health care services which are provided should be safe, 
effective, patient-centered, timely, efficient and equitable. In addition to that hospitals and 
clinics should ensure that patients are the center in the whole health care delivery process. 
For that health facilities should be responsive to the values, beliefs and culture of patients 
in all different aspects to create healthy environment which affect health outcomes. 
Hospital concept as treatment places in all aspects should have good reputation between all 
members as such as: staff, attendants, patients and management.  
As shown in the (annex14), and after using checklist No (Annex 3) Shifa hospital which is 
considered the major hospital in the Gaza Strip didn‘t have any beds or rooms for cancer 
patients, Oncology department was transferred temporary to the Rantisi hospital from 2015 
till now. Rantisi hospital which covers middle area, Gaza city and north area of Gaza strip 
it contains just 30 beds and chairs and 12 rooms (three from the total rooms for isolation) 
for inpatient cases and 20 beds and chairs and 2 halls for outpatient cases which is 
inadequate in comparison with total cases in the mentioned areas which will effect on the 
patient privacy, comfort and quality of care provided. The same in European hospital it 
contains 30 beds and 7 rooms (two of them where isolated rooms) for inpatient cases and 
29 bed and 4 rooms for outpatient cases which is clearly insufficient for the total cases in 
Khanyounis and Rafah cities with total cancer patients beds 60 which represents 0.03 
bed/1000 population which consider very low percentage in comparison to other countries 
like Turkey 2.68 bed/1000 populations and France 6.18 beds/1000 populations, and there 
are EL-Hayat Hospital which considered one of the private hospitals in the Gaza Strip it 
contains 19 beds and 9 rooms in for inpatient cases and 1 hall with 14 beds and chairs for 
outpatient cases but it still waiting for licensing to start working from Ministry of Health. 
 Qualitative analysis regarding building capacity and quality 
The researcher concluded through collecting and analyzing many key informant interviews 
and focus group cited by the key informants and breast cancer patients accompanied by 
some facial expressions describe their disagreement and dissatisfaction about the building 
quality for oncology patients. 
A consultant oncologist said that "The buildings situation is catastrophic in the oncology 
department in the European Gaza Hospital, there is leakage of water to the walls of rooms, 
so for sorrow we have bad walls in the inpatient rooms that maybe broken anytime in 
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addition to the whole building must be reconstructed to protect the privacy of breast 
cancer patients”. 
Another consultant oncologist added that "The building quality in both oncology centers in 
the Gaza Strip doesn’t meet the low level of patients requirements, there is no respect for 
the privacy or humanity patients especially poor ones”. A senior oncologist said that 
“oncology centers in both Rantisi and European Gaza hospitals are needed to be fully 
reconstructed as soon as possible for staff and patients satisfaction in addition to have the 
best possible health outcomes”. 
A private hospital manager said “there is absent of the concepts  psychological and 
emotional aspects of the cancer patient when cancer departments are designed which 
include everything in the building such as walls colors, pillows and curtains should be 
according to standards which help in decrease patients stress, but there is  aspects didn’t 
take any attention”. He added “oncology departments are considered as the places where 
cancer patients waiting to die there, policy makers should stop and think again and 
again”. 
One of the breast cancer surgeons said that “oncology building has great deficit regarding 
to the capacity with the total number of breast cancer patients in the Gaza Strip and there 
is no respect to the patients and staff privacy or humanity”. 
Another chief surgeon said that ―our hospitals aren’t prepared well enough to receive all 
patients”. A third surgeon ― It’s for a sorrow, that patient has enough burden from her 
disease, so she needs a five stars center to start her journey with treatment plan and adapt 
with her disease”.  
A specialist surgeon added "most of our hospitals aren’t equipped enough and we have 
poor and delay in maintenance system of facilities and this increase the burden of the 
disease”. 
Another specialist added that " The current place for breast cancer patients and for all 
cancer patients isn’t suitable at all even for the staff, it is not enough, we are promised that 
we will have another better place from long time, and about the pathology department 
which consider the most important place which has a special concern it needs more 
development for equipment and staff". 
63 
 
 A manager of institution for breast cancer patients care said that "We succeeded to transfer 
33 breast cancer female to Jordan for their treatment, and they said as if we aren’t treated 
in Gaza. We don’t want to blame the siege any more, we need capacity building for the 
available workforces". 
Regarding the pathology unit a chief pathologists said "Our working place is not 
appropriate, is not appropriate place for working and its space is not wide enough, we are 
promised  from MOH to be transferred to another suitable place, but  we are waiting since 
a long period of time”. 
From patients perspective the researcher found that the result of focus group is nearly as 
key informants results with some variations. One patient from Rantisi hospital said that 
"the space is very limited and not enough ". 
"They should respect us as patients and reconstruct a specific building for cancer 
patients".  
Another patient added "the place is too much narrow, crowded and noisy". 
"The sanitation is good, but the problem is that we have mutual bathroom with males 
which is a big problem and in the same time there is no good ventilation". 
"Sanitation should be better than this because we have possibility to loss our immunity 
always ". 
One patient from European Gaza Hospital mentioned that "the place have a small size and 
narrow and there is no privacy, every patient should be in isolated room from other 
patients". 
Another women from Rantisi hospital have a different opinion said that "the place is good 
and have a good ventilation". 
Other women said "the place is generally accepted almost but the problem is the 
overcrowded". 
From the collected data we can conclude that there is inadequate building design of cancer 
service in Gaza, the main problem was the limited space, especially the number of rooms 
and the quality of it. Consequently, the rooms become overcrowded and lead to poor 
privacy, high noise, uncomfortable setting, and poor ventilation. 
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4.5 Information system and research 
 The main goal of data and research center should be used as reference to set priorities in 
health in addition to develop strategies to be confirmed that decisions making are based on 
evidence data, accurate and complete data and solid research techniques that help in the 
process of diagnosis and treatment of breast cancer, it help planners and policy makers to 
understand the size of breast cancer as a health problem and the needed infrastructure to 
decrease that burden. In addition it help planners and policy makers to assess the social and 
policy environments to decide whether or not to move forward with scientifically valid 
approaches to breast cancer control. One planner stated that ―Cancer is one of the best 
opportunities to do evidence-based public health, where we don’t implement policies 
unless we have good science behind them”. 
In contrast, when the data which used in decision making are limited, incomplete and not 
evidence based as consequence this will affect negatively in the process of planning. In 
addition to that when staff who are working in data and research unit not be integrated into 
planning this also lead to negative results, moreover breast cancer data systems or linkages 
with other surveillance programs may be insufficient and unsuitable. All these factors will 
affect negatively in the breast cancer incidence and treatment data reporting system as 
sequence data analysis will affected also. 
 Qualitative analysis regarding information system and research about 
breast cancer  
A manager oncologist said that "There is no cancer research center and researches done 
individually, there is no united system for the data". 
Another oncologist said "There is no researches ever, there are a lot of information and 
data about breast cancer and we should deal with it well and help the researches to use 
this data to decrease the burden of breast cancer ". 
A manager consultant surgeon "I don’t know if an information system presented in 
governmental hospitals regarding breast cancer patients". 
Another surgeon said "the available information about programs related to breast cancer 
management in the Gaza Strip are not enough, there should be frequent evaluation for the 
breast cancer data and information". 
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A specialist surgeon in breast cancer added "Most of breast cancer research are 
individualized and most of it from master students and it is unmanaged well, we have 
archive system and all breast cancer patients file are separated alone". 
A consultant oncologist said "There is no regular researches on breast cancer, I am as a 
doctor I should have an easy access to cancer registry to be updated, there is no central 
agency for cancer and there is no follow up from the managers and most of data about 
breast cancer is fragmented, in addition to diagnosis code which is not always used in the 
files ". 
A specialist surgeon said that "There is a national cancer center for cancer information 
and data but this is not enough we need more and more ". 
Another specialists added that "we should build linkages between hospitals, primary care 
centers and cancer registry center to make it easier to access the data for researches and 
to know where the real gaps in cancer control are".  
A specialist surgeon of breast cancer said that "we asked policy makers to make a united 
system for cancer patients including their names, ages, history of the diseases and 
everything related to the patients to overcome files loss and to make researches easier". 
A manager of institution for breast cancer patients' care said that "we don’t have good 
cancer health information system and in the available system we don’t have transparency".  
A pathologist said that "The only place for cancer information is cancer registry and they 
disseminate reports from time to time despite the bad conditions, there are good archiving 
system in the pathology department and we make follow up for patients files regarding 
pathological aspect, after that it's not from our responsibilities". 
He added that "Even now we use traditional hard copies for recording, and from 2016 
MOH made a program for reporting and research and it will depend on ICD 10 or ICD O 
systems, and before that it need a great effort to make a report".  
From the collected data, it was obvious that there are many gaps appeared in this block 
related to breast cancer management, it mainly related to the insufficient knowledge in 
research methodology and the there is no incentive factors or plans to improve the research 
in Gaza. Most of research efforts are limited and restricted to graduated thesis which done 
individually .Moreover the information system, even if it is existed in Gaza it may suffer 
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from poor linkage which can influence negatively the outcome of breast cancer control and 
consequently, the burden of breast cancer is poorly known. 
4.6 Breast cancer medical records 
Medical records are considered an important part of a breast cancer patient management 
process. Which give information about the patient health in the past, current situation and 
the future plan in addition its crucial for the continuity of patient. Moreover it has an 
important role in the process of planning and management of health care services, research 
in health care in addition to make statistics related to provide health care. Medical health 
team including doctors, nurses and others make documentation in medical records so it 
becomes easier to know the patient health history from the files in follow up visits so for 
that it should be available and saved in a suitable manner. In other side, when medical 
records didn‘t include all information about the patient health status or not saved well, this 
leads to increase breast cancer patient suffering due to loss of files or information so may 
need to repeat other investigations. If there are gaps founded in the medical record that 
affect the patient care, this means that the recording system of medical files also contains 
gaps and not working properly and all health care provided will be affected (WHO, 2006c). 
Medical records should contain complete information about the patient medical history and 
current situation in addition it should be updated because these file will help all health care 
providers who are included in the management process of cancer patients. Documentation 
of patient medical history facilitates in sharing information with new staff who will be 
included in management process as new doctors, nurses, students and psychologists. This 
will confirm to us that breast cancer patient can continue to receive the best care possible 
(Breast cancer .org, 2016). Documentation of medical notes, patient history, follow up and 
prognosis of the disease act as a learning tool, they are needed in medico-legal 
circumstances and more importantly, for patient safety and communication between multi-
disciplinary team members in addition it can be used for research to know more about risk 
factors, causes of morbidity and mortality of the disease. 
 Completeness of Breast cancer medical records in the Gaza strip 
 Medical records form an essential part of a patient‘s past, present and future health care 
(WHO, 2006d). Patient record completeness considered as quality indicator of patient 
medical record. Quality of medical patient records facilitate sharing of valuable 
information for continuing of patient care, and it would help in reducing medical errors, so 
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it will affect positively in patient safety in addition it is considered as a reference for 
decision making and health policy planning (Gommnami, et al. 2016).  
4.6.1 Demographic domain: 
After auditing the completeness of 120 files using checklist (Annex 6), it seemed that most 
items of demographic domain are necessary in the completeness of the medical files 
underwent great defects, as shown in table (4.2). About 95% of the patient's files contained 
a patient's name, which is a strong power that can help the informatics workers to record 
the cases without any confusion if it is used properly. But the rest of this domain contents 
which include (ID number, age, DOB, Gender, telephone number, address and marital 
status) are almost not available in the records or may found partially which may reflect 
negatively in the patient care safety and continuity of the care. 
Table (4.2) Completeness of demographic data domain in breast cancer medical 
records  
Demographic data 
domain 
Score of completeness 
Total 
Complete Partial Incomplete 
N % N % N % No 
Patient’s name 114 95% 5 4% 1 1% 120 
Patient’s ID number 2 2% 45 37% 73 61% 120 
Patient’s age 0 0% 38 32% 82 68% 120 
Patient’s DOB 0 0% 48 40% 72 60% 120 
Patient’s Gender 6 5% 85 71% 29 24% 120 
Patient’s address 0 0% 8 7% 112 93% 120 
Patient’s home tel. 1 1% 5 4% 114 95% 120 
Patient’s marital 
status 
0 0% 5 4% 114 94% 120 
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4.6.2 Medical record domain 
Regarding medical record domain, date entry represent 83%, chief complain represent 
74%, diagnosis plan represent 72% and discharge summaries represent 69%, which is good 
but need more strengthen to improve the quality of care provided for patients , but in 
contrast author identification had a great deficiency which may need more efforts to 
encourage health care providers to document their work to protect themselves from legal 
issues, and as shown in the table (4.3) below there is no electronic medical records for 
breast cancer patients which is very important part for patient care, the EMR can play a 
crucial role in decision making process, coordination of health services between different 
departments, categorize the care of patients according their priorities, assist in reducing 
medical mistakes, improving quality, reducing personal and financial costs, etc. In 
addition, it can facilitate transferring patient information from one health facility to another 
one in effective manner and in this way help in referral system of patients and improving 
accessibility to healthcare (Okpala, 2013).  
Table (4.3) Completeness of medical record domain in breast cancer medical records  
Medical record domain 
Score of completeness 
Total 
Complete Partial Incomplete 
N % N % N % No 
Chief complaint 89 74% 13 11% 18 15% 120 
Author identification 33 28% 13 11% 5 4% 120 
Dated entry 100 83% 20 17% 0 0% 120 
Record legacy (EMR) 0 0% 0 0% 0 0% 120 
Medical impression 33 27% 13 11% 74 62% 120 
Diagnosis plan 87 72% 21 18% 12 10% 120 
Discharge summaries 83 69% 22 18% 15 13% 120 
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4.6.3 Medications record domain  
Regarding medications record domain, as shown in the table (4.4), treatment consistency 
ranks the first percentage with represent 91% which consider a strong point that help in 
patient recovery and safety, but from the other hand medications side effects and 
medications side effects are almost lost in patients records which decrease the quality of 
medical records and this leads to increase the medical error and interrupt patient continuity 
of care.  
Table (4.4) Completeness of medications record domain in breast cancer medical 
records 
Medications record 
domain 
Score of completeness  
Total Complete Partial Incomplete 
N % N % N % No 
Treatment plan 92 77% 17 14% 11 9% 120 
Treatment consistency 109 91% 4 3% 7 6% 120 
Medication dosage 69 57% 31 26% 20 17% 120 
Medication side effects 0 0% 0 0% 120 100% 120 
Adverse reactions 3 3% 6 5% 111 91% 120 
4.6.4 Patient history and examination domain 
Documentation of the patient history and examination is important to help health care 
providers to gather more information about patient history, it also help health care 
providers to deal with the patient in an appropriate manner and they can identify the best 
treatment plan for the patient. As shown in the table (4.5) there are 38% of the total files 
has medical and surgical history which should to be more high to increase the quality of 
care provided for the patients, moreover documentation of family history and psychosocial 
history which considered important components in the treatment plan for the patients are 
not found which will affect negatively in the care provided to the patients.  
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Table (4.5) Completeness of patient history and examination domain in breast cancer 
medical records 
Pt. history and 
examination domain 
Score of completeness 
Total 
Complete Partial Incomplete 
N % N % N % No 
Family history 2 2% 11 9% 107 89% 120 
Psycho social history 0 0% 0 0% 120 100% 120 
Surgical-Medical 
history 
45 38% 53 44% 22 18% 120 
Physical exam 27 23% 58 48% 35 29% 120 
 
4.6.5  Breast cancer characteristics domain 
Completeness of breast cancer characteristics domain in breast cancer medical record play 
a vital role in the process of diagnosis and treatment plan for the patients, as seen in the 
table 4.6, in general there is great deficit in documentation of breast cancer characteristics 
in patient's files, cancer laterality represents about 47%, which is not enough and may 
interrupt patient safety , and about other contents they are partially mentioned or even not 
available which need more focusing from decision makers to enhance the documentation 
process in breast cancer medical files to prevent and decrease medical errors and 
interruption of care provided for the patients and moreover to facilitate and accelerate the 
diagnosis process which helps in treatment plan for them and decrease complications . 
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Table (4.6) Completeness of breast cancer ch.ch domain in breast cancer medical 
records 
Breast cancer 
characteristics 
domain 
Score of completeness 
Total 
Complete Partial Incomplete 
N % N % N % No 
Cancer laterality  57 47% 37 31% 26 22% 120 
Cancer 
morphology 
41 34% 21 17% 58 48% 120 
Cancer behavior 
(aggressive -metastasis) 
31 26% 22 18% 67 56% 120 
Cancer grade  21 18% 25 21% 74 61% 120 
Cancer stage  3 2% 14 12% 103 86% 120 
 
4.6.6 Chemotherapy record domain  
The quality of documentation in the medical record is dependent upon the consistency and 
completeness of information entered into the record by all individuals involved in the 
patient‘s care (Abiy, et al. 2018)). Most components of chemotherapy domain were 
recorded nearly completely as shown in the table (4.7), which affect positively on the 
patients' health, quality of care, continuity of the care and early recovery. 
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Table (4.7) Completeness of chemotherapy record domain in breast cancer medical 
record 
Chemotherapy 
record domain 
Score of completeness 
Total 
Complete Partial Incomplete 
N % N % N % No 
Diagnosis 83 98% 0 0% 2 2% 85 
Chemotherapy 
regimen 
78 92% 0 0% 7 8% 85 
Height and Weight 68 80% 0 0% 17 20% 85 
BSA 74 87% 0 0% 11 13% 85 
 
4.6.7 Overall domains 
The most complete recording across domains was identified for medical record domain 
which represent 26%,while the poorest one were indicated for demographic data domain 
1%, history of examination domain 1% and medications record domain 2%. All domains 
are partially or incompletely recorded which had many weaknesses in documentation 
process that need to be more strengthen to improve the quality of care provided for breast 
cancer patients. 
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Table (4.8) Completeness of medical records for each domain 
Items 
Score of completeness 
Total 
Complete Partial Incomplete 
N % N % N % No 
Demographic 
data domain 
1 1% 78 65% 41 34% 120 
Medical record 
domain 
31 26 % 82 68% 7 6 % 120 
Pt. history and 
examination 
domain 
1 1% 49 41% 70 58 % 120 
Medications 
record domain 
2 2% 105 87% 13 11% 120 
Breast cancer 
characteristics 
domain 
9 8 % 45 37% 66 55% 120 
Chemotherapy 
record domain 
71 84% 13 15% 1 1% 85 
        
 
4.6.8 ICD-O3  
As shown in the (annex15) Rantisi hospital ranks the first in writing ICD-O3 with 
percentage 46 %, but almost all hospitals are near to each other wish slight variations, 
about 40 % of all breast cancer files in all hospitals providing breast cancer services missed 
ICD-O3 classification and there are many files that are classified under breast cancer C50 
and in fact they are not breast cancer patients. 
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4.6.9 Variations of completeness score between hospitals 
Complete and accurate documentation of health information about the patient health status 
helping to improve the quality and continuity of care provided. It also facilitates 
communication health staff about health status of the patients, needed investigation, 
treatment plan, planning, and quality of delivered care. On measuring the completeness of 
medical records it was revealed that European hospital ranks the first in documentation of 
demographic data represent 53%, Shifa and Rantisi hospitals have almost the same 
percentage with overall percentage 34% which means that they need to be higher to 
improve the quality of provided care for patients and for patient's safety. From medical 
record aspect, Shifa hospital was the first represent 66% which is good but not enough, and 
European hospital was 55% with overall percentage 60%, this domain should be supported 
more to decrease medical errors and to help in patients treatment plan. Documentation of 
medications domain is almost the same in all hospital with overall percentage 50% but it 
should be strengthen for patient safety and decrease adverse effects of medications on 
patients. Patient history and examination domain ranks the lowest percentage among all 
domains which represent an overall percentage among all hospitals 30 % which is too 
much low that should be motivated to help in diagnosis and treatment process for the 
patients. Documentation of Chemotherapy record domain ranks the first among all 
domains between hospitals which represents 78% of overall percentages and as shown in 
the table (4.9), there is no chemotherapy services at Shifa hospital, and Rantisi hospital 
represent 88% it considers as a strong point and affect positively in the patients' health 
outcomes, in the other side European hospital represents 68% that need to be more higher 
to help in patient recovery. About the last which is breast cancer characteristics domain as 
shown in table (4.9), European hospital have the highest percentage 42% while other 
hospitals had the same percentage 28% with an overall percentage 33% which is very low 
that may affect negatively on the patients diagnosis and treatment plans. 
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Table (4.9) Variations of completeness score for breast cancer medical files by 
domains between hospitals  
Hospital name Shifa hospital 
Rantisi 
hospital* 
European 
hospital 
Total 
Demographic 
data domain 
26 % 24% 53% 34% 
Medical record 
domain 
66% 60% 55% 60% 
Medication 
record domain 
50% 
 
54% 46% 50% 
Chemotherapy 
record domain 
NA 88% 68% 78% 
 Pt. history and 
examination 
domain  
36% 30% 24% 30% 
Breast cancer 
characteristics 
domain 
28% 28% 42% 33% 
 
*Temporal place 
4.7 Cancer registry and research  
Cancer registries is unique part in the process of breast cancer management because it 
provide population-based data which assist in monitoring of geographic variation and 
changes in risk factors, survival rates, morbidity and mortality over long periods of time. It 
has an important role in the process of collecting population-based data and information 
about all cancers types which are diagnosed, treated in addition to their morbidity and 
mortality rates. Recently, most of cancer registries has expanded their work tasks to 
include the data analysis, treatment and care and what are the suitable ways for cancer 
prevention.  It also can help in assessing if the target of cancer services provision are met 
or not, it addition it can also provide policy makers about the important data for cancer 
services distributions and where the gaps are located. Its tasks are closely linked to the 
evidence bases research approaches and best practical techniques to fight against cancer 
diseases and are adapted in parallel (Arndt V., 2016). 
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Breast cancer registry aims to collect and conduct analysis on data from local breast cancer 
cases to provide comprehensive reporting on demographics, risk exposures, clinical 
examinations, treatments, clinical outcomes and psychosocial impacts on patients. These 
reports will allow patients, medical professionals and public health policymakers to better 
understand the breast cancer landscape stay informed with up-to-date facts on the disease. 
These reports will also provide insight and evidence to support advocacy for better 
prevention, detection and treatment of breast cancer (HKBCR, 2018). 
 Qualitative analysis regarding breast cancer registry and research 
Most of the key informants confirmed that there are many gaps in research and cancer 
registration and it must be strengthen and they commented by the following statements: 
Manager of cancer registry said that about breast cancer as a health problem in the Gaza 
Strip "There are many reasons that can’t be limited, but in general breast cancer may be 
the early detection of the disease increases its incidence. Because the patient can be 
diagnosed simply when she started to complain through doctors visits. In addition to the 
integrated reasons like the chemicals, radiation and pollution in general". 
"There is no cancer research department is the Gaza Strip; it is the core of prevention”. 
Another key informant commented "Breast cancer is like a war, we should won it by early 
detection and screening". 
A specialist in cancer registry explained about the real number of registered breast cancer 
cases and said that "The number of cases we have are larger than the real number because 
we rely on many sources of information, either from clinics or hospitals that provide 
surgical services. We collect cases from different sections, histopathology departments, 
referrals or death registrations. But if the numbers were less than half the numbers that 
discovered, there would be a defect". He added that "The pickup of cases is based on ICD-
O3 and the files are reviewed before that, despite that there is shortage of information". 
Cancer registry manager talked about the current cancer registry system" there is gaps and 
challenges facing accessibility of data in current existing system even in accuracy 
sometimes. The development was in computerizing the system and we are wishing that 
medical staff would apply this system and commitment with this system". He added that 
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"Research efforts in my view are individualized, we have a great gap in the researches 
which are adopted by institutions and this is may be available abroad too". 
Another key informant added that "we have many gaps in the existing registration system, 
it should be more developed and more accurate because policies made based on the 
existing data". 
A specialist in breast cancer said that "cancer registry should be computerized from A to Z 
to make it easier for accessibility and analysis". 
The manager of cancer registry talked about the main obstacles facing cancer registry in 
the Gaza Strip and said that "Firstly we have mentioned that we lack the surveillance 
system about cancer in Gaza and secondly there is no the clear statistics".  
Another key informant added " One of the main obstacles facing cancer registry which its 
need to electronic registration system". 
From the obtained data from key informants, it‘s a cleat that cancer registry play an crucial 
role in  breast cancer control as its one main part of information system but it's endured 
also some gaps and challenges, in fact there were some efforts trying to develop and 
improve it, but they are still limited with constraints. One of the main gaps are the 
performance quality is low of cancer registry due to mal coordination between hospitals, 
deficiency in the well qualified team, and in addition to the incompleteness of the medical 
files which affect negatively in the database, analysis and information system because 
based on the real information policy makers can know what are the most common 
prevalence and incidence of cancer and try to put a policy to decrease it as possible as they 
can.  
4.8 Breast cancer financing 
 It's known that the diagnosis of breast cancer is sometimes costly and in addition to that 
the journey of management is also has a financial impact. Breast cancer financial burden 
which are presented in the management process of breast cancer should be assessed 
accurately from all different aspects. Financial costs and burden still remain an obstacles 
facing breast cancer patients and their families too, with some groups bearing a 
disproportionate burden. There should be further studies and researches related to 
improving monitoring and support of financial costs in relation to out-of-pocket costs and 
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exploration of the ‗value for money‘ proposition within the private system. Reducing 
financial costs related to breast cancer patients management should be a long term goal due 
to its importance in reducing the burden of disease on patients and their families in 
addition to improving financial impacts is also important in the short term. When costs of 
management and availability of support become a part of treatment discussion and process 
it will be helpful in decreasing the burden of financial costs (Paul, et al. 2017). 
A survey was conducted by the Association of Oncology Social Work (AOSW) reveals 
that there is a negative impact in recovery process from more than half of cancer due to the 
financial costs of cancer. Health care providers who are working with cancer patients know 
well the stressors that facing cancer patients and in addition to that they understand the 
negative impact they can have on family, caregivers, and most importantly the patients. 
 Qualitative analysis regarding breast cancer financing  
Key informants summarized their concerns about the financial barriers by the following: 
A manager oncologist said that "There is no specific budget for cancer in general, a lot of 
cancer tasks done randomly as available, there is no financial support for patients, and 
there are a lot expensive tests that patients can't do it, and MOH didn’t have the 
preparedness to make contract with other organizations to decrease the burden on 
patients". 
Another manager in oncology said that "Financing for cancer is not fixed and it is 
changeable from time to time, and the current budget is from MOH in West Bank and there 
is no continuity in the medication, the cost of chemotherapy medications is very expensive 
it overcome 70 million shekels yearly (treatment outside Gaza), and the patient doesn’t pay 
from his pocket anything, and there are very rare percentage from patients who buy 
medications". 
A specialist surgeon in breast cancer said "Breast cancer patient is full covered financially 
from MOH, diagnosis cost, lab costs and surgeries are all free".  
Another surgeon said that "Sometimes breast cancer patient and most cancer patient are 
blackmailed to finish his investigations so he or she went to the private sector to end his 
investigations quickly ".  
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A manager pharmacist said that "there is something called financial toxicity which means 
that is the cost of medications and what it causes due its defect on the patient, ministry of 
health and the country ".  
A manager nurse said that "there is no specific budget for oncology, the political aspect 
plays an important role regarding this ". 
To sum up, the researcher found that there are many barriers in financial aspect which 
constituted the main obstacles facing breast cancer management in the Gaza Strip and this 
include that there is no fixed budget for oncology department costs in Gaza, the budget has 
many interruptions which affect continuity of care, in the other side breast cancer patients 
is totally financially free from the costs of care in MOH hospitals, but sometimes the 
patients go to private hospitals and pay out of pocket to fasten her care. 
4.9 Essential medications 
Cancer is a disease that have obvious increasing in morbidity and mortality rates in 
developing countries and which considered as a public health problem worldwide. The 
availability of essential medicines for cancer patients is playing an important role in the 
process of treatment various different types of cancer, there are many types cancer 
medications are available today but on the other hand it has a high cost and may have 
limited benefits. However, different efforts are exerted to evaluate the effectiveness of 
these medications but still there is a complicated gaps due to the variation in therapeutic 
end-points and the use of other alternative medications to assess the impact of treatments. 
There is a challenge in the selection of cytotoxic medications for an essential medications 
list, especially for developing countries which have a limited resources. One of the main 
obstacles is that the treatment of cancer is not defined by the selection of appropriate 
cytotoxic medication alone but treatment with an effective cytotoxic protocol is just one 
single component of a national cancer control program. A national cancer control program 
also contains of primary prevention. It should also include programs for cancer early 
diagnosis, screening, and suitable treatment and palliative care. And surely cancer patients 
often develop complications after period of time, it is also should be taken in consideration 
that they need supportive care with analgesics, antibiotics and other medications for 
treating side effects of chemotherapy (Robertson, et al. 2016).  
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Effective management of breast cancer depends on holistic process which include: early 
detection of breast cancer, good diagnosis process, and accurate treatment plan. One of the 
main challenges in the providing care to breast cancer patients is the affordability and 
accessibility of cytotoxic modifications, especially developing countries with limited 
resources (Robertson, et al. 2016).  
 Qualitative analysis regarding essential medication for breast cancer 
patients 
Many key informants noted that from the major obstacles that facing breast cancer 
management is the shortage related to the infrastructure and the medical supplies such as 
medication and chemotherapy. 
A manager oncologist said that "Medications for breast cancer patients are developed for 
advanced stages and part of this medications are not available in Gaza so we forced to 
refer the patient outside Gaza". 
Another specialist said that "There is no continuity in the medications and chemotherapy 
regimens that given for breast cancer patients, there are interruptions between cycles for 
long times and the reason still unknown, so the patients forced to buy some medications 
but not all of them can do that very low percentage can do this". 
Another specialist added that "Hormonal therapy is not available for long time about 6 
months or more so we are between two solutions and both of them are difficult on the 
patient, the first one is telling the patient to buy the medications and rare percentage who 
can buy it, the second one is to refer the patient outside Gaza and this also hard on the 
patient because it cost a lot ". 
A manager of private hospital said that "A lot of breast cancer medications are not 
available for long time, and if this medications are available in Gaza so the patients didn’t 
need to be referred and they will refuse that ". 
A manager of institution for breast cancer patients' care said that "the main difference 
between us and others which consider one of the main gap, is that we haven’t specific 
specialization in the oncology such as  palliative care specialty, palliative surgery and so 
on, the problem is what we have is the shortage in the infrastructure. MOH and the 
government should know what is the best treatment for all patients and it should be 
available always without any interruptions to prevent any delay in the treatment plan, and 
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then we can say that patients are OK regarding availability of medications, but in contrast 
if there is any interruptions of medications during the treatment plan then it will cause the 
situation more worsen, the cancer will return aggressive and metastatic. We should have a 
suitable plan to make locking on the treatment of every patient. That is why we don’t have 
high survival rate". 
A manager pharmacist said that "Essential medications for oncology are about 65 types for 
the essential drugs of MOH and most of times we have gaps in the availability of it". He 
added "From my experience, we must take care and try not to be sick as possible as we 
can, because treatment and medications are difficult to get them ". 
"Medications for cancer patients became a chronic crisis, we try to adapt with it 
sometimes there is good stock and sometimes there is a great deficiency ". 
 He explained the interruptions of chemotherapy protocols for breast cancer patients and 
said that "Sometimes oncologists can't continue the same protocol that they start with the 
patient due to the deficiency of medications ". He added "Interruptions in protocols make 
oncologists and pharmacists unable to continue the same protocol or start new one". 
"There are new diagnosed cases, we need to start chemotherapy with them and old cases 
can't continue their treatment so we lost the expected results from protocols". 
 He commented to the special criteria that they follow when there is deficiency in the 
chemotherapy and he said that "We have a special criteria in selection patients when there 
is deficiency in chemotherapy, and this make dilemma to select patients to take 
chemotherapy and other patients will not take it". He added "From 70 patients we should 
select just 10 cases to take medications and this is a hard decision ". 
"For example like Herceptin it's very important medication for breast cancer patient, every 
dose of it costs MOH about 2100$ if we have about 100 breast cancer patients need it and 
we have about 30 vials just !". 
"We have the decision for who will take the medication based on special criteria which 
include patients who are rejected for security reasons, young age patients and prognosis of 
the disease and other patients will be referred". 
"Deficiency rate was about 80% in last September and October, we have a temporary fund 
but it is not enough, we need sustainable solutions". 
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"Cancer is a matter of time, delay or prevention of medications exacerbate the patient 
condition ". 
 )ٟغ١١ٌ اٚذٌا زظزٕث بِ عزٌّا ("Cancer didn’t wait medication arrival". 
"We have a fixed stock with average from 1 month to 3 months, for in case of deficiency of 
medications". 
د ٚ"فطلاٌ ًِبو ٚ ذىفز١ث غػٌٛا بٕػ بٕؽا ٗٔا بٍٕل ٚ حززف ذعا حزِ لا ٚ .. ضمٔ ٟف بّ٠ا " "there always 
defect, no anytime there was a perfect and complete medications for sorrow ". 
"The most difficult moment is when patient asking about her medications and you reply 
that medications are not available and you don’t have any idea when it will be arrived". 
From patients perspective the researcher found that there are contradictions opinions about 
access to essential medications as one patient said that "my chemotherapy medications was 
available in all my cycles treatments, I received 4 doses and all was available". 
Some of focus groups attendants stated about the availability of their medications, for 
example one women said that "my medications was available always ". 
 One women said that "I received all my chemotherapy cycles without any interruptions". 
She added "There is no any delay in any doses of my chemotherapy ". 
Another patient commented that "my doctor prescribed 8 doses for me, just one was 
delayed due to the pervious dose side effects".  
Another patient mentioned that "I was delayed in my dose for one and half month and the 
cause was me because I wasn’t prepare myself psychologically to receive chemotherapy". 
While in other aspect one patient mentioned that "I didn’t receive my chemotherapy in the 
previous months and other three previous times due to unavailability of my medications ". 
Another women added that "I was referred to Egypt to continue my treatment plan". 
 She said too "When I heard that my medications are unavailable I became depressed and 
told myself that my death became soon". 
Another women said that "sometimes medications are available at the hospital but they 
didn’t give us all the quantity ". 
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From the collected information it seems that there are a contradictions in opinions, the 
researcher can reach to the result that in spite of the effort exerted to provide the necessary 
drugs and chemotherapy for breast cancer patients, there are still some challenges and gaps 
to overcome. It appeared the main challenge facing breast cancer treatment in the Gaza 
Strip is the sustainability of medications especially for the chemotherapy and opioids.  
4.10 Leadership and governance 
Governance in health means is how to establish effective rules in the health facilities as 
such as enhancing suitable policies, programs, and health activities in different levels 
related to public health goals to achieve health system  related objectives regarding all 
aspects (Brinkerhoff, D. W., & Bossert, T, 2008). Good leadership and governance which 
focuses in improving transparency and credibility, facilitates support and guidance, and in 
addition to  it ensures the mechanisms for approving, endorsing health for who are need it. 
In the other side, Effective management which makes follow up on the processes which are 
doing in a structured and timely manner with appropriate managerial consultation (USAID, 
2009). In contract, there still some major obstacles facing effectiveness of leadership and 
governance in the health sector which leads to the deteriorate the situation of health 
systems, as sequence the quality of care will be affected to in addition decrease the 
development process of human resources which will lead to unsatisfied health outcomes. 
 Qualitative analysis regarding leadership and governance for breast 
cancer patients 
A consultant oncologist said that ―oncology departments constitute a big burden on the 
MOH, for that MOH doesn’t give enough attention to these departments”. 
 A specialist surgeon said that ―MOH doesn’t work in effective way in the Gaza Strip, no 
any policy makers are motivated to take a decisions that enhancing breast cancer 
management in Gaza”. 
Another specialist surgeon said that “MOH neglect the oncology departments sometimes". 
He added "There should be a clear policy to support oncology departments and patients in 
all Palestine". 
One manager of private hospital said that "MOH doesn’t give oncology departments a 
priority like other departments ". He added that " they ignore it too much, there is no a 
clear policy regarding oncology in Gaza ". 
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Another key informant said that "we need a strong leadership that can support breast 
cancer management and control it". 
The researcher conclude from the analysis of key informants interviews that there are a 
huge gap in leadership and governance related to oncology departments and patients 
should be strengthen and should be give more attention to improve breast cancer 
management.  
4.11 Management of breast cancer 
4.11.1  Breast cancer Prevention  
All efforts exerted to prevent breast cancer still not enough, but on the other side factors 
that contribute development of breast cancer can be reduced by using special prevention 
and screening activities. The most important preventive activates are regarding modifiable 
risk factors such as make changes in sedentary lifestyle, good nutrition, overall physical 
activities and BMI, and interventions for females who are suspected to be in the dangerous 
area of developing breast cancer specially who are used tamoxifen and other anti-estrogen 
medications, for that, the first step to enhance prevention plan is to determine women who 
are at high risk to have breast cancer. 
 Screening and early detection programs still remain the best available measures for 
patients who are diagnosed with breast cancer to prevent complications of the disease. 
When women who are diagnosed with breast cancer in early stages this help in early 
treatment plan in addition it will gives a good prognosis related to patients health 
condition. Moreover, early detection will enhance in decreasing morbidity and mortality 
rated and as sequence the survival rate will be increased (Berry et al. 2005; Elmore et al. 
2005). 
 Qualitative analysis regarding breast cancer prevention 
The key informants agreed on the shrinking efforts and many gaps in breast cancer 
prevention in Gaza and they expressed that by the following expressions: 
A manager oncologist said that "there is no prevention programs absolutely, but mat there 
are screening programs and it is not good enough and I am personally not satisfied about 
it because it's not in regular pattern". 
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An oncologist said that "there is no any prevention system for cancer in general, but there 
are screening program for breast cancer and it is not satisfied". 
A specialist surgeon in breast cancer said "Early detection is a big dilemma and it needs a 
lot of resources, it needs governmental strategy other than strategy at the MOH level". He 
added "The Government should cover MOH programs totally". 
 Another surgeon said that "there is no any prevention programs here in the Gaza Strip, the 
health education activities in addition to increase the awareness among community should 
be increased ". He commented also "Prevention is hard, we can't prevent breast cancer or 
other types of cancer, but we should make regular screening programs especially for 
women who are at high risk to discover the disease as early as possible". 
"I’m personally not satisfied about screening and prevention programs in the Gaza Strip, 
we need to discover the disease in early stages so we can start treatment plan as possible 
as we can and this will help in prolonging patient's life". 
 Another surgeon added that "there is no any prevention programs from MOH or from 
private sectors, MOH should have national perception". 
A manager of private hospital said that "from the basic there is no prevention programs, 
we designed a special hall in our hospital just for health education sessions". He added 
that "Health services is the basic measure for each country, all over the world" health is 
the basic "(صبطلاا ٟ٘ خؾظٌا)". 
A pathologist said that "I think breast cancer ranks the first in prevention and screening 
program, because there are many organizations and institutions provide fund for it 
financially and in other ways ". 
The results that were obtained from the participants in the focus group regarding the 
prevention of breast cancer were in parallel with the results found during key informants 
interviews. The majority of patients who participated in the focus groups discussion were 
explained that they read about breast cancer in internet or on TV or other patients 
experiences but in general details with no much information about the symptoms or causes, 
how to prevent it, but in the other side one women said that " I was attend educational 
activity in private institution about breast cancer" 
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Another one said "I went in frequent times to assess myself in UNRWA clinics". She added 
that "There was a female nurse educate me how to make breast self-examination".  
While the majority of patients did not attend any health educational lectures about breast 
cancer as they said ―I heard about breast cancer on the T.V and internet by I never thought 
I will suffer from it”.  
Another one said “I heard about breast cancer from the people and the TV but I never 
know its symptoms, causes”. 
 Another patient said that "I knew about breast cancer from the experience of my friend but 
I don't know that I will be a breast cancer patient like her". 
From that obtained result from both key informants and focus groups it is shows that there 
are a clear limited efforts and activities regarding breast cancer prevention through health 
education were present (as breast self-exam), but it needs more attention and to be 
strengthen and unified efforts form policy makers to establish and implement a strategy for 
breast cancer prevention, with coordination with other ministries like media and education 
ministries. 
4.11.2 Screening  
Screening is considered as a secondary prevention technique which can be defined as 
examining women without signs and symptoms of the disease in order to detect disease in 
its early stages for earlier treatment or to categorize women who are in the risky zone. It is 
mostly considered as the first step in the diagnosis process while primary prevention 
involves health promotion and risk reduction in the general population so that invasive 
cancers do not develop. These primary preventive measures include the cessation of 
smoking, lifestyle and diet modification, vitamins and micronutrients supplementation  
There are many techniques that are used in screening process of breast cancer: 
 • The first approach is breast self-examination which has been prompted widely by most 
of cancer organizations, institutions and authorities all over the world. It depends mainly 
on providing health education about regular self-examination for women and especially to 
women who are in high risk to be with breast cancer (WHO, 2006d).  
• The second approach is clinical breast examination as it considered as one of the primary 
approaches that are used in screening for breast cancer. It's mostly depends on the 
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knowledge and skills of health care staff and in addition to the availability of diagnostic 
facilities. For that it's important to use evidence based approaches in training and in 
standard techniques to make sure that health staff are well trained (WHO, 2006e). 
 Mammogram 
It is defined as a tool that used to diagnose breast cancer by using imaging modality with 
low energy x-rays for imaging of breast tissue to detect any abnormalities. It facilitates to 
use standardized vires of breasts to assess any mass or lesions in the breast (WHO, 2014). 
It plays a crucial role in the process of breast cancer diagnosis especially it helps to detect 
cancer in early stages because it enables health care providers to show changes or 
abnormalities in the breast up to two years before a patient or physician can assess hem. In 
the Gaza Strip, there is an extra advanced mammogram device was installed at the MOH 
(Al-Rimal Clinic) in 2017. It is expected that this advanced mammogram machine will 
increase MOH capacity to deliver high quality mammography and to reduce coverage gap 
by more than 3,000 tests per year (UNFPA, 2018). 
 Qualitative analysis regarding screening and mammogram  
The weak and non-continuity of screening programs in Gaza is confirmed by the results 
commented from the key informants. Other key informant explained that there are some 
efforts to do screening programs but it represented for small funded programs and not for 
long time, beside that it faced many obstacles. 
 A manager oncologist said that "Breast cancer ranks the first in screening and there 
projects for short time then finished". 
Another oncologist said that "we have early detection programs for breast cancer although 
it is initial programs but it had a good results and many cases were discovered in early 
stages". 
A manager of institution for breast cancer patients' care said that "we discussed the 
deficiency in screening programs with many of policy makers, we discovered breast cancer 
cases and then! Costs? ". 
A specialist surgeon said that "Screening tools are not good enough". He added "We need 
small centers, with mammograms for diagnosis and screening (in relation to other diseases 
we don’t need big resources for the diagnosis)". 
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Another surgeon said that "Early detection of breast cancer: our people are somewhat 
aware but not comprehensive awareness as there is no universal steps taken by each 
women above 40 years". He added "there is no specific policy for screening programs in 
MOH for breast cancer" 
"Women should be categorized according to their risk score, not doing screening is a big 
insult for breast cancer care". 
"People are aware about breast cancer, because of community based centers activities (we 
have 8 mammograms in the Gaza strip), 3 in Remal primary clinic and Shifa hospital". 
"Early screening of breast cancer is available but not organized, “every woman should do 
a screening program for herself” and know to which risky group she belongs to: High risk 
group: family history +ve, long time taking of contraceptive pills, obese". 
Every one of us should perform a screening program for himself/herself"" 
"Every woman should by the government of herself (خِٛىؽ ْٛىر َسلا ذط ًو)" 
"We should increase people awareness regarding screening of breast cancer in all hospital 
and centers in Gaza, and instructed affected women to advice every women such as her 
relatives and friends to do screening".  
A manager of private hospital said that "every person should make routine tests every 6 to 
12 months, and who had risk factors should make screening from time to time". He added 
"Late detection of cancer leads to increase mortality rate ".  
Another specialist surgeon in breast cancer said that "there is no clear protocols for early 
detection". He mentioned also "Early detection programs are funded by international 
organizations and it had limited time and in irregular pattern, and these organizations 
concerned to finish the fund just by anyway ".  
A manager pharmacist said that "from 45% to 50 % are advanced cases because there is 
no screening". He expressed also "Early detection in breast cancer means high percentage 
of recovery about 90 to 100 %". 
The participants in the focus group were asked if they have previous knowledge about 
screening test to exclude cancer before their diagnosis of breast cancer the responses of 
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most of them were "No"; and most of them agreed that they did not know about screening 
tests or did it before.  
One patient said that " I never do any screening test before, and I don’t know where and 
how to do it". 
Other women added "I heard about screening before but I didn’t do it for cultural 
reasons". 
Another women added "I was diagnosed with breast cancer suddenly without any early 
detection test or exam". She added "we should have continuous health education and 
screening activities to help in prevention of this disaster". 
But in the other side one women mentioned that "I read about screening of breast cancer 
and I went to UNRWA clinic for more clarification and for my bad luck I had a mass and it 
was in stage two". Another one added "my daughter is a nurse and she supported me to 
make screening and how to make breast self-examination and the results was bad". 
From the collected data, the researcher found that there are screening programs for breast 
cancer patients but it's not in ongoing process and for short time based of the fund, it 
should be supported form policy makers to establish and implement a strategy for breast 
cancer early detection and prevention, with collaboration of other ministries and 
community to increase the awareness of people about the importance of screening and 
early detection of the disease in early stages. 
4.11.3  Diagnosis of breast cancer 
 Detection of cancer in early stages may reduce the mortality rates significantly over period 
of time.  To identify early stages of breast cancer is consider the most important point for 
early treatment, management and good prognosis. There are different diagnostic devices 
which are used to diagnose breast cancer such as mammography, magnetic resonance 
imaging, ultrasound, computerized tomography, biopsy and tumor markers tests (Wang, L, 
2017). 
 Qualitative analysis regarding breast cancer diagnosis  
As an extension gaps founded in breast cancer prevention and early detection in Gaza, the 
diagnosis of breast cancer at late stages appears as consequence. The data collected from 
the key informants concerning this situations allow us to think that breast cancer diagnosis 
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in Gaza is certainly enduring critical conditions and it need a hard job to overcome this 
crisis as the key informants said. 
A manager oncologist said that "we have good diagnostic services, breast cancer case take 
about 3 weeks to be diagnosed and if all equipment and medication are available patient 
will take her treatment in a less time". He added "In UK, patients need from 4 to 5 weeks to 
be diagnosed and have treatment" 
"If the patient went to a general physician we add more 1 to 2 weeks to the defined 
diagnostic duration"  
 A consultant oncologist said that "the problem is before arriving patient to the hospitals, 
she needs long time to take analgesic then go to the primary health care for symptomatic 
care". 
"Doctors in primary clinics must be educated about risk signs of breast cancer to diagnose 
cases early". 
A specialist surgeon said that "Radiologists aren’t expert very much (MRI isn’t in a ratio 
with population, we have deficiency in MRI) in other hand, we can’t have MRI in all cities 
of Gaza Strip as expert in MRI are rare". He commented also "Advanced steps in 
diagnosis are deficient in Gaza as sentinel lymph node biopsy, which can’t be performed 
by all surgeons, only two surgeons master it" 
A specialist surgeon said that "For diagnosis of breast cancer facilities are present". 
 Pathologist said that "there are diagnostic facilities for breast cancer and there are a 
great deficiencies in the infrastructure like pathology department at Shifa hospital and it 
considers as the biggest pathology department in the MOH". He added  "We need more 
resources for diagnosis that are more developed other that the traditional ones, regular 
maintenance for diagnostic facilities and more staff, sometimes we have reply and 
sometimes we are ignored ". 
"In the worst times, we need about two weeks to one month to have pathological results 
regarding breast cancer biopsies". 
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Another specialist surgeon said that "breast cancer patient needs about 6 weeks from chief 
complain to be diagnosed and start treatment internationally, here in Gaza we are almost 
in the same average" 
"Governmental hospitals used for confirm diagnosis and other private hospitals support 
us". 
A manager pharmacist said that "not all tests are available, and we must be confirmed 
100% that this patient has breast cancer".  
From the patient's perspective, the researcher found that almost the results of focus group 
is not far from the key informants results, and most of gaps summarized in mal 
coordination between hospitals, deficiency of diagnostic facilities or limited number of 
human workforce "Doctors and other specialists " and also the patient plays a role in the 
delayed of breast cancer diagnosis. 
One women explained that "after a mass detection in my breast, my doctor asked for a 
biopsy, then sent to pathology department and I waited about one month for the result". 
Another women said that "I had a mass in my chest and I told my daughters and they told 
me don’t worry its doubts just, but when it became a bigger I went to Al Ahli hospital , the 
doctor requested mammogram for me then asked for a biopsy". 
Another women expressed " there was a mild pain in my chest then there was swelling 
then I did breast examination and I found a mass in my chest, I went to a private doctor for 
fast results, he was serious in my complain, he asked for lab tests, ultrasound, and a 
biopsy, I went to a private lab to have a fast result because in MOH hospitals it takes long 
time, the result was ready in 3 days and it was not good ". 
One more women added about the long process of diagnosis and she said that "there was a 
small mass like " a bean " in my chest, I didn’t care a lot about it and no one told me to 
follow up and to go to the doctor, after one year I want to a doctor at Shifa hospital he did 
investigations for make and he took a biopsy from the mass and the results was negative, 
he asked me to show the result to another consultant at Al Ahli hospital for more 
confirmation and reassurance, they remove the mass and they tool another biopsy and sent 
it to a private laboratory and the result was catastrophic and it showed cancer cells for my 
bad luck ". 
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One patient explained her journey of diagnosis process with sad facial expressions and she 
said that "I had repeated screening test , I discovered one small mass like a bean , then 
after one month it was bigger about 3 cm, I asked my family about it and they replied its 
normal and you shouldn’t be worry about it and after one more month it became a bigger I 
was worry about it, I went to a private medical institution for follow up, my doctor was 
asked for a biopsy test for this mass, then I referred to Indonesian hospital then to Shifa 
hospital for more investigations and take a biopsy they told me the result needs about one 
month, I went to private laboratory for fast result and after one week I had the results " ب٠ٚ
خغ١زٌٕا ذفزػ بِ ٟٕز٠ر" and I wished in that moment didn’t know the result ".  
Another women described how much her diagnosis process was painful she said that" I 
had a minimal pain with a small size mass at my right breast, I ignored that but after one 
month I went to Red Crescent society after I was referred from UNRWA clinic , he 
requested blood tests, CT scan and mammogram then it showed there is a tumor with 
about 2 cm size, they took a biopsy from my breast and it showed there was a cancer , after 
that I was shocked, depressed and afraid but ) لله ذّؾٌا خ١ػار(I am satisfied m thanks Allah, 
for follow up we went to a private doctor for less waiting time and reassurance and to have 
a quick appointment rather that Shifa hospital I need to wait long and longtime". 
4.11.4  Treatment of breast cancer 
 There are different treatment options are used for breast cancer management and all of 
these options aim to reduce the disease severity or get rid of this disease, prolong of patents 
life and in addition to that to improve the quality of life after the patient diagnosed with 
breast cancer by the best suitable and available procedures. The most effective and 
efficient treatment can be applied when the patients are diagnosed at early stages of the 
disease and in addition it should follows evidence-based standards of  health care as 
sequence many cases will be highly responsive to treatment and have good prognosis 
(WHO, 2007). 
Treatment options for breast cancer can be vary depending on cancer characteristics such 
as cancer stage, its size, location, if it is metastasized to other body organs or not in 
addition to the overall physical health of the patient. Treatment options for breast cancer 
include surgery, radiotherapy, and chemotherapy, hormonal and targeted therapies. These 
treatment options can be used alone or in combination together depending on the stage of 
the cancer. When breast cancer is diagnosed in early stages, the surgical treatment is of 
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breast cancer is consider the best option and these surgeries are vary depends on the size 
and location of the cancer such as lumpectomy (breast-conserving surgery) or mastectomy 
(surgical removal of breast tissues) with the removal of clear margins of both invasive and 
non-invasive cancer. Systemic treatment can be used as post-surgical procedure as 
adjuvant therapy to enhance removal of the disease and overall quality of patient health as 
consequence increase the survival rate. In the other side, when breast cancer is diagnosed 
in advanced stages, systemic treatment are the best choice in controlling the spread of the 
disease in addition to the palliative treatment. Controlling of breast cancer in advanced 
stages can be done by using neo-adjuvant systemic treatment which means that the patients 
have other medications before the main treatment option. This type of treatment is used to 
shrink the tumor size which will facilitates later subsequent treatment, surgical options, and 
long-term outcomes.  
Breast cancer management which include detection, diagnosis, and treatment of breast 
cancer, during this journey patients may complain of other psychological and emotional 
stress. For that, it is crucial to understand all patients needs for better emotional and 
supportive care throughout their journey (Ng, Z et al. 2017). 
 Qualitative analysis regarding breast cancer treatment  
A manager oncologist said that "Chemotherapy and surgical treatment are available 
treatments options for breast cancer patients but not always". He added "Radiotherapy 
isn't available ever, sometimes biological therapy is available and sometimes not so we 
refer patients abroad".  
Another oncologist said that "we have interruption in chemotherapy medications, and 
radiotherapy isn't available at all".  
A specialist surgeon said that "All options of treatment can be done in Gaza except for 
radiotherapy, and we have a problem in chemotherapy as we have interrupted cycles (on 
& off)". He mentioned also "The conservative breast management done by few surgeons" 
Another surgeon described cancer surgery treatment in Gaza endure some gaps as it 
appeared from the collected data ―The intensive care unit refuses to admit the cancer 
patients after surgery or if they are metastasized, they consider it as a hopeless case not 
from the first priorities, so sometimes I hesitate to do a surgery for a cancer patient”. 
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“We are surgeons not specialized in oncology, we can't deal with every cancer. We can do 
it once but not many times because I have no team to support me and to follow the case 
with me, so we need a specialist's team for oncology surgeries ". 
A manager pharmacist said that "chemotherapy is available but not all times, radiotherapy 
and PET scan are not available at all ". 
Participants in focus group results was almost matching with key informants results, one 
patient said that about the difficulty in having her medication by explaining, "When I didn’t 
found my medication I was obliged to travel to Egypt or to West Bank to have my 
medication, and as all we know this cost a lot of money and time too ". 
 Another women said that "I paid the cost of my treatment two doses, I bought it from 
Egypt, It was expensive, and we know how much bad the situation here in Gaza ". 
Other women clarified her treatment journey and said that "after I had my surgery in my 
breast, I received two doses then it was interrupted, I was afraid too much, I asked for 
referral abroad to continue my treatment". 
One more women was depressed from repeated visits to hospital and she said that "I went 
to hospital 3 consequences times and my doses are unavailable, I paid a lot for 
transportations but without any interest". 
Another women added "I took all my treatment doses here in Gaza, but when I need 
radiotherapy treatment for sorrow it wasn’t available here in Gaza so I refereed to West 
Bank for it". 
But in the other side there are a group of participants are satisfied about the treatment here 
in Gaza as one women said "I had surgery here in Gaza for my breast and after that I took 
all my doses and I am fine, but every time I am here for follow up". 
Another patient said that "I received all my doses without any interruptions" she added that 
"I don’t want to be referred abroad because all what I need is present here in Gaza". 
One women commented that "my doctor prescribed to me 4 doses and all of it was 
available, there is no any delay or interruptions, but when I need radiotherapy treatment 
isn't available here in Gaza so I must be refereed". 
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From the collected data, the researcher conclude that the surgical treatment in Gaza is 
acceptable but it seems that some areas of breast cancer surgery treatment is absent or 
should be strengthen as palliative surgery, cosmetic surgery , it needs a special skills and 
well-trained qualified staff, both patients who are participated in focus groups discussion 
and key informant persons showed that drugs of breast cancer treatment are usually present 
as chemotherapy or sometimes there are interruptions, but occasionally some drugs were 
not available and all of them agreed that there is no radiotherapy here in Gaza which 
obliged doctors to referred patients abroad to continue their treatment which increase the 
burden on the patients . In conclusion it‘s a clear that there are many results are 
contradicted, the researcher can reach to the result that in spite of the efforts exerted to 
provide the necessary treatment (surgery, chemotherapy and radiotherapy) for breast 
cancer patients, there are still some challenges and gaps need to be overcome. 
4.11.5 Palliative and Emotional care for breast cancer patients 
Palliative care aims to improves the quality of life for breast cancer patients in addition to 
their families too who are complaining of life threatening conditions, by using special 
approaches to reduce or prevent patients suffering by adding it with treatment plan which 
constructed by specialists in palliative care and this can be done including different aspect 
rather than medical condition such as physical, psychosocial and spiritual aspects 
(Sepúlveda, et al. 2002). Palliative care is a wide approach that focusing in providing 
holistic care to cancer patients that concentrates on the whole aspects in the patients, not 
just their medical condition or cancer. Its goal is to prevent or treat cancer patients, as early 
as possible, which include: signs, symptoms and side effects of the treatment, moreover it 
deals with other aspects such as emotional, psychological, social, and spiritual needs. 
Palliative care has other names like supportive care, comfort care and symptomatic 
management. Palliative care can be provided in different places such as hospitals, an 
outpatient clinics, specialized centers in palliative care, or at home under the direction of 
health care providers. 
In addition it can be provided at any point during breast cancer management process, from 
diagnosis till the end of life (NIH, 2017). 
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 Qualitative analysis regarding Palliative and Emotional care for 
breast cancer patients 
The obtained results from the key informant interviews, it shows that the gaps of palliative 
and emotional care in Gaza was evident. The key informants described the gaps in this area 
by the following statements:  
A manager consultant said that "Psychosocial and emotional care aren’t available at all, 
and we should have a palliative care center". 
A consultant oncologist said that "psychological support is a big failure for MOH   ز١جو )ًشف
خؾظٌا حراسٌٛ)". He added also “There should be a palliative center for cancer patients with 
a well-trained team in palliative care including doctors, a specialist nurses, a 
psychologists, physiotherapists and of course with needed medications for palliative care 
and for sorrow that all are not available here in Gaza". 
"There is no specialized programs or institutions for psychological or emotional support 
for breast cancer patients in the Gaza Strip". 
A manager of institution for breast cancer patients' care said that "there is no palliative 
center or palliative care here in Gaza". He added also "it's ok to see her dying ب٘ٛفٛش٠ ٞدبػ"
"دّٛزث 
"Terminal stage patient is next to newly diagnosed patient in the same room"  
A specialist surgeon said that "We haven’t any kind of supportive or emotional care". 
"Most emotional care came from patient family and friends, there is no specific unit for 
emotional support".  
 "Palliative care is almost absent, we haven't specialized palliative care center for cancer 
patients in Gaza ". 
Another surgeon said that "psychological support is present recently inside hospitals, there 
are special groups for psychological support at Shifa hospital but support be in general, 
they are in an initial phase but there presence is good ". 
"Almost palliative care and surgery is absent here in Gaza because they consider it as a 
hopeless cases".  He mentioned that also "It's actually something unethical not to have a 
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palliative surgeries here in Gaza, most of surgeons don’t need hopeless cases to be 
recorded on them and they knew that the outcome isn't good almost ". 
A manager of private hospital said that "we are as a private hospital must provide holistic 
care for breast cancer patients including social and emotional care to guarantee that the 
patient will come back again". 
A manger nurse said that "we sent a message to MOH before about 8 years that we need a 
psychosocial worker for oncology patients for emotional and psychological support and 
till now there is no reply". 
The data collected about palliative and emotional care from the participants in the focus 
groups interviews were resemble to the results of key informants interviews, as one women 
described her suffer from cancer and she said "I was very depressed when I was diagnosed 
with breast cancer, I didn’t found any specialist who should provide the appropriate 
emotional and psychological support for me". 
Another women expressed her pain by words and she said that "the problem is not with 
cancer, the problem that we need other to stand with us who can provide to us enough 
emotional support, at least to forget a little bit of our pain". 
Other women commented that "we should have psychological and emotional support even 
during we take our medications doses, but for sorrow it's unavailable ". She added "We got 
emotional support from our daughters, husbands, and friends, there is no a specialist here 
in hospital to do this ". 
One more women added that "after I received my chemotherapy dose, I had side effects 
post chemotherapy, my doctor decided to admit me to inpatient department, I felt sad and 
depressed, I admitted for 5 days, I didn’t meet any psychological or emotional support 
ever, which in that time I really need it because I felt "I am near to death ""." ِٓ خج٠زل بٔأ
دٌّٛا" 
One patient said that " I was too much afraid when I knew that I had breast cancer , and I 
am afraid more and more when I knew that it was metastasized , I didn’t found the enough 
emotional and psychological support from the staff or from my family , they are waiting me 
to die". 
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Another women said that "I was admitted for post chemotherapy care , in the same room 
there was a another gasping patient , I was too much afraid and I went to home and I 
didn’t continue my treatment , we should have a special center for that". 
From the qualitative data which are collected from the key informants and participants in 
the focus groups, we can conclude that palliative and emotional care in Gaza is very 
limited or absent also palliative surgery is absent. There researcher recommended that 
there should be a special center for palliative care for cancer patients here in Gaza with 
specialized and well trained staff from all different medical fields who are experts in 
dealing with cancer patients ,in addition the breast cancer patients in Gaza not only should 
being supported for the physical, psychological and emotional consequences of the disease 
alone, but the family should have a strong role in supporting and encouraging them to be a 
part of the palliative care and emotional support of the patient. 
4.11.6 Quality of care and Follow up  
Quality of care is defined as accessible, delivering health care that is timely, 
geographically reasonable, and provided in a setting where skills and resources are 
appropriate to medical need (WHO, 2006e). The best possible care should be provided to 
the cancer patients, even we are in the century 21
st
, still there are many gaps that facing the 
continuity and quality of care provided to the breast cancer patients  which affect 
negatively to the safety, efficiency and affordability of the care and as consequence poor 
breast cancer management (Spinks, et al. 2014).In oncology, quality of care is a major 
issue for patients and providers, when the patient has already diagnosed with breast cancer 
it's important to take in consideration that patient satisfaction paly very important role in 
the quality of care provided. 
Follow-up care process for breast cancer patient's care includes many activities such as the 
clinical examination, laboratory investigations and imaging techniques. Examination 
process of breast cancer may be different from patient to patient which depends mainly on 
the size of cancer, location, if it is metastatic or not and in addition to the treatment plan. 
Mostly follow up care which includes making observation of general health of cancer 
patients in regular intervals comes after receiving the main recommended treatment. 
Mostly, after breast cancer patients receiving the main treatment, they are monitored for a 
period time for follow up care in special facilities or in out patients clinics then later in 
primary care centers patients. Follow-up care aims to detect early side effects post main 
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treatment are received, assessment of general health condition and in addition to ensure 
patients‘ rehabilitation (Grunfeld, E, 2005). It's an exited feeling when breast cancer 
women finished her treatment plan but in the other side there is still existence a fear feeling 
from recurrence of cancer. Most of breast cancer treatments can cause side effects which 
vary from patient to patients according to patient overall health, these side effects may be 
appeared directly after receiving treatment or after short period of time in addition it may 
last for few days and other may last for long time. Health education for breast cancer 
patient is very important thing that enhance in reducing treatment side effects and patient 
should be notified that they should visit health care providers in case of changes that 
happened or if they need more clarifications. If patients noticed any changes or 
abnormalities they shouldn't wait till the next appointment and they should visit health care 
providers immediately (ACS, 2017). 
After finishing treatment plan, all breast cancer survivors should have appointments that 
decided with health care providers for follow-up care. This means they should visit health 
care providers in regular manner for medical follow up, investigations and overall 
assessment such as blood tests and in addition to the physical examination to ensure that 
there are no abnormalities are found, or any problems that occur due post breast cancer 
treatment. Moreover may include assessment of psychological and emotional status of 
patients that may develop months or years after treatment ends (ACS, 2017). 
From the collected data it seems that many gaps emerge from breast cancer care, it's 
difficult to judge on the quality of cancer care and follow up in general, and it depends on 
the type of care (prevention, diagnosis, screening, treatment and follow up) or at the level 
of care provided to the patients. In general, most of the key informant persons who are 
participates in the interviews commented about the quality of care and follow up in Gaza to 
be acceptable to some extent as they said: 
 A manager of institution for breast cancer patients' care said that "there is a big problem 
that excited in the follow up process related to cancer patients in general, there should be 
reminder system of the breast cancer women didn’t come to her appointment, in addition 
to that there should be a special employee who is responsible on calling patients to remind 
them about their follow up appointments. At least follow up appointments should last for 5 
years after patients finishing their main treatment". 
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 A consultant oncologist said that "In Gaza the cancer care is accepted compared to the 
neighbor countries like Egypt and it takes more priorities especially in chemotherapy 
treatment and surgical treatment".  
Another manager oncologist said that “there is a wrong concept in Gaza that oncology 
departments are responsible for cancer services from A to Z but sometimes the problem 
with cancer patient is not related to cancer, she needs follow up from other specialties”. 
A specialist surgeon said that "quality of care depends on many things such as the place of 
treatment which means that there are difference in the quality of care provided to cancer 
patient in different palaces and this depends on hospital and the availability of hospitals 
facilities that means not all hospitals have the same level of quality care".  
Another surgeon added that "breast cancer patient when she need for follow up her is 
listed as cancer patient in general without any specialization for surgeries".  
One radiologist added that "the care provided to cancer patients is like five stars services" 
َٛغٔ ضّخ دبِذخ" because in radiology departments maximum 3 weeks the patient wait her 
result and if it was delayed she made a trouble ". 
Another key informant had another opinion and she said that "In the Gaza Strip, there is 
nothing called quality or we hear about it but it's not applicable even in oncology 
departments, moreover  services delivered to the patients are just meet their low needs 
without high level of quality". He added "If we want to take about quality of care m firstly 
we oncology patients should have a special building with high quality and qualified staff". 
One more key informant added that "How we can take about quality of care and there are 
a lot of services aren’t available here in Gaza and patients should be referred for it". 
From the patients perspective about the quality of care and follow up they have different 
results, one women said that "I can evaluate the quality of care provided to us as patients 
about 6/10 ". 
Other patient added that "I am fully satisfied about the follow up system and quality of care 
, every 3 months I have an appointment with my doctor , it's about 9/10". 
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One more patient had experiences in private and governmental hospital and she expressed 
that "the quality of care in private hospital was excellent, but it was totally opposite in the 
governmental hospital". 
 She added that "I prefer to go to the private clinic, because the care better than 
governmental hospitals, care in the hospital is very bad and the doctors don't care for us". 
Other women was angry from long waiting time and poor ventilation and when she asked 
about the quality of care she replied "it's very bad, we don't have a good care to have a 
quality, we must be in a hotel not in this grave". 
 She added that “Why when we go to the doctor's private clinic and pay for him he treated 
us well and with respect? He didn’t treat us the same in the governmental hospital”. 
From the collected data the researcher noticed that there are contradictory opinions from 
key informants and patients regarding the quality of care and follow up for breast cancer 
patients which based on the hospitals, facilities, available treatment ,qualified staff and the 
patients themselves, so we can say that most of the burden in breast cancer management is 
localized on the three oncology departments in the three hospitals Shifa, the European 
Gaza and Rantisi specialized hospital, while the other departments have a limited role in 
the follow up of the breast cancer cases. The researcher may explain the differences 
between the key informants points of view concerning the breast cancer management and 
follow up, according to the type of care was provided and in which hospitals, but there is 
no doubt about the presence of many gaps through the breast cancer care and follow up in 
Gaza. It should be revised and make a special criteria for follow up and to assess the 
quality of care for breast cancer patients from specialized expert to decrease the burden of 
the disease. 
4.11.7  Referral system between facilities and abroad 
 Last reports showed that there are  increasing in the number of referral for cancer patients 
from Gaza Strip to other hospitals outside Gaza Strip due to unavailability of radiotherapy 
or some types of medications related to cancer  in addition to some types of diagnostic tests 
and devices are not exist in Gaza. The lack of development process in the existing health 
system in the Gaza Strip increase the burden of breast cancer disease due to that patient 
preferred to be referred outside Gaza. Most of referrals are for getting diagnosis and 
treatment services in five common specialties: cardiovascular diseases, oncology, 
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orthopedics, neurosurgery and ophthalmology. WHO report revealed the percentage and 
causes for referrals and it's as the following: 28% of oncology patients referred for 
chemotherapy and 30% for radiation treatment and other cancer patients were referred for 
either consultation or ―management of disease. In total, 1,523 patients had to leave the 
Gaza Strip in 2010 for oncological care and made up 12% of all referrals (WHO, 2010). 
 Qualitative analysis regarding referral system  
The referral system between the facilities and abroad endured some gaps especially long 
waiting time related mainly to the poor communication and coordination between the 
hospitals involved in breast cancer management, which lead sometimes to confusion and 
misunderstanding between them or between the providers and patients as most of key 
informants explained. 
A manager oncologist said that "referral consider as a big obstacle facing patients because 
not all patients have the ability to travel via Erez cross point because they are rejected for 
safety and security reasons as Israel told them". 
 A consultant oncologist said that "I am personally satisfied about referral abroad system 
and committee but I am not satisfied about the criteria of referral". 
“Crossing Erez or Egypt border is consider one of the main obstacles facing cancer 
patients that one day is opened other days is closed, moreover not all the patients have the 
same chance to be referred, and sometimes many of them are rejected or delayed or denied 
by Israel occupation or even the caregiver”. He commented also "About 50% of cancer 
cases referred for drugs deficiencies, if this problem solved the percentage of referral will 
be decreased too much surely ". He added that "patients insist to be referred due to 
cultural factors that people in Gaza believed that the care outside Gaza is better than 
provided in the Gaza Strip and there is treatment outside Gaza for metastatic cancer, and 
the same management was in Gaza, they prefer to be referred it from outside the Gaza". 
"Most of cancer cases are referred due to deficiency of the diagnostic and treatment 
facilities, there is interruptions in chemotherapy and there is no radiotherapy treatment 
here in Gaza". 
A specialist surgeon said that "Sometimes Referrals are based on personal relations, 
doctor relations, in addition if the patient have appointments in doctor's private clinic this 
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means not all the patients have the same chance to be referred ". He added "Most of breast 
cancer patients are poor people and referral cost a lot".  
٠ربظِ ٚذث زفبظ٠ ٚذث ٌٟا ٚ ءازمف ْبؽزظٌا ٝػزِ ُظؼِ()ف  
"Patients have an easy access to the governmental hospitals but with no facilities" 
"Majority of Gaza families are poor and have low economic status and when they have a 
cancer in a family member; that means they have a double burden on the family to afford it 
especially if she referred and if she needs a caregiver". 
A manager pharmacist said that "we hope referral patients will be finished by availability 
of the needed services, at least medications and not to be referred due to deficiency in 
medications". He commented also "There must be a clear policy for medication transfer 
and didn’t be affected by political or geographical aspects". 
Another key informant added about the process if referral from primary health facilities 
and he said that "The cases were referred from primary health care or others hospitals 
arrive on the outpatient clinic without any details or information; there is no 
communication between the primary health care and the hospitals. All the processes are 
individually made. Referrals are not coordinated, there is no specific protocol or criteria 
for referral patients between primary health facilitates and hospitals”. He added "There is 
no referral from the primary health care that means we haven’t internal referral system 
even its present its very week and should have a clear policy ".  
One other key informant added that "even the treatment available here in Gaza, some 
patients or their families insist to be referred abroad because they don't trust treatment 
here in Gaza". 
"Cultural reason play important role in referral process, people and patients should know 
that treatment available here in Gaza is the same abroad". 
"Many patients or their families who had metastatic cancer insist to be referred abroad, 
they believe that we can do nothing for them here, but outside they can be treated and find 
the appropriate care for them, they insist to be referred without any benefit". 
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"Patient and their families believe that they can receive better care outside Gaza so they 
insist to be referred we don't ignore that we need a better place but it doesn’t mean the 
care is not good".  
Another key informant added and confirmed to unneeded referral and said that "many 
patients do not need to be referred, some of these cases are at terminal stags to be referred 
and sometimes these cases are referred even the facilities for their diagnosis and treatment 
are present here, in spite that they insist to be referred, they don’t trust health system here 
in Gaza ". He added "They just need to be referred, they don't know how much it cost them 
and MOH". 
In conclusion external referral system is a crucial and critical aspect that needs more 
attention from policy makers, with re rearrangement of referral criteria. Doctors are forced 
to refer cancer patients for many reasons related to the availability of medical equipment, 
deficiency of medications or deficiency in specific specialist in addition to cultural factors 
that people in Gaza believed that the care outside Gaza is better provided than here, and It 
is clear that the internal referral system suffered from some weakness points especially 
communication and coordination between both the primary and secondary health care 
levels which lead sometimes to confusion and misunderstanding between the providers and 
patients. 
4.12  Major obstacles facing breast cancer management 
Obstacles facing breast cancer management play a crucial role in the evaluation of breast 
cancer management in Gaza is , knowing it help decision makers to identify the existing 
troubles then take the appropriate actions to correct or minimize it . 
 Qualitative analysis regarding major obstacles facing breast cancer 
management: 
During the discussion with the key informants about the problems they found in their work 
in breast cancer management, many factors are discovered. Obstacles and challenges that 
were faced during breast cancer management in Gaza varied between the key informants; it 
may be due to their different points of view that may arise according to their different work 
positions, experiences, expectations and their priorities. The main problem areas that were 
observed are listed below as they mentioned.  
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A manager oncologist said that "There are two aspects must be strengthen to improve 
breast cancer management which are manpower and diagnostic resources". 
A consultant oncologist said that "there are four major obstacles facing breast cancer 
management which include: availability of cancer drugs, health education for staff and 
patients and financial support". 
A specialist surgeon said that "major obstacles facing breast cancer management are: 
Lack of facilities for diagnosis, No good primary health care programs to pick up cases". 
He added "There is no awareness programs (TV programs)". 
  " a lot of people will start to make follow up  ""بٌٙبؽ ع رٚذر دذث صبٔ ز١زو ٟللازؽ  
Another specialist surgeon said that "there are many Major obstacles facing management 
of breast cancer in the Gaza Strip which include: Culture, Instability in funding (some time 
we need to redirect funding), Policy of screening and early detection of cancer, Expert 
radiologists are needed, Screening facilities should be distributed more, Training of 
surgeons and Psychosocial support is needed". He commented also "We need a national 
screening program".  
A manager in cancer registry said that "there are two main obstacles facing breast cancer 
and all cancer types in general which are lack the surveillance and there is no the clear 
statistics". 
 A specialized surgeon in breast cancer said that "there must more control on private 
hospitals which make screening and surgeries which are untrusted, moreover health 
education and population awareness still at low level". 
On the other hand the collected data from the participant in the focus group showed that 
there are many obstacles facing breast cancer patients as one patient said that "my big 
problem is with long waiting time when I have an appointment I should wait for my rule at 
least 2 hours". 
Another women added about the overcrowded of people and patients and she expressed 
that "the place is small and there are a lot of patients here, there is no good ventilation but 
I should bear that because I need to take my medications". 
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One women said about absence of tests and other diagnostic facilities at hospitals "Some 
tests are unavailable at the hospital as the tumor marker tests, it should be provided, we 
should so it in a private laboratories and it costs a lot". She added "my doctor asked me 
for MRI , I went repeated times to Shifa hospital because it was broken and need 
maintenance then I decided to do it in a private center it costed me about 400 shekels". 
Another patient said about the political situation consider the main obstacles "The political 
situation, closure and the siege represent consider the most important obstacles for us as 
patients and for the drugs availability and referrals". 
From the collected data from both key informants and participants in the focus group it 
showed that there are many obstacles are existed in breast cancer management in Gaza. It 
includes financial, administrative, coordination, screening, health education and 
availability of medications obstacles as well as unstable political situation (siege, division 
between Gaza and West Bank), inappropriate oncology buildings, shortages in the human 
resources and their development, workload, long waiting time and the shortage in some 
necessary equipment and supplies which are used in diagnosis and treat breast cancer 
patients. 
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5 Chapter Five 
Conclusion and recommendations 
5.1 Conclusion  
Universally, breast cancer ranks the first type of cancer among females and it considered 
the most common cancer in Palestine. Management of breast cancer can't be 
individualized, it requires multiple interventions provided by variety of health 
professionals from different levels over prolonged periods of time. This study aims to 
evaluate the management process of breast cancer in the Gaza Strip to assess available 
strategies and health care facilities serving breast cancer patients and challenges - barriers 
for service provision. This chapter summarizes the results and findings in the study and 
introduce suggestions and recommendations to improve the management process.  
This study highlighted several domains and sub-domains in breast cancer management and 
it might help in identifying some gaps, barriers and challenges in the management process 
of breast cancer in the Gaza Strip. 
There are many challenges-barriers are discovered during the journey of management 
process of breast cancer in Gaza. It includes financial, cultural, and administrative and 
coordination factors as well as unstable political situation mainly, siege and division 
between Gaza Strip and West Bank, inappropriate oncology buildings, insufficient 
diagnostic equipment and resources, unavailability of some treatment options, shortages in 
the human resources and related in service education and workload. The following points 
describe the gaps in details based on WHO six building blocks. 
5.1.1  Health Workforce 
It appeared that there are many gaps related to human resources who are included in breast 
cancer management in the Gaza Strip in many specialties as oncologists, pathologists, 
social workers nutritionists and physiotherapist, which affect negatively in the 
management process and the situation will be exacerbated in the next few years especially 
after the retirement of some specialists and some of the qualified workforce without 
replacement. The challenges of health workforce in Gaza is not only limited to the 
deficiency in the number of some specialists, but it also include in service education 
programs for all the staff, scholarships (inside and outside the country) and training 
activities to increase theoretical and practical aspects related to breast cancer management. 
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5.1.2 Services delivery 
The researcher found that based on the collected data that the oncology services in the 
Gaza Strip are inadequate and facing many gaps, in additions to that many services are 
unavailable, moreover to the limited space and number of the services which lead to 
overcrowded rooms and increase waiting time which lead to bad ventilation and 
cleanliness, as sequence reducing the privacy and comfort of patients which increase the 
burden on them. In addition to poor coordination among health facilities in different levels 
which may affect negatively to the quality of care provided, the staff performance, 
morbidity, and morality, the satisfaction of breast cancer patients and as consequence bad 
outcome. 
Buildings: regarding breast cancer services buildings in the Gaza Strip, they suffer from 
serious gaps mainly related to their limited space which usually leads to overcrowding of 
patients in the available rooms and probably affect negatively on the work flow, quality of 
care provided and increase patients waiting time. Moreover, problems are found in the 
availability of the comfortable furniture, and environment besides poor ventilation, 
sanitation in bathrooms, noise, prolonged waiting time and the lack of privacy for patients 
which may harm them physically and emotionally and then increase their risk for infection 
and bad prognosis. 
5.1.3 Health information system and research 
The information system and research regarding breast cancer in the Gaza strip could be 
considered inadequate and have many gaps that interrupt it. Cancer registry as a main part 
of the information system for cancer endures also some gaps in spite the effort done to 
enforce it. The underperformance of cancer registry is related mainly surveillance system 
which is not clear and moreover there is no updated statistics, in addition to the ignorance 
from stakeholders, the poor coordination between hospitals and primary care centers , 
shortages of qualified staff, incompleteness of medical files, and research which is 
considered a crucial part in the process of breast cancer management because data and 
research should be used in setting priorities and to develop strategies and policies in health 
care system to ensure that decisions are evidenced based, accurate and complete data but 
most of research in the Gaza Strip about breast cancer are individualized and there is no 
cancer research center which help on management and control of breast cancer by evidence 
based data.  
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5.1.4 Essential Medicines  
Access to essential medicines is another challenge facing breast cancer management in the 
Gaza Strip which increasingly putting the lives of breast cancer patients at risk, some of 
breast cancer treatments, including all radiotherapy and increasingly chemotherapy, are 
completely unavailable in Gaza or there are interruptions in chemotherapy medications. 
This means many patients require costly referrals to hospitals in East Jerusalem, the rest of 
the West Bank, or abroad which lead to delay the cycles of patients and this affect 
negatively on the patients form different aspects and increase the burden of the disease. 
Effective treatment and availability of essential medications for breast cancer patients are 
playing a crucial role   in improving the patient health condition as sequence they have a 
good chance of survival.  
Breast cancer patients medical records: Documentation of the patient demographic data, 
patient complain, history and examination, breast cancer characteristics, is important to 
help health care providers to gather more information about patient history.  It also help 
health care providers to deal with the patient in an appropriate manner and they can 
identify the best treatment plan for the patient, from the collected data it was noticed that 
all domains are partially or incompletely recorded which affect negatively on the patients 
care and its sustainability.  
5.1.5 Health Financing 
 Not only does breast cancer take an enormous effects on the health of patients and 
survivors, it also has a tremendous financial impact. The costs and financial impacts of 
breast cancer constitute as  a bid burden in management process for many breast cancer 
patients, their families and MOH, moreover there is no any specific budget for oncology 
patients in the Gaza Strip which increase the financial burden on the patients to pay for 
unavailable diagnostic services or medications and many pf patients can't do that due to 
their bad economic status and can't cover their financial needs which lead to deterioration 
in their lives and lower the quality of life. 
5.1.6 Leadership and Governance 
It was clear that there are many challenges affect negatively on leadership and governance 
related to breast cancer management mainly summarized in minimal attention from policy 
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makers and stakeholders in addition to that there is no specific and clear policies that help 
and support breast cancer management and reduce the burden of the disease. 
5.1.7  Breast cancer management  
Breast cancer management process is a multi-steps process including prevention, 
screening, diagnosis, treatment, referral system and follow up and most of them facing 
obstacles interfere the management process of breast cancer it will be summarized as the 
following: 
Breast cancer prevention and screening: those services included many weakness points 
that interrupt management process; there is no any prevention programs for breast cancer 
in the Gaza Strip which leads to decrease the awareness of people about breast cancer and 
increase the burden of the disease, screening program are found but sporadic programs and 
not in ongoing matter which delay the diagnosis of cases in late stages, in addition there is 
no clear policy for screening that encourage women to do screening in regular pattern. 
Breast cancer diagnosis: from the results, there are many gaps and challenges  that inhibit 
the process of early diagnosis of breast cancer cases such as the shortages in diagnostic 
facilities as mammogram, MRI, CT, in addition to that there is no good coordination 
among hospitals and primary care centers, limited number of human workforce " doctors 
and other specialists " play another role in the delay of cancer diagnosis due to 
misdiagnosis or insufficient examination and also the patients and family poor awareness 
plays a role in the delayed diagnosis of breast cancer. 
Breast cancer treatment:  there are various treatment options of breast cancer faced by 
many challenges and gaps, there are chronic and significant shortage in the diagnostic and 
treatment services in the Gaza Strip which decrease Gaza hospitals ability to meet patients 
needs in breast cancer management, in addition to the shortage in many types of 
medications that are needed in treatment plan, it will be summarized as: 
 Surgical treatment: it's acceptable in sort of but there are specific surgeries are absent or 
need more qualified and skilled staff as cosmetic surgery and palliative surgery. 
 Chemotherapy: often drugs of breast cancer treatment usually were present as 
chemotherapy or sometimes there are interruptions but occasionally some drugs were 
not available, there are serious gaps that found in the continuity of treatment due to 
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frequent shortages in essential medications, which are very important to have successful 
treatment. 
 Radiotherapy: this type of treatment is not available in the Gaza Strip from long time, 
which is very important for breast cancer patients treatment and prognosis, the patients 
in forced to be referred outside Gaza for radiotherapy treatment to West Bank or 
Egyptian hospitals. 
 Palliative treatment: palliative care suffer from serious gaps in Gaza‘s hospitals. This 
evidenced by the absence of palliative clinics, interruptions of pain killers medications, 
unavailability of palliative surgery services and the lack of skilled staff to provide this 
crucial type of care and shortage of training about palliative care for the staff. In 
addition to that there is absent of psychological and emotional support in hospitals it is 
almost provided by families and friends. 
Referral system: referral system (internally and externally) facing many challenges that 
decrease the quality of breast cancer services provided to patients, the internal referral 
system between the health care facilities suffer from poor communication and coordination 
between the teams involved in the breast cancer management that leads sometimes to 
confusion and misunderstanding between them and the result is the delay in breast cancer 
patients diagnosis. Moreover, external referral is crucial sometimes due to deficiency in 
diagnostic facilities as PET scan or the treatment options is unavailable as radiotherapy, 
which leaves no chance for the health care providers and the patients to be referred outside 
Gaza which increase the burden on both the patients and the MOH. 
Quality of care and follow up: the quality of care and follow up for breast cancer patients 
are fluctuated which based on the hospitals, facilities, available treatment ,qualified staff 
and the patients themselves, most of burden of follow up falls on oncology departments 
just. Moreover there is no specific criteria or policy to follow and evaluate the quality of 
care provided for breast cancer patients. 
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5.2 Recommendations  
5.2.1 Health Workforce 
 Increase the number of experts in oncology by giving advanced courses in 
oncology in Gaza or outside Gaza. 
 Advertise for scholarships with full coverage for the scarce specialties such as, 
oncology, pathology, onco-surgery and palliative care.  
  Delay the retirement period for specialties suffer from scarcity. 
 Activate in service education in regular pattern for health staff in oncology 
department to be updated and increase the quality of care provided to the patients.  
5.2.2 Services delivery 
 Developing a plan to build a national cancer center, it could be financed through 
national and international charitable organizations with coordination with MOH. 
 The researcher suggests some rules for hospitals and health staff who are working 
in oncology departments which will help in service delivery for the patients which 
include: 
o  Make a follow up appointments.  
o Define a specific number of patients to be checked by each doctor each day. 
o Define visiting time.  
o Follow up for sanitation of departments by infection control committee. 
o Preventing smoking in hospitals, providing some air conditioning sets and 
removing the electrical generator in Rantisi specialized hospital far from the 
oncology departments. 
5.2.3 Health information system and research 
 Establishing cancer research center and a national committee for health and cancer 
research and conducting additional research in breast cancer related topics.  
 Encouragement of health staff, local universities, and other institutions to conduct 
relevant studies and researches related to cancer control and gaps areas. 
 The researcher also suggests to conduct a periodic and regular auditing for patient's 
medical records and reports, and to the collected data techniques and how it be 
entered, managed and analyzed. 
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 Train the entire registry personal and unify the registration procedures using the 
ICD-O3 classification and train doctors about how to use it to help in classification 
and management of cancer. 
 Developing a plan to establish E cancer system, it could be financed through 
charitable organizations with coordination with MOH for easy access to patients 
files and prevent data loss. 
5.2.4 Leadership and Governance 
 Improvement of the breast cancer control strategy in the Gaza Strip and modifying 
its underperformance and define the weakness points, starting by sharing it between 
the stakeholders and policy makers with wide dissemination of it within the 
country.  
 The researcher suggest that cancer should be from the MOH and other policy 
makers first priorities because its burden affect multi aspects of the patient, 
government and the community.  
 Establish and reviewing the existed guidelines and protocols for breast cancer 
control in Gaza. 
5.2.5 Breast cancer management  
 Enforce the role of primary health care in controlling breast cancer through 
prevention and screening activities.  
 Sharing primary health care with palliative care.  
 Starting a broad health education program in the educational institution. 
 Activate community based activities to increase people awareness about breast 
cancer, how to prevent it and how to make self-examination and the importance of 
screening.  
 Establishment of specific department for palliative care. 
 The reactivation and support of other cancer organizations and institutions which 
can play vital roles in reducing the suffering of breast cancer patients.  
 Regular monitoring of patients perspectives and regular feedback about the breast 
cancer care services and quality provided to them through meetings, routine data 
collection, reporting, patients satisfaction questionnaires and interviews.  
  Develop a plan for regular trainings and advanced courses for health staff who are 
included in breast cancer management about the proper communication skills, 
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emotional supportive for breast cancer patients and to be updated about the newest 
in breast cancer management. 
5.2.6 Recommendation for further research 
 Breast cancer researchers and MOH should make an integrated studies that help in 
providing evidence based data about causes factors of breast cancer across the life, 
in addition to the development of creative prevention and diagnosis approaches that 
are applicable and accessible for all patients. 
 Establishing and enhancing a special center for health research in addition to 
conduct additional research in breast cancer management related topics. 
 Motivate researchers working in oncology departments, health programs, local 
universities, and other institutions to conduct studies related to breast cancer 
management gaps and barriers to control it and to decrease its burden.  
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Annexes 
Annex (1): Palestine Map  
 
Source: (PCBS, 2017) 
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Annex (2): Distribution of Gaza Strip Governorates 
 
Source: (PCBS, 2010) 
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Annex (3): Distribution of available rooms and beds 
Daily Care Ward Inpatient Ward 
Hospital Name 
 No. of Beds 
No. of 
Rooms 
No. of Beds No. of Rooms 
    Al-Rantisi Hospital * 
    European Gaza Hospital 
    Other hospitals 
    Total 
*Temporary place 
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Annex (4): Distribution of human resources 
Hospital name : 
 
Categories  
No of Full 
time 
No of Part 
time 
No of scholars 
abroad  
No of volunteers  
M F M F M F M F 
Oncologist         
Nurses         
Surgeons         
Radiologists         
Pathologists         
Nutritionist         
Others          
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Annex (5): Distribution of diagnostic equipment and facilities  
Hospital 
name  
 
Facilities 
status 
No of 
facilities 
No of 
Working 
facilities 
No of 
facilities 
No of 
Working 
facilities 
No of 
facilities 
No of 
Working 
facilities 
Total 
cases 
/ 
month 
Imaging 
X-ray 
 
       
Ultrasound        
MRI        
CT scan        
PET scan        
Gamma 
Camera 
       
Linear 
accelerator 
       
Basic lab tests 
CBC        
Chemistry        
Tumor 
markers 
       
Diagnostic and Preventive tools 
Mammogram        
Fluoroscopy        
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Annex (6): Completeness of breast cancer patients medical files  
Breast cancer patients medical records evaluation questionnaire 
Serial Number: 
Member name: DOB: Member ID: 
Provider name: 
Reviewer: Date: 
The Medical Record : 
1. Demographic characteristics: 
Each page within the Medical Record contains the patient‘s name 
      
0 1 2 3 4 5 
Each page within the Medical Record contains the Patient‘s ID number  
      
0 1 2 3 4 5 
Each page within the Medical Record contains the Patient‘s age 
      
0 1 2 3 4 5 
Each page within the Medical Record contains the Patient‘s DOB 
      
0 1 2 3 4 5 
Each page within the Medical Record contains the Patient‘s Gender 
      
0 1 2 3 4 5 
Each page within the Medical Record contains the Patient‘s address 
      
0 1 2 3 4 5 
Each page within the Medical Record contains the Patient‘s home telephone number(s)   
      
0 1 2 3 4 5 
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Each page within the Medical Record contains the Patient‘s marital status 
      
0 1 2 3 4 5 
 
2. Medical record characteristic: 
Patient‘s chief complaint or purpose for visit is clearly documented. 
      
0 1 2 3 4 5 
Appropriated professional diagnoses are recorded. 
      
0 1 2 3 4 5 
Plan of diagnosis: diagnostic tests : laboratory, radiology and pathology are listed for each 
visit 
      
0 1 2 3 4 5 
All entries in the medical record contain the author‘s identification.  
      
0 1 2 3 4 5 
All entries in the medical record are dated.    
      
0 1 2 3 4 5 
Is the record an Electronic Medical Record (EMR)? 
      
0 1 2 3 4 5 
Relevant hospital discharge summaries are included with the medical record.  
      
0 1 2 3 4 5 
If a consultation is requested, there is a note from the consultant in the record. Consult 
reports reflects practitioner‘s review with initials or signature.  
      
0 1 2 3 4 5 
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3. Medications Record :  
Plan of treatment: medications are listed for each visit 
      
0 1 2 3 4 5 
Plan of action and treatment are consistent with diagnosis. 
      
0 1 2 3 4 5 
A medication record includes dosages, routes of intake and dates for initial and refill 
prescriptions.  
      
0 1 2 3 4 5 
Discussion of medication side effects and symptoms are reviewed with the member and 
documented.  
      
0 1 2 3 4 5 
Allergies and Adverse Reactions are prominently noted in the record. Prominently noted on 
the front of the chart or inside the front cover of the chart or on a designated problem list or 
medication page or at the time of each office visit.  
      
0 1 2 3 4 5 
 
4. The history and physical exam  
Family history - including medical history of parents and/or sibling(s) 
      
0 1 2 3 4 5 
Psychosocial history 
      
0 1 2 3 4 5 
Surgical history - including serious accidents, injuries, operations. 
      
0 1 2 3 4 5 
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Significant illnesses and medical conditions are indicated on the problem list  
      
0 1 2 3 4 5 
A comprehensive review of systems with an assessment of presenting complaints (as 
applicable).  
      
0 1 2 3 4 5 
 
5. Breast cancer related characteristics 
Does the morphology (histopathology) of the cancer mentioned? 
      
0 1 2 3 4 5 
Does the behavior (aggressive- metastasis) mentioned? 
      
0 1 2 3 4 5 
Does the file contain a clear grading system for the cancer? 
      
0 1 2 3 4 5 
Does laterality mentioned? 
      
0 1 2 3 4 5 
Does the staging of the cancer mentioned clearly? 
      
0 1 2 3 4 5 
6. Chemotherapy record 
Chemotherapy treatment plan request model has a clear diagnosis 
      
0 1 2 3 4 5 
Chemotherapy treatment plan model has a clear weight and height for the patient 
      
0 1 2 3 4 5 
 
135 
 
Chemotherapy treatment plan model has a clear body surface area 
      
0 1 2 3 4 5 
 Chemotherapy plan regimen table in the request is filled  
      
0 1 2 3 4 5 
Chemotherapy regimen plan has a clear author‘s identification 
      
0 1 2 3 4 5 
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Annex (7): Focus group questions  
 Target hospital  Focus group No. 
 Duration   Date  
 Facilitator name  Reporter name 
1. What do you know about your disease, and what are the sources of your knowledge 
about it? 
(Prompt: educational sessions, family history, other female experience, breast self-
examination, clinical examination, and screening)   
2. Please explain your journey to reach breast cancer services in Gaza strip? 
 (Prompt: accessibility, affordability, obstacles, governmental hospitals, private 
clinics, primary health care, NGO's) 
3. How was your process of diagnosis? 
 (Prompt: screening, place of diagnosis, availability of diagnostic facilities)  
4. What is your impressions about the staff who are providing breast cancer care for you? 
(Prompt: Doctors, Nurses, Pharmacists, lab technicians and administrators) 
5. Please, discuss your type of treatment after you diagnosed of breast cancer (Prompt: 
surgical, hormonal, chemotherapy, radiation)? Discuss your feelings after obtaining 
treatment in your health? (Prompt : Physical ,Emotional , Psychological, Social) 
6.  Explain your feedback about your treatment and procedures were performed? 
7.  Explain your experience of referral internally (between hospitals and clinics) or 
abroad?  
8. Please explain to me your opinion about hospital building design (outpatient, 
inpatient) departments? 
(Prompt: Privacy, Comfortability, Cleanliness, Ventilation) 
9. Finally, please describe your impression about the provided services during the 
journey of diagnosis and treatment? 
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Annex (8): Key informants questions  
 Key informant name   KII No. 
 Position   Duration  
 Reporter name   Date 
 Facilitator name 
1. Do you feel that the magnitude of breast cancer in Gaza strip is changing?  
(Prompt: Incidence, prevalence, morbidity, mortality)  
2. Please, describe your organization roles for breast cancer patients care? 
(Prompt: Diagnosis, treatment, control)  
3. Can you tell me about breast cancer screening programs in Gaza? 
(Prompt: education, detection, role of your organization)  
4. What about treatment of breast cancer in Gaza strip?(Prompt: Surgery, chemotherapy, 
availability of medications, number of available services) 
5. Please, what is your opinion about the process of internal referrals (between the 
facilities)? And what about referral abroad? 
(Prompt: obstacles, causes of referral, waiting time) 
6. What do you think about the quality of care that breast cancer patients received in Gaza 
strip? (Prompt: good vs bad and why?) 
7. Please give me your impressions about the current buildings where breast cancer 
patients care are provided? (Prompt: Suitable, Privacy, Comfortability, Cleanliness, 
Ventilation)  
8. Please, tell me about the availability of information and research about breast cancer in 
Gaza strip? (Prompt: health information system, sources of data, up to date information …) 
9. Please describe breast cancer diagnosis and treatment process obstacles in Gaza strip? 
(Prompt: accessibility, affordability, financial, lack of resources, medications 
deficiency, protocols referral process) 
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Annex (9): Helsinki committee approval 
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Annex (10): An agreement letter from MOH hospital general administration 
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Annex (11): Distribution of human resources 
Categories 
Shifa 
hospital 
European 
Gaza 
Hospital 
Rantisi 
hospital 
Total 
Al- Hayat 
hospital
1 
M F M F M F M F M F 
Oncologists - - 2 1 4 - 6 1 4 (3)* - 
Surgeons 42 1 19 - - - 61 1 (6)* - 
GPs - - - (1)* - 1 - 1(1)* (6)* - 
Nurses - - 16 14 14 14 30 28 (6)* (6)* 
Radiologists 5 3 5 1 3 - 13 4 (1)* - 
Pathologists 3 1 - 1 - - 4 1 (2)* - 
Psychosocial - - - - - 1 - 1 (2)* - 
Nutritionist - - - - - - - - (1)* (1)* 
* Part time 
1: Not opened yet 
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Annex (12): Distribution of diagnostic facilities (Radiology techniques): 
Hospital 
Radiology techniques 
X-ray US MRI 
CT 
scan 
PET 
scan 
Gamma 
camera 
Linear 
accelerator 
Governmental hospitals 
Abu Yousef Al-
Najjar hospital 
3 1 0 0 0 0 0 
Al-Aqsa hospital 2 4 (2) 1 0 1 0 0 0 
Shifa hospital 1 6 (5) 1 2 (1) 1 3 (1) 1 2 (1) 1 1 (0) 1 1 (0) 1 
European Gaza 
hospital 
2 2 1 1 0 0 0 
Indonesian hospital 1 (0) 1 2 0 1 0 1 0 
Nasser hospital 2 2 0 1 (0) 1 0 0 0 
Rantisi specialized 
hospital 
1 1 0 1 0 0 0 
Private hospitals and centers 
Ajjour center 0 2 0 0 0 0 0 
Al-Hayat hospital 1 2 0 1 0 0 0 
El-Helou hospital 1 3 0 1 0 0 0 
Gaza scan center 1 1 0 1 0 0 0 
Palestinian German 
center 
1 0 0 0 0 1 0 
Semi & Non-governmental hospitals and centers 
Al-Ahli hospital 1 3 0 0 0 0 0 
Al-Awda hospital 4 4 0 0 0 0 0 
Al-Quds hospital 2 4 1 1 0 0 0 
Patient‘s friend 
society 
1 3 0 0 0 0 0 
Public aid hospital 1 2 0 1 0 0 0 
Red Crescent society 1 1 1 1 0 0 0 
Total 26 43 5 14 0 1 1 
 (-)
1
: No of working devices 
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Annex (13): Distribution of diagnostic facilities (laboratory techniques): 
Hospitals 
Laboratory techniques 
CBC Chemistry Tumor marker 
Governmental hospitals 
Abu Yousef Al-Najjar 
hospital 
2 2 (1)1 0 
Al-Aqsa hospital 4 (3)1 3 1 
Shifa hospital 9 2 0 
European Gaza hospital 4 2 0 
Indonesian hospital 4 5 0 
Nasser hospital 3 3 0 
Rantisi specialized hospital 3 2 0 
Private hospitals and centers 
Ajjour center 0 0 0 
Al-Hayat hospital 1 1 1 
El-Helou hospital 2 2 1 
Gaza scan center 0 0 0 
Palestinian German center 0 0 0 
Semi & Non-governmental hospitals and centers 
Al-Ahli hospital 2 2 0 
Al-Awda hospital 2 1 1 
Al-Quds hospital 2 3 1 
Patient’s friend society 2 2 1 
Public aid hospital 2 4 1 
Red Crescent society 3 2 1 
Total 45 36 8 
 
(-)1: No of working devices 
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Annex (14): Distribution of rooms and beds in oncology departments in Gaza Strip  
Hospital 
Inpatient care 
ward 
Day care ward 
 
 
 
Comments 
No. of 
rooms 
No. of 
beds 
No. of 
rooms 
No. of 
beds & 
chairs 
Shifa hospital 0 0 0 0 Under construction 
Rantisi hospital 12 30 2 20 Temporary place 
European Gaza 
hospital 
7 30 4 29  
Total 19 60 6 49  
Al- Hayat Hospital 9 19 1 14 Not opened yet 
 
Annex (15): Variations of completeness ICD-O3 between hospitals: 
Hospital name Missed ICD-O3 
Shifa Hospital 40 % 
Rantisi Specialized 
Hospital 
46 % 
European Gaza hospital 35 % 
All Hospitals 40 % 
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  بالموافقت على المشاركت فً الذراصت رٌضاثإشعار للم
 
 
 اٌظ١ذح اٌفبػٍخ 
  .. رؾ١خ ؽ١جخ ٚثؼذ
  دراطخ ػٕٛأٙب :٠مَٛ اٌجبؽش ثئعزاء 
  لمرٌضاث صرطان الثذي فً قطاع غزة " لعلاج " حقٍٍم الخذماث الصحٍت المقذمت
ٌمذ رُ اخز١برن ثظٛرح ػشٛائ١خ ٌٍّشبروخ فٟ ٘ذا اٌجؾش اٌذٞ ألَٛ ثٗ ٌٍؾظٛي ػٍٝ درعخ اٌّبعظز١ز فٟ اٌظؾخ 
  ِغّٛػخ ثؤر٠خ ػٍّب ثأْ :, اشززاوه ط١ىْٛ ِٓ خلاي اٌّشبروخ فٟ عبِؼخ اٌمذص أثٛ د٠ض  –اٌؼبِخ 
 الاشززان فٟ اٌذراطخ رطٛػٟ , ٠ؾك ٌه اٌمجٛي أٚ اٌزفغ. 
 لا ٠ٛعذ إعبثبد طؾ١ؾخ ٚأخزٜ خبؽئخ 
 ؤصز ػٍٝ اٌخذِبد اٌظؾ١خ اٌزٟ رزٍم١ٕٙب.إعبثبره طزىْٛ فٟ ِٛػغ طز٠خ ربِخ ٌٚٓ ص 
 اٌظز٠خ ِىفٌٛخ لا داػٟ ٌٍزؼز٠ف ثبطّه. 
 أغزاع اٌذراطخ ٌٍجؾش اٌؼٍّٟ فمؾ. 
 زغزق اٌّغّٛػخ اٌجؤر٠خ ِب ٠مبرة ِٓ طبػخ إٌٟ طبػخ ٚٔظف.طزظ 
 اٌّٛاطلاد ِىفٌٛخ ٌّٓ ٠زغت ثبٌّشبروخ 
 
 
 
 
 
 الباحث: مؤمه خلٍل عٍذ
 كلٍت الصحت العامت  
 أبو دٌش –جامعت القذس 
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 إشعار للخبراء بالموافقت على المشاركت فً الذراصت
 
 
  ح /ح اٌفبػً/اٌظ١ذ
  .. رؾ١خ ؽ١جخ ٚثؼذ
  اٌجبؽش ثئعزاء دراطخ ػٕٛأٙب : ٠مَٛ
  لمرٌضاث صرطان الثذي فً قطاع غزة " لعلاج  " حقٍٍم الخذماث الصحٍت المقذمت
عبِؼخ اٌمذص  –ٌمذ رُ اخز١برن ٌٍّشبروخ فٟ ٘ذا اٌجؾش اٌذٞ ألَٛ ثٗ ٌٍؾظٛي ػٍٝ درعخ اٌّبعظز١ز فٟ اٌظؾخ اٌؼبِخ 
  اوه ط١ىْٛ ِٓ خلاي اٌّشبروخ فٟ ِغّٛػخ ثؤر٠خ ػٍّب ثأْ :, اشزز ثؼذ اٌّشبٚرح ِغ اصٕ١ٓ ِٓ اٌخجزاء أثٛ د٠ض
 الاشززان فٟ اٌذراطخ رطٛػٟ , ٠ؾك ٌه اٌمجٛي أٚ اٌزفغ. 
 لا ٠ٛعذ إعبثبد طؾ١ؾخ ٚأخزٜ خبؽئخ 
 إعبثبره طزىْٛ فٟ ِٛػغ طز٠خ ربِخ ٌٚٓ صؤصز ػٍٝ اٌخذِبد اٌظؾ١خ اٌزٟ رزٍم١ٕٙب. 
 .اٌظز٠خ ِىفٌٛخ  
 فمؾ. أغزاع اٌذراطخ ٌٍجؾش اٌؼٍّٟ 
 ِب ٠مبرة ِٓ طبػخ إٌٟ طبػخ ٚٔظف. اٌّمبثٍخطزظزغزق  
 
 
 
 
 
 الباحث: مؤمه خلٍل عٍذ
 كلٍت الصحت العامت
 أبو دٌش –جامعت القذس 
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 cibarA ni tcartsbA
 : مؤمه خلٍل عٍذ الباحث إعذاد
 إشراف : أ.د. ٌحٍى عابذ
 د . خالذ ثابج            
 
 ملخص الدراسة:
ؽ١ش أٔٗ لا ساي ٠ٙذد ؽ١بح ِئبد  اٌضذٞ أوضز أٔٛاع اٌظزؽبْ ش١ٛػبً فٟ فٍظط١ٓ ٚفٟ وً اٌؼبٌُ أ٠ؼبً ٠ؼزجز طزؽبْ 
فٟ ِمذِخ أٔٛاع اٌظزؽبْ اٌزٟ رظ١ت طزؽبْ اٌضذٞ ٠أرٟ  ؽ١ش .ُظ١ذاد فٟ وً ػبَ ِٓ وً دٚي اٌؼبٌالألاف ِٓ اٌ
جخ الاٌٚٝ زر٠ؾزً اٌّ لا ٠شاي ثأْ طزؽبْ اٌضذٞ. رف١ذ رمبر٠ز ٚسارح اٌظؾخ فٟ لطبع غشح عّ١غ دٚي اٌؼبٌُإٌظبء فٟ 
ٌذٌه فئْ رم١١ُ اٌخذِبد اٌظؾ١خ اٌّمذِخ ٌؼلاط ِز٠ؼبد طزؽبْ اٌضذٞ فٟ لطبع غشح رٍؼت دٚراً ِّٙب ًاٌظ١ذاد  ث١ٓ
 ٚوشف ٚػلاط  ِٚزبثؼخ طزؽبْ اٌضذٞ. ٚأطبط١ب ًفٟ ِٕغ
مذِخ ٌؼلاط ِز٠ؼبد طزؽبْ اٌضذٞ فٟ لطبع غشح رؼزجز ٘ذٖ اٌذراطخ الأٌٟٚ ِٓ ٔٛػٙب ٌزم١١ُ اٌخذِبد اٌظؾ١خ اٌّ
ؽ١ش رظٙز أّ٘١خ ٔزبئظ ٘ذٖ اٌذراطخ فٟ رظٍ١ؾ اٌؼٛء ػٍٝ رؾظ١ٓ فؼبٌ١خ إٌظبَ اٌظؾٟ فٟ ِٕغ ِٚٛاعٙخ ٚػلاط 
فٟ رشخ١ض  رٙبءِٚذٜ وفبٌٍّز٠ؼبد طزؽبْ اٌضذٞ ِٓ خلاي رمذ٠ُ ِؼٍِٛبد ٚ ث١بٔبد ػٓ اٌخذِبد اٌظؾ١خ اٌّمذِخ 
 ٚػلاط اٌّزع.
 الهدف من الدراسة:
اٌٙذف اٌؼبَ ِٓ اٌذراطخ ٘ٛ رم١١ُ الاطززار١غبد اٌّزبؽخ ٚاٌخذِبد اٌظؾ١خ اٌزٟ رخذَ ِز٠ؼبد طزؽبْ اٌضذٞ 
ثبلاػبفخ اٌٟ رؾذ٠ذ اٌفغٛاد ٚاٌّؼ١مبد اٌزٟ رؤصز ػٍٝ رمذ٠ُ اٌخذِبد اٌظؾ١خ اٌّمذِخ ٌؼلاط ِز٠ؼبد طزؽبْ اٌضذٞ 
 فٟ لطبع غشح.
 :منهجية الدراسة
ٍِف ؽجٟ ٌّز٠ؼبد طزؽبْ اٌضذٞ فٟ لطبع غشح   021خ وّ١َخ ٔٛػ١خ, ؽ١ش أْ اٌغشء اٌىّٟ اشزًّ ػٍٝ رم١١ُ اٌذراط
) ٚاٌّظغٍ١ٓ فٟ اٌّزوش اٌٛؽٕٟ 6102-7102ِٓ ِظزشفٝ اٌشفبء ٚاٌزٔز١ظٟ ٚالأٚرثٟ رُ رشخ١ظُٙ خلاي اٌفززح (
ٌزطذ ؽبلاد الأٚراَ ٚػ١بداد الأٚراَ فٟ لطبع غشح ٚاشزًّ أ٠ؼبً ػٍٝ صلاصخ لٛائُ فؾض رشًّ( اٌطٛالُ اٌطج١خ 
اٌّٛعٛدح فٟ ػ١بداد ٚألظبَ اٌّمذِخ ٌٍخذِبد اٌظؾ١خ ٌّز٠ؼبد طزؽبْ اٌضذٞ فٟ لطبع غشح, ػذد الأطَزح ٚاٌغزف 
ٟ ػذد الأعٙشح اٌزشخ١ظ١خ اٌّٛعٛدح فٟ لطبع غشح اٌزٟ رظزخذَ فٟ اٌزشخ١ض اٌّجىز ِزػٝ الأٚراَ, ثبلإػبفخ إٌ
ٚاٌىشف ػٓ طزؽبْ اٌضذٞ, أِب اٌغشء إٌٛػٟ فمذ اشزًّ ػٍٝ ػًّ ِغّٛػز١ٓ ثؤر٠ز١ٓ ٌّز٠ؼبد طزؽبْ اٌضذص فٟ 
اٌظؾ١خ ٌّز٠ؼبد  لطبع غشح, ثبلإػبفخ إٌٟ ػًّ ِمبثلاد ِغ خجزاء ِٚخزظ١ٓ ِشبرو١ٓ فٟ رػب٠خ ٚرمذ٠ُ اٌخذِبد
 طزؽبْ اٌضذٞ.
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 أهم النتائج :  
اٌزٟ رؼ١ك ػٍّ١خ ِؼبٌغخ طزؽبْ اٌضذٞ فٟ لطبع غشح اثزذاَء ِٓ  زؾذ٠بدوشفذ ٘ذٖ اٌذراطخ ػٓ ػذد ِٓ اٌفغٛاد ٚاٌ
شىٜٛ اٌّز٠غ, ِزؽٍخ اٌزشخ١ض, ٚطٛلا َإٌٝ ؽزق اٌؼلاط اٌّزبؽخ. ِؼظُ اٌفغٛاد ٚاٌّؼ١مبد رزّضًَ فٟ ٚعٛد ٔمض 
), , ٚأخظبئ١ٛ اٌزغذ٠خ١ٛ ٔفظ١ْٛئاٌىٛادر اٌجشز٠ٗ ح خبطخَ (أخظبئ١ٛ الأٚراَ, أخظبئ١ٛ ػٍُ الأِزاع, أخظبفٟ ػذد 
اٌزٟ رزؼٍك  ِٕبطجخ ٌّز٠ؼبد طزؽبْ اٌضذٞ ٚاٌزٟ رفزمز إٌٝ اٌخظٛط١خ ٚاٌزاؽخ ثبلإػبفخ ٌؼذَ ٚعٛد ِجب  ْ 
رظزخذَ فٟ رشخ١ض طزؽبْ اٌضذٞ. أ٠ؼبً ٠ؼبٟٔ , ٚإػبفخ ٌذٌه ٚعٛد ٔمض فٟ اٌّؼذاد ٚالادٚاد اٌزٟ ثبٌّز٠ؼبد
 اٌّزػٝ ِٓ الإٔزظبر ٌٛلذ ؽٛ٠ً ٌزٍمٝ اٌخذِخ.
ػٓ ٚعٛد ثؼغ اٌفغٛاد فٟ ٔظبَ رؾٛ٠ً اٌّزػٝ  ث١ٓ اٌّزاوش ٚاٌّظزشف١بد اٌظؾ١خ طٛاًء  ٚعذد اٌذراطخ أ٠ؼبً 
ػذَ ٚعٛد أٞ ثزٔبِظ دائُ داخً أٚ خبرط لطبع غشح, أِب ثبٌٕظجخ ِب ٠خض خذِبد ِٕغ طزؽبْ اٌضذٞ, رج١َٓ ػٓ 
ِٕٚزظُ ػذا خذِبد اٌىشف اٌّجىز. خذِبد رشخ١ض طزؽبْ اٌضذٞ رٛاعٗ اٌؼذ٠ذ ِٓ اٌزؾذ٠بد اٌزٟ رؼ١ك ػٓ اٌىشف 
اٌّجىز ٌظزؽبْ اٌضذٞ. ثؼغ الأدٚاد اٌزشخ١ظ١خ اٌؼزٚر٠خ رٛعذ ثشىً ِؾذٚد عذا أٚ غ١ز ِزبؽخ ػٍٝ الإؽلاق ِضً 
ٌّظؼ اٌّمطؼٟ ٚغ١ز٘ب ِٓ الأعٙشح, ثبلإػبفخ ٌذٌه ٠ٛعذ ػٛاًِ أخزٜ رؤصز ػٍٝ أعٙشح اٌزٔ١ٓ اٌّبغٕط١ظٟ ٚأعٙشح ا
. أِب ثبٌٕظجخ ٌخ١براد ػٍّ١خ رشخ١ض اٌّزع وٕظجخ ٚػٟ اٌّزػٝ, ػٛاًِ صمبف١خ ٚدٚر اٌطج١ت ٚإٌظبَ اٌظؾٟ أ٠ؼب
بَ ػٍٝ عٛدح ٚوّبي طٍجاٌزٟ رؤصِز  اٌؼلاط ٌّز٠ؼبد طزؽبْ اٌضذٞ فٟ لطبع غشح فٟٙ رٛاعٗ أ٠ؼبَ اٌؼذ٠ذ ِٓ اٌفغٛاد
اٌزػب٠خ اٌظؾ١خ وٕمض اٌؼلاط اٌّزىزر ٚٚعٛد أمطبع فٟ اٌؼلاعبد اٌى١ّ١بئ١خ اٌؼزٚر٠خ ٚأ٠ؼب ػذَ ٚعٛد اٌؼلاط 
الإشؼبػٟ فٟ لطبع غشح. أِب ثبٌٕظجخ ٌٕظبَ اٌّؼٍِٛبد, ٔظبَ رطذ الأٚراَ ثبلإػبفخ إٌٝ اٌظغلاد اٌطج١خ اٌخبطخ 
اٌؼذ٠ذ ِٓ اٌزؾذ٠بد, وً اٌؼٛاًِ اٌظبثمخ رؤصز طٍج١بَ ػٍٝ ػٍّ١خ ػلاط ِزع  ثبٌّز٠ؼبد فٟٙ أ٠ؼبد رٛاعٗ أ٠ؼب
 طزؽبْ اٌضذٞ ٚأ٠ؼب ػٍٝ عٛدح اٌخذِبد اٌظؾ١خ اٌّمذِخ ٌّز٠ؼبد طزؽبْ اٌضذٞ.
 :أهم التوصيات
 رٛطٟ ٘ذٖ اٌذراطخ ػٍٝ اٌزبٌٟ :
 ثبٌشىً اٌظؾ١ؼ. ىشف اٌّجىز ػٕٗ ٚػٓ أٌ١خ ػلاعٗاٌػًّ خطخ ٚط١بطبد ٌّٕغ ؽذٚس طزؽبْ اٌضذٞ ٚ 
رٛظ١ف أؽجبء فٟ لظُ الأٚراَ ٚرذر٠جُٙ ع١ذاَ ٌزمٍ١ً اٌؼتء ػٍٝ أؽجبء الأٚراَ ثبلإػبفخ إٌٝ أخظب٠١١ٓ  
 .ٚأخظبئ١١ٓ فٟ ػٍُ اٌزغذ٠خ ٔفظ١١ٓ ٚاخظبئ١١ٓ فٟ ػٍُ الأِزاع
خذ ثؼ١ٓ الإػزجبر اٌخظٛط١خ الأص ٌٍزؼبًِ ِغ ِزػٝ اٌظزؽبْ ِغ بػًّ خطخ ٌجٕبء ِزوش أٚراَ خ 
ٌزاؽخ ٌٍّزػٝ أٚ اٌؼًّ ػٍٝ رؾظ١ٓ اٌّجبٟٔ اٌؾبٌ١خ ِٓ خلاي رؾظ١ٓ اٌزٙٛ٠خ ٚرٛف١ز اٌزاؽخ ٚإٌظبفخ فٟ ٚا
 اٌّجبٟٔ
ػًّ رذر٠ت ٌٍطٛالُ اٌطج١خ ػٍٝ اٌؼلاط اٌزظج١زٞ ٚو١ف١خ اطزخذاِٗ ِغ اٌّزػٝ ٚػًّ خطخ ٌٛعٛد ِزوش  
 خبص ٌٍؼلاط اٌزظج١زٞ ٌٍّزػٝ  فٟ لطبع غشح.
 .ِٚزوش الأٚراَ ػٍٝ اٌزظٕ١ف اٌؼبٌّٟ ٌلأٚراَ رذر٠ت اٌطٛالُ اٌطج١خ 
 خ إػبف١خ ػٓ ػٍّ١خ ػلاط ِزع طزؽبْ اٌضذٞ ٚو١ف١خ اٌؾذ ِٕٗ.١ػًّ ثؾٛصبد ِظزمجٍ 
